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 Degeneration of the intervertebral disc (IVD) is directly associated with the leading causes 
of disability in the industrialized world, neck and back pain. Current treatments focus on pain relief 
and mitigating symptoms rather than addressing the underlying source of pain, which in the 
majority of cases stems from radiculopathy. Strategies from tissue engineering have been 
introduced for the past 20 years to create biological treatments that can replace the pathologic 
tissue with a biomimetic implant that possesses regenerative potential. The current state of the 
field of IVD tissue engineering includes strategies for repair and replacement of individual 
components of the disc, the nucleus pulposus (NP) and annulus fibrosus (AF), but only a handful 
of technologies for total disc replacement (TDR) have shown promise for clinical translation in 
vitro and in vivo.  
 Total disc replacement with biological tissue-engineered IVDs (TE-IVDs) has only been 
tested in small animal models to date. This dissertation sought to address the need for a larger 
animal model that is clinically relevant to humans by demonstrating the feasibility of the canine 
cervical spine as a pre-clinical model of TDR with TE-IVDs. In this work, the focus was to 
investigate the appropriate implantation conditions for TDR in the cervical spine and the ability of 
TE-IVDs to integrate host tissue, mature, and restore function in vivo (Chapter 2). TE-IVDs for 
the canine cervical spine were developed as composite structures made of cell-seeded alginate NP 
surrounded by circumferentially aligned cell-seeded collagen AF. This in vivo study was the first 
to demonstrate that stably implanted TE-IVDs produced integrated tissues that resemble native 
IVD structure with viable cells in a canine pre-clinical model of TDR. 
  Despite the favorable outcomes in stably implanted TE-IVDs, new challenges were 
identified in the canine model that had not been encountered in rodents before. Segment instability 
caused 50% of TE-IVDs to displace out of the disc space upon implantation and scaled-up TE-
IVDs had yet to match native-like properties pre-operatively. The instability issue was addressed 
(chapter 3) by investigating a combined treatment approach of TE-IVD implantation with a 
resorbable plating system proposed to assist in transferring compressive loads of motion segments 
along the vertebral bodies and retain TE-IVD implants in the disc space. To improve potential 
functionality of TE-IVDs, the study described in chapter 4 leverages the tunable AF region of the 
TE-IVDs to investigate the potential of high-density collagen as AF scaffolds and assess the effects 
of initial scaffold concentration and cell seeding density with hMSCs on the remodeling of the 
resultant composite TE-IVD structure. Collectively, these studies offered promising alternatives 
to promote the success of TDR in a pre-clinical animal model with TE-IVDs.
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CHAPTER 1  
Introduction 
Overview of Intervertebral Disc 
1.1.1 Biological structure and function 
 The intervertebral disc is a fibrocartilaginous joint structure located between the 
vertebral endplates of the spinal column. The intervertebral disc (IVD) is responsible 
for allowing spine flexibility and a range of motion with six degrees of freedom, while 
simultaneously assisting the vertebral bodies (VBs) in protecting the spinal cord and 
branches of peripheral nerves that stem from the spine (Fig. 1.A). The human spinal 
column contains 23 IVDs, categorized by their location within the spine and by their 
adjacent VBs. The 6 IVDs in the neck are known as cervical (e.g. C2/C3 is located 
between the axis vertebra C2 and the adjacent inferior vertebra C3). The thoracic region 
follows with 12 IVDs (T1/T2-T12/L1) from below the base of the neck to the middle 
back; then from the lower back to the sacrum, the lumbar region is extended with 5 
IVDs (L1/L2-L5/S1). Due to its characteristic avascular nature, absorption of nutrients 
in the IVD is limited to the top and bottom interfaces with the cartilaginous endplates 
(CEPs).1 Along with the CEPs, the VBs, and the surrounding ligaments and 
musculature, the IVD constitutes the functional motion segments of the spine. 
 The range of motion in these functional motion segments is known to vary 
considerably by level or location in the spine. The upper cervical segments are 
characterized by flexion-extension and over 80° of axial rotation at the C1/C2 level,2-3 
but the median range of motion of lower cervical segments remains between 5-15° of 
axial rotation and less than 5° of lateral bending. Flexion-extension bending moments 
are also predominant in segments C4 to C6, towards the middle of the neck. The 
thoracolumbar region has been shown to reach a median range of motion of up to 20° 
in axial rotation at the first thoracic motion segment T1/T2 and decrease to less than 5° 
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rotation at the lower segment levels from T10 to L5/S1. In flexion-extension the mid-
to-lower-thoracic segments T6 to T11 do not exceed 10°, but from T11/T12 to L4/L5 
the segments can range between 15 to 20°. Similarly, lateral bending range of motion 
exceeds 15° in the thoracolumbar region reaching up to 25° in the lower segments below 
T11.4 Although the range of motion in spinal segments differs across segment levels, 
varying geometrical parameters of the adjacent VBs give rise to these major differences, 
but the structural composition of the IVD is relatively consistent throughout the spine.  
 The IVD is a composite tissue comprised of three main tissue regions: the 
nucleus pulposus (NP), the annulus fibrosus (AF), and the CEPs that associate the disc 
with the adjacent vertebrae (Fig. 1.B). The NP consists of a soft gelatinous mesh of 
collagen fibrils, predominantly types I and II,5-6 to which chains of brush-like 
proteoglycans, mostly aggrecan and biglycan (GAGs) attach. These GAGs contain 
sulfates and uronic acid groups, to which their distinctive negative charges are 
attributed, and attract molecules of water to produce osmotic swelling of the NP. The 
AF consists of an oriented lamellar array of collagen fiber bundles, predominantly types 
I, II, and VI,7 that are circumferentially aligned around the NP and attached to the CEP 
and VB boundaries. The distribution of proteoglycans present in the AF varies radially 
with decreasing GAG content at the AF layers further away from the NP. The 
orientation of the collagen fibers at each lamella also varies in an angle-ply laminate 
fashion with respect to the radial distance from the NP. The laminate structure of the 
AF contains the swelling of the NP and directs diffusion of metabolites primarily 
through the CEP, where nutrients exchange occurs with the VBs. The AF also limits the 
radial bulge, allows distention, and rotation to facilitate mobility of the motion segment. 
A thin layer of hyaline cartilage ranging between 0.5 to 15 mm thick comprises the top 
and bottom CEPs.1 These CEPs provide a graded transition from the fibrocartilaginous 
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disc, rich in water, proteoglycans and collagen, to the mineralized (calcium-rich) 
vertebral bodies. 
 
Figure 1.1. A) Schematic of the location of the IVD in the spine with a cross-sectional 
view of the major structures surrounding the IVD that the motion segments protect. 
Image adapted from: https://medlineplus.gov/ency/images/ency/fullsize/19469.jpg. B) 
Representative image depicting the main regions NP and AF that comprise the IVD, and 
their predominant constituents of collagen and proteoglycans. Image adapted from 
Whatley et al.8 
 The NP and AF have distinct predominant cell types that guide the turnover and 
remodeling of the extracellular matrix (ECM), and maintain the overall health of the 
IVD. The NP contains chondrocyte-like cells that link with the collagen fibrils but 
remain with a round phenotype. On the other hand, the AF contains fibroblast-like cells 
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that align preferentially with the orientation of the collagen fibers at each lamella 
throughout the depth of the tissue. The NP cells are accustomed to a unique hypoxic 
environment and are scattered at 2 to 5 million cells/mL within the avascular matrix.9 
AF cells are densely distributed throughout the ECM at least at 9 million cells/mL and 
are mechanosensitive to tensile and compressive loads experienced in the tissue.8  
1.1.2 Tissue Development and organization 
 The specialized IVD structure derives from the natural and physiologic 
environment to which the primitive IVD tissues are exposed during embryonic 
development and their developmental pathways are dependent on the expression of 
several genes. Most IVD tissues are derived from mesenchymal origins. During tissue 
development, musculoskeletal tissues of the spine start out as mesenchyme from the 
mesoderm with cells embedded in a water-rich soft ECM that allows for free diffusion 
of metabolites. As the embryo matures, this water-rich soft ECM in the primitive spine 
region is exposed to a wide range of physical and biochemical cues that activate 
developmental pathways and promote cells to differentiate from chondrocyte-like 
phenotype to fibrochondrocyte-like phenotype. The physiological environment near the 
IVD is unique in that the vertebral bodies undergo ossification and surrounding 
ligaments develop a preferentially aligned structure, but the IVD tissues become 
organized in a composite manner. Furthermore, while the CEPs retain a cartilaginous 
phenotype, the NP and AF develop and mature differently. The NP is originated from 
the notochordal region of the embryo and its development is driven by the expression 
of Forkhead box A2, Brachyury, and Notochord homolog genes.10 The AF, VBs, and 
CEP stem from the segmented mesodermal layer surrounding the notochord called 
somites, which give rise to other musculoskeletal tissues such as skeletal muscles and 
tendons, and help direct peripheral nerve segmentation.11 A segment of these somites, 
the sclerotome, is instructed by the Sonic hedgehog factors and transforming growth 
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factor-beta to control the vertebral ossification process and form VBs, CEP, and AF.12-
13 After vertebrae proliferate from the sclerotome, notochordal cells die by apoptosis, 
although a varying number of notochordal cells remain in numerous mammalian 
species. 
 
Figure 1.2. The mesodermal axially oriented layer that surrounds the notochord during 
embryonic development gives rise to several vertebral motion segment tissues including 
VBs, CEP, and AF, while the NP derives from notochord. Image adapted from Cook et 
al.11  
1.1.3 Mechanical and biochemical properties of the IVD 
 The mechanical behavior of the IVD structure is relevant to assess the degree of 
health or disease of the disc because it is directly related to its biochemical constituents 
and composite structure. An estimated 70% of the dry weight of the IVD is comprised 
of collagen with decreasing concentration from the NP towards the outer region of the 
AF that ranges between 50-300 μg/mg wet tissue.5,14 Between 2-45% of the NP dry 
weight is constituted by non-collagenous proteins (e.g. elastin, fibrillins, adhesive 
glycoproteins such as fibronectin and laminin), while this ranges between 5-25% of the 
AF dry weight. These constituents are believed to assist collagen fibers in their 
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mechanical and ECM remodeling roles; for example, approximately 10% of the human 
IVD is comprised of elastin, which are believed to assist collagen fibers recover after 
deformation.5 Relative dry weight contents of GAGs in the IVD regions are estimated 
between 50-65% of the NP and 10-20% of the AF,7,15 with aggrecan as the predominant 
proteoglycan in the NP. The collagen network and GAGs in the ECM jointly resist 
compression of the IVD in the NP and provide tensile strength to the concentric fibers 
in the AF. 
 The IVD functions as a pressure vessel whereby swelling of the NP caused by 
the GAG-rich matrix maintains osmotic pressures as high as 2.3 MPa and water content 
between 70-90%,16-17 whereas the collagen fiber laminated AF provides the necessary 
boundary conditions to help distribute up to 80% of the compressive loads in the spine 
along the CEPs to the VBs.18-19 The material properties of each constituent region, NP, 
AF, and CEP have been extensively studied individually and in combination with their 
adjacent vertebrae as functional motion segments.20 Due to its biochemical composition, 
the IVD and, consequently, the spinal motion segments exhibit viscoelastic and biphasic 
mechanical behavior. The collagen fiber bundles and hydrated mesh that constitute the 
extracellular matrix are responsible for this time-dependent poroelastic mechanical 
response. The NP exhibits mostly isotropic behavior with a compressive stiffness of 3-
31 kPa, while the AF contains the NP due to its tensile modulus of 0.2-136 MPa and 
compressive modulus of 0.116-2.3 MPa.8 The ranges of mechanical properties vary 
according to testing modalities and condition of the tissues under study; however, the 
trends are consistent in that fibrous AF contains higher tensile properties than 
compressive and NP is measured in compression, under osmotic pressure, or in shear. 
Alterations to the composition and structure of the IVD due to disease or injury often 
leads to mechanical instability of the spine and further breakdown of the entire motion 
segment. 
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Degenerative Disc Disease 
1.2.1 Epidemiology and etiology of degenerative disc disease 
 Chronic pain of the back and neck are among the most prevalent causes of 
limited activity in people younger than 45 years old, the second most common reason 
for visits to the physician in the western world, and the third most frequent cause for 
surgical intervention.21-22 At least 80% of the population will experience neck or back 
pain in their lifetime. Nearly two-thirds of the world is affected by neck pain especially. 
Low back pain is estimated to cost society $100 billion annually and $11-17 billion in 
the US alone.23-27 Degenerative disc disease (DDD) has been linked as the leading cause 
of chronic pain of the spine.28-30. Although the specific etiology of DDD is not well 
known, the risk factors associated with high probabilities of suffering neck and back 
pain caused by DDD have been well documented. Diseases of the vasculature in which 
blood flow is compromised, individual habits such as smoking, and pathological 
metabolism such as in diabetes are highly correlated with affecting the nutrient supply 
to the already metabolically-challenged IVD.31-40 Environmental factors such as those 
affected by work-related activities and genetic predisposition have also been 
demonstrated to play a role in affecting natural ageing processes of the spine.31-36  
1.2.2 Mechanisms of disease progression 
 The progression of DDD has been associated with changes in the composition 
of its constituents driven by compromised diffusion of nutrients and accumulation of 
waste products. This, in turn leads to a loss of tissue hydration that results in a cascade 
of effects exacerbating the precarious disc nutritional state further. During disc 
degeneration, the ECM in the NP and AF is degraded and the IVD loses its physiological 
pressurization and swelling. The NP becomes dry and total number of viable cells 
declines, thereby reducing ECM turnover. Without pressure from the NP, AF fibers lose 
tension and organization, thus resulting in disc thinning and structural collapse. 
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Collagen fibrils in the AF are damaged, increasing the risks for tears and accelerating 
disc degeneration further.31,37 The CEP undergoes calcification characterized by the 
appearance of bone spurs and decreased diffusion of nutrients to the IVD. Furthermore, 
in the most severe cases of degeneration, narrowing of the foraminal canal space leads 
to impingement of the nerve roots that stem from the spinal cord and symptoms of 
radiculopathy and myelopathy. Other effects of this cascade of IVD degeneration 
include neovascularization, where blood vessels gain access to previously avascular 
regions, and disruption of the neural networks surrounding the outer AF and the CEP, 
thereby provoking an inflammatory response and excruciating pain.38-40 
1.2.3 Symptomatic characterization and clinical identification 
 Clinicians look for certain symptoms associated with radiculopathy, but due to 
the intermittence of discomfort in patients, the relationship between neck and back pain 
with radiological (abnormal) observations is relatively inconsistent.37 Due to these 
conflicts, factors such as medical history, neurological, and physical exams are used in 
conjunction with medical imaging. Neurological and physical exams are used to identify 
problems with limb movements and/or posture, which can help rule out extraspinal 
diseases. Certain symptoms typically associated with DDD can also be related to other 
non-degenerative spine problems. Initial diagnostics with radiographs help exclude 
scoliosis, spondylolisthesis, and fractures, among other spine ailments. The current 
standard diagnostic procedure is the low-pressure discography, albeit its interpretation 
remains controversial.41-42 The discography involves an injection technique by which 
the suspected pathologic disc is pressurized with an X-ray dye to assess the discomfort 
levels that the patient is sensitive to. Computed tomography (CT) scanning by itself 
does not help evaluate discogenic pain, but it can be used to rule out spondylolisthesis 
and/or osteophyte formation after DDD had long affected the disc space and disrupted 
the bony endplates.43 Although a discogram obtained under fluoroscopic guidance and 
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radiopaque dye is the most direct tool to diagnose disc degeneration,44 magnetic 
resonance imaging (MRI) can help determine whether the pain a patient experiences is 
derived from DDD. Employing MRI can help evaluate the hydration within the IVD by 
means of T2-weighted images, and observe potential pain inducing factors in the spinal 
canal and surrounding neural tissues. 
 T2 mapping with T2-MRI involves measuring the relaxation time decay of IVD 
tissues, which is related to the biochemical composition of the disc structures.45-48 A 
system for grading degeneration in IVD as evaluated via T2 mapping, namely the 
Pfirrmann grading, has been shown to provide reliable intra- and interobserver 
results.45,50 The Pfirrmann scale employs five grades to rank T2 signal intensity and disc 
morphology (Fig. 1.3): grades I and II are representative of normal discs, grade III discs 
display reduced T2 signal or dehydrated discs, and grades IV and V are often described 
by disc height loss and of other normal features. A grade III disc can be treated 
conservatively, while higher grades may require surgical intervention. 
 
Figure 1.3. Representative discograms of a disrupted L4-L5 disc (encircled in red) that 
reproduced clinical pain in patient as compared to adjacent healthy discs from a sagittal 
view (Left) and coronal view (Center); images adapted from Hasz 2012.44 IVDs 
representing levels of Pfirrmann’s grade (Right): from A to E correspond to grades I 
through V; image adapted from Lotz et al.45 
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Current and Proposed Treatments for Disc Degeneration 
1.3.1 Conservative treatments for neck and back pain 
 Distress of patients with neck and back pain are initially addressed with 
conservative treatments to help ameliorate discogenic pain. Non-steroidal anti-
inflammatories, opiates, and corticosteroid injections are commonly used to relieve the 
cascade of pain signals, but they do not influence the radiculopathy and structural source 
of the pain. Often, physical therapy is recommended to help patients manage pain on 
their own; however, the risk for further injury without further assisted treatment can 
increase in these cases. As such, surgical treatment is ultimately the last resort for nearly 
4 million patients worldwide.51 
1.3.2 Surgical treatment alternatives 
 The current standard of treatment for discogenic pain is based on severity of the 
condition in which the patient presents and the level of conservative treatments 
previously attempted. Impingement of nerves can be relieved by spinal decompression 
via opening of the foramen around the spinal nerve in a vertebral portion with minimally 
invasive surgery (e.g. laminectomy and foraminotomy). In the most severe cases, 
decompression of pinched nerve roots is achieved by removal of IVD tissues (i.e. 
discectomy) in the affected motion segment. The golden standard of surgical 
intervention involves partial or total discectomy accompanied by fusion of the adjacent 
vertebrae to relieve effects on soft neural tissues and maintain disc height in the disc 
space. However, the loss of range of motion resultant of this fusion increases the risks 
for subsequent surgical revisions, in some cases due to pseudarthrosis and adjacent 
segment disease.52-53 Synthetic devices have also been designed as alternatives for 
spinal fusion to help maintain segment stability and preserve range of motion; but the 
extent to which these perform better than standard spinal fusion is not clear yet.53-58 
Furthermore, these metallic or ultra-high molecular weight polyethylene prosthetics 
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have been shown to degrade and wear, thereby elevating the risk of surgical revision 
and failure of the device.56-57 While dynamic stabilizing devices designed to provide a 
controllable range of motion to the functional segments have shown promise, current 
standard of treatment using spinal fusion holds being the golden standard of care.59-60 
1.3.3 Biological treatments: molecular, cellular, and tissue alternatives 
 Attention has been given to biologic-based treatments as alternatives to the 
standard surgical interventions to address the need for a therapeutic solution that repairs 
or even replace the pathologic IVD with a long-term regenerative potential. Biological 
treatments offer promise in that they are designed to accommodate to the diseased 
environment in a biomimetic way, to integrate with the native tissues, or to follow 
developmentally inspired behavior that engages the body into repairing its own 
tissues.61-62 Discs that present with early signs of degeneration such as those described 
by grade III on the Pfirmann’s scale are suitable for biological therapies at the molecular 
level, such as recombinant genes and proteins. The mechanism of action with molecular 
therapies leverages the existing cell population to promote ECM deposition, stimulate 
cell growth, and/or modify gene expression, as well as to interrupt the degenerative 
process with appropriate molecular signals and factors. Several in vivo studies have 
reported promising results with increased GAG content following intradiscal injection 
of exogenous factors or after cell-based gene therapy.63-65 Once the loss of viable cells 
ensues in diseased discs, such as in grade IV degeneration, biological therapies require 
incorporating donor cells. The transplanted cells are meant to reboot the mechanisms of 
ECM turnover and aid in restoring the function of IVD tissues. Fully differentiated IVD 
cells and articular chondrocytes have been successful at retarding DDD with in vivo 
canine models.66-67 Transplantation of mesenchymal stem cells (MSCs), embryonic 
stem cells (ESCs), and induced pluripotent stem cells (iPSCs) also proved their potential 
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to differentiate into IVD cells and repair disc tissues in vivo, when strategically 
implanted or stimulated.68-69 
 In the worst cases of disc degeneration as in grade V, most recent efforts have 
been devoted to engineering whole IVD tissues with biological implants that potentially 
reconstruct the composition and function of the entire segment. Since the advent of 
tissue engineering by Langer and Vacanti,70 the efforts to repair and replace diseased 
tissues have grown across multiple disciplines and physiological systems. More 
recently, several groups have attempted to develop tissue-engineered IVD treatments 
with the objectives of repairing or replacing NP, AF, or whole IVDs.71 
1.3.4 Tissue engineering of the IVD: NP engineering, AF engineering, and whole disc 
engineering 
 Over the years, engineered NP tissues consisted of combinations of natural and 
synthetic polymers72 that aimed to mimic the hydrating capabilities of GAGs to relieve 
the dehydration and disc height loss in a diseased NP,73 but have recently shifted to 
combinations of naturally occurring matrix components such as GAGs and hyaluronic 
acid (HA) with cells that can repopulate a degenerated NP.74 Although many of these 
options have been explored pre-clinically and clinically, increasing concern prevails 
about the consequences of implanting a medical device without fully understanding the 
extent to which other IVD tissues and local cell populations will be affected. An ideal 
tissue-engineered strategy for NP repair should not only restore mechanical function but 
should provide the necessary cues to promote tissue regeneration and cellular activity 
in the long term. Strategies for AF repair focus primarily on addressing tears caused by 
injuries where incorrect motion or mechanical loading provokes the propagation of a 
fissure of the fibrous AF wall. Biomaterials have been widely studied as an alternative 
to traditional AF sutures to patch small defects in the AF; among which injectable 
hydrogels and sponges remain the most popular due to their facile delivery during 
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surgical intervention. Treatments with alginate, agarose, gelatin, collagen, fibrin, silk, 
HA, polyglycolic acid (PGA), and polycaprolactone (PCL) have been proposed alone 
and in combination with cells;74-75 however, most of these approaches fail to produce an 
aligned matrix with cells of the characteristic elongated phenotype in situ. Concerns 
about the ability of these materials to effectively transfer tensile loads across the defect 
site and restore mechanical function of the AF have also led to induce crosslinking of 
the implanted biomaterial as well as to the development of composite biomaterials that 
reproduce the native tissue fiber architecture.76-78 
 To this end, a combined approach of tissue-engineered whole IVDs was 
pioneered by Mizuno et al.79 employing a PGA/PLA AF with an alginate NP composite 
scaffold seeded with cells. Since then, efforts to create composite implants that mimic 
the native IVD structure have been advancing over the last two decades. Gelatinous 
materials such as agarose, hyaluronan, and alginate were often proposed for the NP 
region, while fibrous synthetic and natural scaffolds like polycaprolactone (PCL), 
biphasic silk with fibrin, demineralized bone matrix gel, and collagen type I gel, 
mimicked the AF region of these engineered tissues.81-87 These innovative alternatives 
have provided meaningful contributions to the development of a clinically viable 
engineered IVD; from identifying the surgical challenges associated to location of the 
implanted segment to understanding the necessary benchmarks to consider in implant 
design. In addition to recreating the native IVD, recent work pays considerable attention 
to ensuring retention of the implant and promoting engraftment via external fixation 
devices or by providing anchorage to the CEP and VBs.88-89 Certainly, engineering a 
whole disc that promotes long term integration with the host tissue in a diseased motion 
segment will require further studies before it can be applicable to humans. 
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Clinical Translation of Total Disc Replacement with TE-IVDs 
  To successfully translate engineered IVD constructs for total disc replacement 
into the clinical stage, studies with several small and large animal models help identify 
challenges and promising strategies with rising technologies. The first in vivo studies 
for screening biomaterials and whole disc replacement biologics employed the use of 
rodent and rabbits. These murine and leporine animal models continue to be useful for 
high-throughput quick screening of early stage technologies developed for clinical 
translation. However, several differences between the spine of these small animal 
models and the human spine prevent these models from being considered far enough for 
clinical translation. For example, in athymic rats, the loading conditions are almost 
exclusively uniaxially compressive and, in fact, axial loads are significantly higher in 
the human disc space. Nevertheless, small animal models are certainly valued and 
relevant as an initial step of in vivo assessment.  
 Building upon previous successes in TE-IVD development and in vivo 
assessment with rodent models, the next logical step in the clinical translation pathway 
is to test our discs in large animal models. Several groups have employed different large 
animal models, among which goats, calves, and minipigs remain popular.90 In addition, 
chondrodystrophic dog breeds are considered important models to study spine 
biomechanics and diseases.91-94 These canine breeds usually consist of small dogs with 
elongated bodies and short legs; they have been shown to spontaneously develop disc 
degeneration around 3-7 years of age95 and the progression of their degenerative 
processes has been well documented and evaluated with a grading scale used in humans 
to characterize disc degeneration.96 The human cervical spine and the canine cervical 
spine also possesses similar kinematic motion patterns. Although the kinematics of the 
canine spine remains an area of continuous research, coupled lateral bending and axial 
rotation has been reported in the cervical spine albeit in larger magnitudes of range of 
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motion than in humans.97 Furthermore, the authors in said study found that axial rotation 
increased in lower levels of the cervical spine (C5/C6), but the flexion-extension 
decreased from that of levels closer to cranial (C2/C3). Notably, variations between 
small and large dog breeds have been seen, where the highest range of flexion/extension 
motion in small dogs is observed in the caudal levels of the cervical spine as in 
humans.98 Moreover, medical and surgical treatments for cervical disc degeneration in 
canines are analogous to those used in human cervical radiculopathy such as the anterior 
cervical discectomy and fusion technique.99 Due to the gradual loss of notochord cells 
upon skeletal maturity in chondrodystrophic breeds such as beagles, the cervical spine 
of small canines proves an ideal animal model for testing tissue-engineered implants 
without the natural regenerative mechanisms that could confound a total disc 
replacement in vivo study.100  
Research Objectives 
 The focus of this dissertation was to develop canine disc-sized composite TE-
IVDs made of cell-seeded alginate and collagen scaffolds that mimic the native IVD 
structure in vitro, evaluate the canine cervical spine as a preclinical in vivo model of 
total disc replacement, and investigate strategies to promote a stable implantation of 
scaled-up TE-IVD constructs ex-vivo and in vitro. This work represents the first study 
to translate whole engineered IVD implants from a small animal model to a large 
preclinical in vivo model, with a long-term goal of providing a biological alternative to 
the current surgical standard of treatment for fully degenerated IVDs. The overriding 
hypotheses were that: 1) TE-IVDs will integrate the canine cervical disc space and 
maintain disc height, physiological hydration, and tissue viability upon implantation in 
vivo (Chapter 2, Appendix A); 2) a combined treatment approach of implanted TE-IVDs 
with resorbable PLGA plating will improve the stiffness of canine cervical spine motion 
segments ex vivo and prevent the extrusion of TE-IVD constructs from the disc space 
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(Chapter 3); and 3) interactions in high-density collagen scaffolds seeded with hMSCs 
will improve baseline AF properties in TE-IVDs in terms of tissue structure and 
composition (Chapter 4).  
Specific Aim 1 (Chapter 2) 
Produce canine-sized TE-IVD and examine the efficacy of replacing canine 
cervical discs by investigating stability of surgical conditions, and tissue 
integration, disc hydration and height after 4 and 16 weeks of implantation. 
 This study was focused on two parts: scaling-up the fabrication of TE-IVDs from 
a rodent-sized disc to an anatomically relevant model of a canine cervical IVD and 
evaluating the efficacy of the canine cervical spine as a preclinical animal model of total 
disc replacement with TE-IVDs. TE-IVDs were fabricated following anatomical 
dimensions of canine cervical NPs in disc spaces between levels 3-4 and 4-5 using 
newly designed 3D printed molds. Injection-molded alginate NP cores seeded with 
canine NP cells were surrounded by type I collagen AF laden with canine AF cells to 
create TE-IVDs. After identifying the appropriate formulation of collagen layers and 
NP size, TE-IVDs with optimal cell content were cultured for 2 weeks and harvested 
for in vivo implantation in canine cervical spines. Skeletally mature beagles received 
total discectomy at levels between C3/C4 and C6/C7 and subsequently were either 
treated with a TE-IVD or left with tissues removed only. Despite some subjects facing 
displacement of the TE-IVDs, the stably implanted TE-IVDs exhibit greater disc height 
and NP hydration than untreated disc spaces post-operatively during 4 and 16 weeks. 
Data also demonstrated that for up to 16 weeks, TE-IVDs integrated to host tissue in the 
cervical disc space without any signs of immune reaction and retained viable cells with 
relevant morphological features that produced native-typical ECM. This study was the 
first to examine the efficacy of total disc replacement of cervical spine with TE-IVDs 
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in a large preclinical model and provided insights about the challenges to expect when 
translating into human-sized disc replacement. 
Specific Aim 2 (Chapter 3) 
Assess the effects of a resorbable plating system on the stiffness of canine cervical 
motion segments and ex vivo stability of implanted TE-IVDs subjected to uniaxial 
compression under a combined treatment approach. 
 Stable implantation was favored by composite TE-IVDs in the canine cervical 
spine model in vivo by maintaining promising cell viability and tissue integration into 
host tissue; however, significant implant displacement occurred at multiple spinal 
levels. This study was focused on a combined treatment approach for TE-IVD 
implantation with a stabilizing PLGA plating system, to enhance motion segment 
compressive stiffness and improve implant retention in the disc space. Canine motion 
segments were assessed as intact controls, after discectomy, with an implanted TE-IVD 
only, and with a TE-IVD combined with an attached resorbable plate. Projections of 
2D-displacements were measured using digital image correlation techniques on video 
recordings taken during uniaxial testing. Plated segments with implanted discs partially 
restored more than 25% of the control motion segment stiffness and outperformed un-
plated motion segments. Plating combined with TE-IVDs also fully restored endplate 
separation and prevented implant extrusion from the disc space at 50% compressive 
strain. Significant differences were observed between the level of implant retention in 
levels C3/4 and C5/6. Collectively, these findings demonstrated that resorbable plating 
assisted in the stabilization of motion segments with implanted TE-IVDs, while 
allowing shared loads with the implants. This suggested that TE-IVD implantation with 
assisted resorbable plating could remain stable in the disc space while integration with 
host tissues, ECM maturation, and optimal restoration of spine mechanics occurs. 
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Specific Aim 3 (Chapter 4) 
Investigate the potential of high-density collagen gels as annulus fibrosus 
scaffolds for TE-IVDs and study the effects of initial seeding density of hMSCs on 
disc structure and composition of cell-seeded constructs 
 The development of whole engineered IVD constructs with in vitro stiffness and 
composition properties that closely resemble those of a native IVD before in vivo 
implantation has proven challenging for composite TE-IVDs. The combined effects of 
initial high-density collagen AF at 10 and 20 mg/mL and initial human MSCs seeding 
density between 2 and 20 million cells/mL at the AF were measured mechanically, 
histologically, and morphologically on composite TE-IVDs. Structural changes in disc 
morphology and apparent AF densification examined over the culture period revealed 
that increasing seeding density and apparent AF density, as a measure of structural 
alignment, were directly correlated with the compressive properties of the TE-IVDs. 
Furthermore, in 10 mg/mL collagen AF discs, increased seeding density 5-10 times that 
of the baseline cell content increased their stiffness in a dose-dependent manner. The 
same effects could not be appreciated in 20 mg/mL collagen AF discs. Also, the 
phenotype of hMSCs appeared elongated and AF-like in the 10 mg/mL group only with 
the highest initial cell content. Alterations in collagen AF structure driven by hMSCs 
remodeling was best identified on moderately-dense collagen scaffolds than either the 
baseline or the highest density one. Although previous work had achieved native-like 
structure in composite TE-IVDs, the interplay between cell content and high-density 
collagen for TE-IVDs had not been studied, despite the comparable thickness of the 
native AF to other dense fibrous tissues. These data support the potential of employing 
modulation of hMSCs seeding density in TE-IVDs with dense AF/collagen matrices to 
achieve a controllable tissue composition and structure of the remodeled AF scaffold.
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CHAPTER 2  
Total disc replacement using tissue-engineered  
intervertebral discs in the canine cervical spine1 
Abstract 
 The most common reason that adults in the United States see their physician is 
lower back or neck pain secondary to degenerative disc disease. To date, approaches to 
treat degenerative disc disease are confined to purely mechanical devices designed to 
either eliminate or enable flexibility of the diseased motion segment. Tissue engineered 
intervertebral discs (TE-IVDs) have been proposed as an alternative approach and have 
shown promise in replacing native IVD in the rodent tail spine. Here we demonstrate 
the efficacy of our TE-IVDs in the canine cervical spine. TE-IVD components were 
constructed using adult canine annulus fibrosus (AF) and nucleus pulposus (NP) cells 
seeded into collagen and alginate hydrogels, respectively. Seeded gels were formed into 
a single disc unit using molds designed from the geometry of the canine spine. Skeletally 
mature beagles underwent discectomy with whole IVD resection at levels between C3/4 
and C6/7 and were then divided into two groups that received only discectomy or 
discectomy followed by implantation of TE-IVD. Stably implanted TE-IVDs 
demonstrated significant retention of disc height and physiological hydration compared 
to discectomy control. Both 4-week and 16-week histological assessments demonstrated 
chondrocytic cells surrounded by proteoglycan-rich matrices in the NP and by 
fibrocartilaginous matrices in the AF portions of implanted TE-IVDs. Integration into 
host tissue was confirmed over 16 weeks without any signs of immune reaction. Despite 
the significant biomechanical demands of the beagle cervical spine, our stably 
                                                 
1 This chapter has already been published: Moriguchi Y, Mojica-Santiago J, Grunert P, Pennicooke B, 
Berlin C, Khair T, Navarro-Ramirez R, Ricart Arbona RJ, Nguyen J, Hӓrtl R, Bonassar LJ. (2017) Total 
disc replacement using tissue-engineered intervertebral discs in the canine cervical spine. PLoS ONE 
12(10): e0185716. 
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implanted TE-IVDs maintained their position, structure and hydration as well as disc 
height over 16 weeks in vivo. 
Introduction 
 Degenerative disc disease (DDD) is a prevalent clinical condition occurring in 
40% of individuals younger than 30 and more than 90% of individuals over the age of 
50,1 which can lead to nerve compression and chronic back pain. Though 
pharmacological and physiotherapeutic treatments relieve early symptoms,2 surgical 
intervention is required in over half a million patients in the US annually.3 The current 
surgical standard to treat DDD involves the removal of the entire IVD followed by 
fusion of the adjacent vertebrae or interposition of a mechanical disc prosthesis to 
preserve motion. However, fusion brings risks of possible pseudarthrosis and adjacent 
segment disease, resulting in a higher rate of reoperation in these patients.4,5 Prosthetic 
total disc replacement devices, developed to maintain segmental mobility, are an 
alternative to fusion surgery. However, recent studies have shown that total disc 
replacement also leads to adjacent segment disease.4,6 The main concern with current 
treatment options for DDD –conservative or surgical– is that they fail to treat the 
underlying etiology and the degenerated disc remains unrepaired.  
 To overcome the limitations of available treatments and enhance patient care 
outcome, biological approaches to IVD repair or regeneration are of increasing interest. 
The first attempt to reconstruct a whole disc segment with biological implants now dates 
back approximately 10 years.7 The feasibility of allogenic disc transplantation was 
demonstrated in clinical trials with favorable outcomes over a five-year follow-up. 
Despite the challenge of widespread deployment of this strategy due to limited implant 
availability and potential disease transmission, the results obtained were encouraging. 
Since Langer and Vacanti pioneered the multidisciplinary field of tissue engineering in 
1993,8 much effort has been directed towards the construction of functional substitutes 
30 
for damaged disc tissues, especially for advanced stages of disc degeneration with 
extensive loss of extracellular matrix and functional structure. Numerous studies have 
assessed tissue-engineered whole disc constructs in vitro, but few have looked at these 
constructs in vivo. Mizuno et al. first developed the tissue engineered disc composed of 
NP cells seeded into an alginate hydrogel surrounded by a polyglycolic acid and 
polylactic acid scaffold seeded with AF cells. This de novo construct was implanted in 
the subcutaneous space of the dorsum of athymic mice, demonstrating the feasibility of 
creating a composite IVD with both AF and NP tissues.9,10 Several other studies have 
reported the development of composite tissue engineered IVD constructs, using 
combinations of materials such as demineralized bone matrix gelatin with type II 
collagen, hyaluronate and chondroitin-6-sulfate (C2/HyA-CS),11 electrospun 
polycaprolactone and agarose;12 and self-assembled NP cells seeded onto calcium 
polyphosphate.13 We have shown previously the development of a tissue-engineered 
IVD composed of an inner NP cell-laden alginate core surrounded by an outer AF cell-
laden collagen layer (Fig 1A).14,15 We demonstrated the in vivo efficacy of this model 
at maintaining disc height and physiological hydration, when implanted in the rat tail 
for up to nine months.16-20 
 Although these results are promising, there are several differences between the 
rat tail model and the human cervical spine that pose significant challenges for clinical 
translation.21-23 The rat tail spine has a significantly different loading profile, and TE-
IVDs will be exposed to higher axial loads when implanted into a human disc space. 
There are also anatomical differences, as the rat tail vertebrae lack a spinal canal 
containing nervous tissue as well as posterior bone and joint elements. To bring this 
innovation toward clinical application, we tested the feasibility of total disc replacement 
using TE-IVDs in a beagle cervical spine model. We determined surgical conditions 
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that promote stable implantation and investigated the ability of TE-IVDs to maintain 
disc height, physiological hydration, and tissue viability in the present study. 
 
Figure 2.1. A) Schematic picture of disc tissue engineering. NP and AF cells were 
separately isolated from canine lumbar spine and cultured in vitro. Cultured NP and AF 
cells were seeded in alginate and collagen gels, respectively, and subsequently both 
composites were combined into a TE-IVD. B) Photographs of TE-IVD fabrication. 
Cultured NP cells were injected into a predesigned mold and encircled with two layers 
of AF cell-laden collagen gels. These AF layers circumferentially contract over 
cultivation time until they reach a size similar to native IVD as observed in top view 
and side view. C) Total discectomy and TE-IVD implantation were performed 
anteriorly under segmental distraction. D) Upon distraction release, stably transplanted 




In vitro generation of tissue-engineered intervertebral discs (TE-IVDs) 
 We isolated nucleus pulpous (NP) cells and annulus fibrosus (AF) cells from the 
intervertebral discs from the cervical spines of skeletally mature beagles. These cells 
were separately cultured for 2–3 weeks and subsequently seeded in an alginate scaffold 
for NP and collagen for AF (Fig 2.1A and 2.1B). For TE-IVD construction, NP cell-
laden alginate (25 × 106 NP cells/mL) was injected into a predesigned mold and 
encircled with two layers of AF cell-laden collagen gels (1 × 106 AF cells/mL). This 3D 
construct of TE-IVD demonstrated the contraction at the AF part during further two-
week cultivation. 
Implanted TE-IVD maintained its position without neurological complication 
 Cervical discectomy was performed in vivo anteriorly as in human surgeries. 
The annulus fibrosus (AF) and nucleus pulposus (NP) were extensively resected under 
the microscope (Fig 2.1C and 2.1D). To determine a condition that promotes implant 
stability, we varied the surgical level operated on and presence or absence of ligament 
resection. With the lateral dimension over 80% of the disc width (most of the AF and 
all the NP portion), the entire antero-posterior depth of the disc was resected, confirming 
exposure of the posterior longitudinal ligament at the bottom (PLL). The PLL was 
resected in four dogs, but not in the others (to help determine favorable implant 
conditions, as aforementioned). Subsequently, all implants were successfully  
inserted into the discectomized segment under segmental distraction using a CASPAR 
distraction system. Upon distraction release, half of the TE-IVDs remained stable (n = 
6), while the other half (n = 6) were considered displaced based on the extent of anterior 
protrusion (The summaries of implant stability immediately after removal of distraction 
are summarized in Tables 2.1–2.3). PLL resection did not have a significant effect on 
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implant stability (p = 0.072). None of the dogs demonstrated segmental instability of 
the experimental level and none of the TE-IVDs demonstrated a propensity of posterior 
displacement intraoperatively. All animals were neurologically normal immediately 
after surgery and remained so for the duration of the experiments, with neurological 
assessments for abnormalities in gait, wheelbarrow assessment, limb hopping, and 
plantar reflex.  
 All animals were imaged postoperatively using X-ray and MRI to monitor the 
implanted TE-IVD and screen for any host reaction (Fig 2.2). None of the dogs had 
neurological symptoms or adverse effects due to TE-IVD implantation, despite being 
free of external fixation or orthosis immediately after surgery. X-rays demonstrated no 
significant pathological abnormality observed in the vertebrae or signs of spinal 
malalignment such as spondylolisthesis among the groups. In MRIs, proximal adjacent 
discs served as a healthy control. The solely discectomized segments demonstrated a 
collapsed black disc on postoperative images and paucity of reparative tissues in the 
disc histology, suggesting that our discectomy procedure induced an incurable lesion by 
resecting the vast majority of the disc. In the TE-IVD implanted groups, location  
of the implant was confirmed by sagittal and axial MRIs. Stably implanted TE-IVDs 
demonstrated hyperintensity in T2-weighed images at 4 weeks and maintained their 
position in the disc space with relatively decreased T2 intensity at 16 weeks. This loss 
in T2 signal is likely associated with a decrease in tissue hydration, and these data were 
consistent with the Safranin-O histology for proteoglycans, which are known to attract 
water into these tissues. Such histology also indicated a continuous connection between 
newly developed tissue and the surrounding vertebral body. This indicated that the 
implanted TE-IVDs engrafted within the disc space despite the biomechanical forces of 
the beagle cervical spine. 
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Figure 2.2. X-ray, MRI and histology of adjacent motion segment, discectomy, and 
TE-IVD at 4 and 16 weeks. Adjacent disc levels showed clear vertebral separation, 
strong hydration signal in sagittal and axial T2 MRI, highly localized T2 map signal, 
and abundant staining with Safranin O. Discectomy levels showed no vertebral 
separation and minimal T2 signal and no soft tissue present between vertebrae. Animals 
receiving stably transplanted TE-IVD showed clear vertebral separation, with tissue 
hydration noted in both sagittal and axial T2-weighed MRI (yellow arrows). At both 4 
and 16 weeks after transplantation, proteoglycan-rich tissue was observed to be well 
integrated into the surrounding vertebrae. 
Engrafted TE-IVDs produced functional tissue that maintained disc height and tissue 
hydration 
 We investigated the ability of TE-IVDs to maintain disc height by measuring 
the disc height index as described previously.16 At 4 weeks, the disc height indices of 
stably implanted TE-IVDs and discectomized discs were 71% and 51% of healthy 
control discs, respectively. Animals receiving TE-IVDs demonstrated significant 
decrease in disc height over time (p<0.001), with stable implants having larger disc 
height compared to the discectomy group at both 4 and 16 weeks (p<0.001 and p = 
0.012, respectively) (Fig 2.3). We further assessed the size and hydration of the NP 
portion in the implanted TE-IVDs following an algorithm based on T2 relaxation time 
(T2-RT) measurements.24 After 8 weeks, stable TE-IVDs had significantly higher NP 
voxel count than discectomy (p = 0.015) and demonstrated a significant increase in 
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NP voxel count from 2 to 8 and 16 weeks (p = 0.009 and 0.020). 
 Mean NP T2-RT, a value representing NP hydration, was significantly higher 
for TE-IVDs than discectomy group at 2 and 4 weeks (p<0.001). There was a significant 
decrease in T2-RT between 2 and 4 weeks in the TE-IVD group, and only this group 
maintained physiological hydration of the NP of ~60% of adjacent healthy discs. 
Conversely, the discectomized segments did not show any region of T2 high intensity 
at 2 and 4 weeks, which confirmed that total discectomy was thoroughly performed. 
However, a very small amount of T2 high intensity region emerged in the discectomized 
segment after 8 weeks, probably due to the fluid accumulation induced by a secondary 
disc degenerative process. This pseudo-NP region observed in one specimen was 
responsible for paradoxical increase of the mean T2-RT at 8 and 16 weeks. 
 
Figure 2.3. Quantitative analysis of disc height index and MRI. A) Stably 
implanted TE-IVD had significant retention of disc height compared to the discectomy 
control at 4 and 16 weeks (asterisks, p<0.001 at 4 and p = 0.012 at 16 weeks, 
respectively). B) TE-IVDs demonstrated significantly higher NP voxel counts than the 
discectomy controls after 4, 8, and 16 weeks (asterisks denote p<0.02 for all time 
points) C) TE-IVD had significantly higher T2-relaxation times than the discectomy 





Figure 2.4. Safranin O staining showed an absence of tissue in the intervertebral 
space of samples in the discectomy group. Healthy tissue in the adjacent motion 
segment showed strong proteoglycan staining the NP, with numerous clusters of round 
chondrocytic cells (open arrows) and less staining in the AF, with more elongated 
fibrochondrocytes arranged in distinct fibrous lamellae (open arrow heads). At 4 weeks, 
TE-IVD samples had strong proteoglycan staining in both NP and AF, with rounded 
cells apparent in the NP (filled arrows) and more elongated cells arranged primitive 
lamellae in the AF. By 16 weeks, staining was more evident in the NP than AF, with 
some clustering of rounded chondrocytic cells (filled arrows). AF cells were clearly 
elongated (closed arrow heads) and aligned. All scale bars are 100 μm. 
TE-IVDs produced collagen- and proteoglycan-rich extracellular matrix in the AF 
and NP 
 A critical benchmark of success for a TE-IVD is the assessment of the biological 
function of the transplanted tissue as assessed by the ability to form robust extracellular 
matrix when implanted into the spine. To evaluate this biological function, we 
performed Safranin O staining for proteoglycans (Fig 2.4) and Picrosirius red staining 
for fibrillar collagen (Fig 2.5). Both stains demonstrated the successful removal of the 
IVD and the absence of any robust healing response from the discectomy group. In 
contrast, TE-IVD implants yielded proteoglycan-rich tissue with distinct morphological 
features of NP and AF. The morphologies of the NP and AF regions were more similar 
at 4 weeks, but highly distinct by 16 weeks. The central NP region contained rounded 
cells and cell clusters characteristic of a chondrocytic phenotype. The morphology of 
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the NP was similar at 4 and 16 weeks, with the cell clustering that is characteristic of 
native NP more evident at 16 weeks. AF tissue showed a moderate level of proteoglycan 
staining at 4 weeks, with staining less pronounced at 16 weeks. At 4 weeks, cells were 
somewhat elongated, but aligned in nascent lamellae. By 16 weeks, cells were highly 
elongated, as in the native AF, and aligned into mature lamellae surrounding the NP. 
Notably, at either 4 or 16 weeks, there was little chronic inflammation or foreign body 
response to TE IVD implants evident from Safranin O (Fig 2.4), Picrosirius red (Fig 
2.5), or Hematoxylin and eosin (supplemental Fig 2.9) stains. At both time points, cells 
in both the AF and NP regions appeared healthy and there was no sign of implant 
rejection, despite the implants being seeded with allogenic cells. 
 
Figure 2.5. Picrosirius red staining showed an absence of tissue in the 
intervertebral space of samples in the discectomy group. Healthy tissue in the 
adjacent motion segment showed little staining for collagen in the NP with numerous 
clusters of round chondrocytic cells (open arrows) and strong staining in the AF, with 
more elongated fibrochondrocytes arranged in distinct fibrous lamellae (open arrow 
heads). At 4 weeks, TE-IVD samples had light collagen staining in the NP and stronger 
staining in the AF, with rounded cells apparent in the NP (filled arrows) and more 
elongated cells arranged primitive lamellae in the AF. By 16 weeks, staining was present 
in both NP than AF, with some clustering of rounded chondrocytic cells (filled arrows) 
in the NP and elongated cells in the AF (closed arrow heads). All scale bars are 100 μm. 
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Figure 2.6. Picrosirius red-stained histology under polarized light showed 
birefringent features associated with collagen fibers. Discectomy samples show 
collagen organization in vertebrae, with no tissue in the intervertebral space. Adjacent 
motion segments show the absence of collagen fibers in the NP and large collagen fibers 
(~50–100 μm) inserting from the AF to the vertebral body (VB). At 16 weeks, TE-IVD 
samples show the presence of some small, unorganized collagen fibers in the NP, with 
larger (~20–50 μm) fibers that insert into the vertebral body (VB). 
TE-IVDs integrated with neighboring vertebrae and reproduced a native disc shape 
and composition structure over 16 weeks of implantation 
 A major challenge in a tissue engineering approach to IVD repair is the 
integration of a newly grown implant into the surrounding vertebrae. To assess the 
integration of the implanted TE-IVD, we used polarized light microscopy in conjunction 
with Picrosirius red staining to evaluate the collagen organization in our implants and 
its connection to neighboring vertebrae (Fig 2.6). As expected, the adjacent segment 
showed structures characteristic of the IVD, including highly aligned lamellae in the 
AF, the absence of fibers in the NP, and insertion of large collagen fibers from the AF 
into the vertebral body (Fig 2.6 and supplemental Fig 2.7). Discectomized segments 
showed no tissue in the disc space, with no connection between collagen in the vertebral 
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body and the intervertebral space (Fig 2.6 and supplemental Fig 2.8). TE-IVD segments 
showed the presence of tissue throughout the intervertebral space. NP tissue contained 
some collagen, composed primarily of small, disorganized fibers (Fig 2.6 and 
supplemental Fig 2.9). AF tissue was composed of large sections of organized collagen 
fibers that inserted in and connected to the vertebral body. 
Discussion 
 In the present study, we demonstrated the feasibility of total disc replacement 
using TE-IVDs in the canine cervical spine. Despite the challenging mechanical 
environment of the beagle spine, the stably implanted TE-IVDs maintained their 
position, integrated with the host tissue through the reorganization process, and yielded 
hydrated disc-like tissues over 16 weeks. Although the morphology of TE-IVD implants 
was distinct from the adjacent healthy IVD, implants contained an NP region with 
cartilaginous tissue with rounded cells and an AF region with organized fibrous tissue 
that inserted into the vertebral body. These implants formed organized tissue in the spine 
that functioned normally throughout the 16 weeks of the study.  Reconstructing a 
discectomized intervertebral segment with de novo biological disc implants is an 
ambitious approach to treating degenerative disc disease of the cervical spine. In 2007, 
the feasibility of whole allogeneic IVD transplantation was demonstrated in a clinical 
study with impressive results at 10 years follow up.7 The potential clinical advantages 
of allogeneic IVD transplantation are limited by the availability of healthy donor discs, 
possible adverse immune reaction, and potential disease transmission. De novo TE-
IVDs, the multi-compartment disc analogs using cells and biomaterials, can potentially 
overcome these limitations of allogeneic implants and yield favorable outcomes. A 
variety of in vitro studies and in vivo studies that employed animal models of 
nucleotomy or partial IVD resection have indicated the promise of using tissue-
engineered constructs for disc replacement,9,11,13,25-40 however, only three translational 
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studies have demonstrated the in vivo efficacy of biological disc implants in the totally 
discectomized segment.11,16 
 In the pursuit of a biological construct that can be contained in the interbody 
cage to reconstruct the segment with non-bony soft tissues, Goldshlager et al. seeded 
mesenchymal progenitor cells into gelfoam sponges formulated with the chondrogenic 
agent pentosan polysulfate implanted into fully discectomized sheep lumbar segments 
in combination with absorbable interbody cages.41 This study demonstrated the potential 
of replacing the disc segment with cartilaginous tissues to offer a means of preserving 
spinal motion, although the reparative tissues were distinct from those of native discs, 
even accompanied with ossification in some areas or specimens. Xin et al reported the 
aforementioned allogeneic disc transplantation and demonstrated the feasibility of 
human telomerase reverse transcription (hTERT) gene-transfected NP to be 
incorporated with allograft IVD transplantation in the beagle cervical spine.42 Although 
their results demonstrated the feasibility of allogeneic disc-based implant to be 
combined with genetic engineering, use of exogenous genes can hamper the clinical 
applicability. Previously, we developed de novo AF/NP composites derived from 
component cells to produce TE-IVDs and demonstrated the efficacy of these discs on 
maintenance of disc height and disc functionality in an in vivo rat model.16 The 
implanted TE-IVD integrated, with the host vertebrae, histologically restored the disc 
constitutive structures (i.e. NP and AF), and physiologically maintained NP hydration 
over 8 months.19 
 To move this approach toward clinical application, larger animals that have a 
more upright cervical spine were utilized in the present study. Many breeds of small 
dogs, such as beagles and dachshunds, develop spontaneous cervical disc degeneration 
as in humans.23 Further, previous studies have revealed that canine IVDs are exposed to 
stress conditions similar to or even higher than those of human discs.21-23,43,44 In 
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addition, the canine spine shows similar anatomical features and analogous degenerative 
processes with human discs.45 Besides showing similar pathological changes, canines 
are also the only animals diagnosed and treated both medically and surgically as humans 
for their disc degeneration.46 As such, canine spinal models have been previously used 
to investigate disc degeneration and to develop surgical treatments such as spinal 
fusion47,48 and regenerative intervention.38 This is especially true of beagles, which are 
frequently used for biological approaches aimed at disc regeneration. These canines are 
classified as chondrodystrophic dogs due to the gradual loss of notochord cells and 
replacement by chondrocyte-like cells by the stage of skeletal maturity.49 Notably the 
absence of such cells at skeletal maturity, which have reparative functions in the 
intervertebral discs, suggests that such a mechanism is not at play for implanted TE-
IVD. In fact, the solely discectomized segments in the present study demonstrated no 
substantial repair in the disc space. 
 Moreover, our experiment employing stand-alone TE-IVD implantation under 
this clinically relevant model gave a fresh insight into development of biological disc 
treatment. First, mechanical stress causes instability and displacement of the implant. 
As evidenced by prosthetic TDR,50 displacement of implant is an arising complication 
when positioned in a fixation-free fashion, predominantly due to the human spine 
yielding severe axial loading. However, all the TE-IVDs at the C3/4 segment were 
stable in our study and maintained disc height up to 70% of adjacent normal discs. 
Biomechanics are known to be different among different levels of the cervical spine51 
and our findings may suggest biomechanics at this level of the beagle spine are more 
favorable to the biological disc implantation. 
 Our data suggested that PLL resection in the experimental segment could 
enhance the intraoperative stability of biological disc implants. The efficiency of PLL 
resection in anterior cervical decompression and fusion has been demonstrated.52 
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Resecting the PLL, one of the stabilizer ligaments in the spine unit, may compromise 
segmental stability of the spine in the motion preserving surgery, however, Yang DL et 
al demonstrated that removal of the PLL improved clinical outcome of prosthetic total 
disc replacement via better enlargement of spinal canal without significant effect on 
spinal imbalance and segmental. The present study also showed that PLL resection did 
not pronouncedly affect the stability of treated disc segments, and to make matters more 
favorable, increased the stability of implanted TE-IVDs with close-to-significance. 
 TE-IVDs that were intraoperatively classified as stable implants, without any 
evidence of displacement, demonstrated better outcomes over the course of 16 weeks 
than the discectomy alone group, while the unstably implanted TE-IVDs demonstrated 
time-dependent degradation after 4 weeks. Notably, implants that were not stable 
displaced immediately upon removal of distraction, suggesting that additional surgical 
techniques maybe be needed to ensure that implants remain in place after surgery. 
Implants that remained in place after surgery were stable until the animals were 
euthanized.  
 In addition to the significant mechanical loading of the beagle cervical, a TE-
IVD implant is also subject to a milieu with very poor nutritional supply. The indirect 
blood perfusion of the TE-IVD is via diffusion from blood vessels of the vertebral body 
through the cartilaginous endplate (EP), but there is no direct conduit of blood perfusion. 
In fact, the role of nutrition, critical in the long-term durability of implanted biological 
treatments, has been largely overlooked.53 This is also corroborated by our finding that 
the NP portion of TE-IVDs at 16 weeks did not maintain as much disc height, NP 
hydration, and proteoglycan content as at 2 or 4 weeks. Further, axial distraction using 
an external fixator can enhance the regenerative capability of cell injection therapy, 
based on the hypothesis that individually both a distracted segment and cell injection 
can stimulate disc repair.54-56 
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 Chronic immune response to TE-IVD implants composed of allogeneic cells 
was notably absent in this study. Previous work has shown that transplantation of 
allogenic mesenchymal stem cells (MSCs) into the rat IVD invoked a minimal immune 
response,57 and that allogeneic articular chondrocytes transplanted into the rabbit IVD 
similarly caused minimal immune response.58 These studies, combined with total disc 
transplantation studies conducted in beagles,42 goats,59 and humans,7 and data from the 
current study, collectively suggest that the disc space has a sufficient level of 
immunoprivilege to tolerate allogenic cell or tissue transplants. Human disc allograft 
was first performed in 20077 and their results showed the implanted disc engrafted 
without any rejection, maintained disc space, and improve the patients' symptoms. 
Combined with other studies, the current study corroborates that allogenic discs and 
disc spaces have some immune privilege as in cartilage in general. As such, the present 
study demonstrates that allogenic cell source is not necessary for successful outcomes, 
as has been noted previously.42 
 Collectively, these data represent the first proof of concept studies 
demonstrating the regeneration of whole IVD in a large animal model. Implants 
engrafted successfully and persisted in the spine for up to 16 weeks, with evidence of 
distinct NP and AF regions. Challenges persist in maintaining function over extended 
periods of time and in characterizing the mechanical performance of these implants. 
Specifically, assessing the continued functionality of transplanted discs over long time 
scales (6–12 months) will be critical for establishing feasibility for human trials. 
Furthermore, the current study focused on transplantation of TE-IVD into healthy 
canine spine. The environment of the IVD in the case of degenerative disc will likely 
be significantly more challenging due to alterations in mechanics and diminished supply 
of nutrients. Future studies will assess the function of such implants in the degenerative 
spine to aid in the translation of this technology to clinical practice. 
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Materials and Methods 
Cell preparation 
 Cell preparation was based on previously described techniques.16,19 Cervical 
spines of skeletally mature beagles were purchased (Marshall BioResources) and IVDs 
were dissected out of the segments. Tissue was washed in PBS (Dulbecco's PBS; Gibco 
BRL) and then separated into AF and NP regions. To isolate the component cells, tissues 
were dissected into small pieces and digested in 125 mL of 0.3% wt∕vol collagenase 
type II (Worthington Biochemicals) at 37°C for 6 h. Digested tissue was filtered through 
100 μm nylon mesh (BD Biosciences) and centrifuged at 936 g for 7 min. Cells were 
counted and seeded in culture flasks with Ham's F-12 media (Gibco BRL) that contained 
10% fetal bovine serum (Gemini Bio Products), penicillin, (100 units/mL), streptomycin 
(100 μg/mL), amphotericin B (250 ng/mL), and ascorbic acid (25 μg/mL). Cells were 
cultured at 37°C, 5% CO2, and normoxia to confluence with media changes twice a 
week. At confluence, cells were removed from flasks with 0.05% trypsin (Gibco BRL) 
and counted with a hemocytometer. Cells were then seeded into TE-IVDs (Fig 2.1A). 
TE-IVD fabrication  
 T2-weighted MRI images were obtained of cervical 3/4 and 4/5-disc levels in 
the beagle (imaging specifics in imaging section). The dorso-ventral and lateral-lateral 
dimensions of the NP region shown in the MRI were used along with the height of the 
disc space to model the TE-IVD core as an elliptic cylinder. A model of an injection 
mold for the NP was created in SolidWorks using the MRI-derived NP dimensions to 
guide the size of the cavities. The injection mold was then 3D printed of UV-curable 
watertight acrylic plastic (Shapeways). TE-IVD implant was created using established 
contracted collagen (AF)/alginate (NP) technique (Fig 2.1B),14-16 such that the ratio of 
NP area to the whole contracted disc area matched the 30% ratio observed in the beagle 
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native disc. Three percent (wt/vol) low viscosity grade alginate (FMC BioPolymer) 
seeded with 25 × 106 NP cells∕mL was mixed with 0.02 g/mL CaSO4 
(Sigma-Aldrich) to crosslink the alginate and injected into the NP mold (Fig 2.1B). Cell-
seeded alginate NP was then removed from molds and placed in the center of a well of 
a 12-well plate. Collagen type I was obtained from rat-tail tendon (Sprague Dawley, 7–
8-wk old) (Pel-Freez Biologicals) using established protocols.15,60 One and a half 
milligrams per milliliter collagen gel solution seeded with 1 × 106 AF cells/mL was 
subsequently poured and gelled around the alginate NP. Constructs were cultured for 2 
weeks in previously described media at 37°C, 5% CO2, and normoxia while collagen 
gel contracted around alginate NP to the proper AF dimensions. 
Total discectomy in canine cervical segments 
 Skeletally mature male beagles (n = 14) were obtained from Marshall 
BioResources. The animals were 12 to 18 months old at the time of surgery, with a 
weight of 15–25 kg. All experimental procedures were reviewed and approved by the 
Institutional Animal Care and Use Committee at Weill Cornell Medicine. Animals were 
housed in a facility accredited by the Association for the Assessment and Accreditation 
of Laboratory Animal Care (AAALAC) in compliance with applicable NY State, and 
Federal regulations. Initially, the animals underwent endotracheal intubation with 
administration of IV propofol, followed by a combination of inhaled isoflurane with 
intravenous fentanyl to maintain anesthesia. Then, the animal was placed in dorsal 
recumbency with the neck hyperextended and secured to the table with adhesive tape. 
The surgical site was prepared by clipping hair and scrubbing with chlorhexidine and 
betadine scrub solution. Animal was preoperatively given a dose of cefazolin 22 mg/kg 
IV which was repeated every 2–3 hours thereafter during the surgical procedure.  
 A ventral midline incision was made from the base of the larynx to the sternum. 
The paired sternocleidomastoideus and sternohyoideus muscles were separated with 
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blunt dissection, exposing the trachea. Retractors were then positioned to retract the 
nearest carotid sheath toward the surgeon and the trachea, esophagus, and opposite 
carotid sheath away from the surgeon. This exposed the paired longus coli muscles, 
which lie on the ventral surface of the cervical vertebrae. The surgical level was 
identified by palpation of the prominent transverse process of C6. Small curved 
hemostats were used to separate the longus coli muscle overlying the ventral annulus. 
 The subsequent steps were carried out microscopically. After the ventral part of 
the AF has been incised and resected with a scalpel and a Kerrison rongeur, two self-
drilling distraction pins were anteriorly inserted into the adjacent vertebrae and the disc 
segment was distracted with a Cervical Distractor System. Under segmental dilatation, 
which is augmented as the disc tissues are resected, the NP was completely extracted 
using a small tartar scraper, a 4–0 bone curette, and a Kerrison rongeur. The dorsal part 
of the AF was also resected under careful microscopic observation to expose the 
posterior longitudinal ligament (PLL) and confirm complete resection of the AF, and in 
several animals, the PLL.  
 One segment between C3/4 and C6/7 was totally discectomized in each animal. 
To determine surgical conditions that promote implant stability in a canine model, we 
employed different surgical levels as well as binary options between additional PLL 
resection or not; four of C3/4, four of C4/5, four of C5/6, and two of C6/7 segments 
were discectomized. Four of the animals underwent PLL resection, while the other did 
not. All the surgical procedures were performed by two fully-trained spine surgeons.  
 The neurologic examinations were performed immediately after surgery and 
periodically throughout the course of the study. These consisted of evaluating the 
animal’s gait in a straight line and turns to both sides, wheelbarrow on pelvic and 
thoracic limbs, individual limb hopping, cross extensor reflex and plantar reflex. All 
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these tests can detect problems with coordination and strength in any of the four limbs, 
or injury to the spinal cord section at or caudal to the surgery site. 
In vivo total disc replacement using tissue-engineered IVDs 
 TE-IVDs were taken out of culture and kept suspended in aforementioned media 
inside centrifuge tubes to maintain sterility. Constructs were brought into the operating 
room and implanted into the 12 segments ranging from C3/4 to C6/7 levels of the beagle 
spine after complete disc extraction in a single procedure, while the disc space was left 
untreated in the C5/6 discectomized segments of two animals. TE-IVDs were slipped 
down on a deliver instrument and inserted into the space. Distraction was slowly 
released and motion of the implanted TE-IVD was qualitatively evaluated for any 
motion and overall stability. Implanted TE-IVDs were categorized as displaced or 
stable, depending on how much of the disc remained within the intervertebral segment 
following release of retractors; in general, if ¼ of the disc diameter was extruded upon 
release we considered this displaced. Bipolar cauterization was used for homeostasis 
and the separated longus coli muscles were sutured to be paired with 5–0 Vicryl sutures. 
The wound was closed subcutaneously with 5–0 Vicryl and cutaneously with 3–0 
polyamide-nylon sutures. Postoperative care was provided by Veterinary Services 
personnel as per the RARC veterinarian. Sutures was removed 10–14 days 
postoperatively. Prior to and following implantation, animals were evaluated via 
physical examination. 
Qualitative and quantitative magnetic resonance imaging 
 All the 14 animals underwent 3 Tesla MRI (Siemens Tim TRIO MRI Scanner, 
Erlangen, Germany) imaging at 1 month and ten at 3 months postoperatively to 
qualitatively monitor location and viability of implanted TE-IVDs on sagittal and axial 
T2-weighted images. For quantitative assessment, the voxel count and average T2 
relaxation time in NP were measured according to an algorithm we previously 
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developed.24,61,62 We used a sagittal multislice multiecho pulse sequence (TR = 2000 
ms, TE = 12 ms, NEX = 2, number of echoes = 12, echo spacing = 12 ms, slice thickness 
= 1 mm, and matrix size = 320 × 320, resolution: 125 μm × 125 μm × 1 mm) to create 
a T2 map based on fitting semi log plots of T2 signal intensity versus relaxation time 
for the 12 acquired echoes. Bruker's proprietary program TopSpin was used for this 
fitting process. A color map was assigned to the resulting T2 map. Next, a standard 
region of interest (ROI) measuring approximately 4 mm2 (comprising 300 voxels) was 
drawn within the center NP of the healthy disc proximal to the experimental segments. 
The average T2-relaxation time (T2-RT) of that ROI was measured, and this value 
minus 3 standard deviations was used to set a subtraction threshold for all voxels in that 
slice. Voxels with T2 values lower than the threshold were subsequently subtracted. 
Thus, only voxels with T2 values representing NP tissue remained in the disc space and 
were then counted. At each time point, the mean voxel count of experimental segments 
was compared with the mean voxel count of proximal adjacent healthy discs. The mean 
T2-RT of NP voxels was also calculated 
and compared with that of the healthy adjacent control. 
Disc height measurements 
 X-rays were performed at one and four months to measure the disc height of 
treated segments. Great care was taken to achieve true lateral radiographs of the index 
segment. The IVD height was expressed as a disc height index, calculated by dividing 
disc height by adjacent vertebral body height on the basis of the modified method of Lu 
et al.63 
Histological assessment 
 Animals were sacrificed one or four months postoperatively by administering a 
barbiturate overdose intravenously at a rate of 120 mg/kg. Spines were collected and 
processed for further ex vivo histological assessments. After fixed by 10% neutralized 
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formalin supplemented with 1% cetylpyridinium chloride (CPC), specimens were 
decalcified, cut in the mid-sagittal plane, and transferred to 75% ethanol. Segments were 
embedded in paraffin, then cut to 5-μm thickness, and stained with Alcian Blue, 
Safranin-O, and Picrosirius Red. 
Data analysis and statistics 
 All the quantitative values from X-rays and MRIs represent the proportion of 
experimental to adjacent healthy control measurements, and were expressed as mean ± 
SD. For the analyses for continuous outcomes in disc height index, NP size, and NP 
hydration, generalized estimating equation (GEE) models were used to assess main 
effects and interaction factors of disc group and longitudinal assessment of time. 
Parameter estimates of means and robust standard errors are reported to describe 
estimated differences in mean changes from baseline controls (discectomy) across 
stable and displaced implantation groups for the 2, 4, 8 and 16-week time points. 
Statistical analysis was performed with IBM SPSS Statistics 22 (SPSS, Chicago, IL, 




Table 2.1.  To determine the surgical condition that promotes stable implantation, 
TE-IVDs were implanted in different spinal levels ranging from C3/4/ to C6/7, and 
with or without posterior longitudinal ligament (PLL) resection. Based on the 
implant stability upon distraction release, half of the TE-IVDs remained stable (n = 6), 
while the other half (n = 6) were considered displaced. Of note, 66.7% of the stable TE-
IVDs were the ones implanted at C3/4 although the association between intraoperative 
implant stability and surgical level was not statistically significant (p = 0.120). 
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Table 2.2. The crosstab demonstrates that the implants at C3/4 had a greater 




Table 2.3. The segments with ligament resection all demonstrated that implant 
stability was nearly significantly higher than the segments with an intact posterior 




Figure 2.7. Histological assessments at 16 weeks of a healthy adjacent motion 
segment. Brightfield images are shown for staining with Hematoxylin and eosin, 
Safranin O, and Picrosirius red, as well as polarized light images of Picrosirius red 




Figure 2.8. Histological assessments at 16 weeks of a motion segment that received 
a discectomy. Brightfield images are shown for staining with Hematoxylin and eosin, 
Safranin O, and Picrosirius red, as well as polarized light images of Picrosirius red 




Figure 2.9. Histological assessments at 16 weeks of a motion segment that received 
a TE-IVD implant. Brightfield images are shown for staining with Hematoxylin and 
eosin, Safranin O, and Picrosirius red, as well as polarized light images of Picrosirius 
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CHAPTER 3  
Resorbable plating system stabilizes tissue-engineered intervertebral discs 
implanted ex-vivo in canine cervical spines2 
Abstract 
 Total disc replacement using tissue-engineered intervertebral discs (TE-IVDs) 
may offer a biological alternative to treat radiculopathy caused by disc degeneration. A 
composite TE-IVD was previously developed and evaluated in rat tail and beagle 
cervical spine models in vivo. Although cell viability and tissue integration into host 
tissue were promising, significant implant displacement occurred at multiple spinal 
levels. The goal of the present study was to assess the effects of a resorbable plating 
system on the stiffness of motion segments and stability of tissue-engineered implants 
subjected to axial compression. Canine motion segments from levels C2/C3 to C5/C6 
were assessed as intact (CTRL), after discectomy (Dx), with an implanted TE-IVD only 
(PLATE-), and with a TE-IVD combined with an attached resorbable plate (PLATE+). 
Segments under PLATE+ conditions fully restored separation between endplates and 
showed significantly higher compressive stiffness than segments under PLATE- 
conditions. Plated segments partially restored more than 25% of the CTRL motion 
segment stiffness. Plate attachment also prevented implant extrusion from the disc space 
at 50% compressive strain, and this effect was more significant in segments from levels 
C3/C4 when compared to segments from level C5/C6. These results suggest that 
stabilization of motion segments via resorbable plating assists TE-IVD retention in the 
disc space while allowing the opportunity for implants to fully integrate into the host 
tissue and achieve optimal restoration of spine biomechanics. 
                                                 
2 This chapter was recently accepted for publication: Mojica-Santiago JA, Lang GM, Navarro-Ramirez 
R, Hussain I, Hӓrtl R, Bonassar LJ. (2018) Resorbable plating system stabilizes tissue-engineered 




 Intervertebral disc (IVD) degeneration is known to alter the stability and 
biomechanics of cervical spine motion segments while decreasing the foraminal canal 
through which nerves stem from the spinal cord, in the most severe cases. Cervical 
radiculopathy that leads to debilitating or excruciating neck pain in patients (63.5-107.5 
per 100,000) is often associated to these changes.1 First-line treatments include physical 
therapy and pharmacologic regimens, but surgical intervention is indicated in refractory 
cases or when the spinal cord is severely compromised. Although standard surgical 
treatments for cervical radiculopathy and myelopathy involve anterior cervical 
discectomy and fusion (ACDF) of the diseased motion segment, loss of spine flexibility 
and reduction of segment range of motion after surgical treatment is suspected to 
contribute to the onset of adjacent segment disease (ASD).1-2 Total disc replacement or 
arthroplasty has also been explored as an alternative treatment to the golden standard to 
preserve segment stability and motion. However, the efficacy of cervical disc 
arthroplasty (CDA) in reducing the incidence of symptomatic ASD remains under 
debate.3,4 Whereas there may be other factors such as progression of the underlying disc 
degeneration that influences the occurrence of ASD, the rates of secondary surgical 
procedures in patients with ACDF is higher than those who received a CDA.5 
Nevertheless, interbody implants and artificial disc replacements6,7 are subject to wear 
and generation of debris that may lead to implant dislodgement, osteolysis, and 
mechanical failure. As such, the importance of restoring segmental motion and native 
IVD function with minimal risks of implant revisions cannot be overlooked. 
 Tissue-engineered implants have been investigated in the last decade as 
biological alternatives to traditional treatments for radiculopathy. Composite tissue-
engineered intervertebral discs (TE-IVDs) that mimic the form and function of the 
native disc have been developed by employing diverse fibrous materials to constitute 
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the annulus fibrosus (AF) and isotropic gels to recreate the nucleus pulposus (NP).8-15 
We have shown previously a composite TE-IVD that leveraged the cell-driven 
contraction of collagen type I gels around alginate cores that demonstrated promising 
results in vitro and in vivo in the murine caudal spine and the canine cervical spine.9,15 
Our implants restored near native function and tissue integration in rat tails up to 6 
months, and stably implanted TE-IVDs maintained cell viability and integration into 
host tissue in the canine model for 16 weeks. However, retention of TE-IVDs in the disc 
space remained to be achieved in 50% of the implanted canine segments. Displacement 
of TE-IVDs during surgery led to destabilization of the motion segment and collapse of 
the endplates resulting in conditions similar to disc degeneration when implants were 
displaced through the ventral side. 
 The benefit of employing a soft engineered implant with a relatively compliant 
mechanical integrity lies in the ability of the TE-IVD to mature in a dynamically 
stimulated environment while facilitating integration with surrounding host tissues. The 
collagen scaffold that constitutes the AF in TE-IVDs undergoes remodeling due to the 
metabolic activity of embedded cells and the organization of its fibers into a structure 
that mimics the native disc is enabled by the initial concentration and contractibility of 
the gel scaffold.16 Notably, TE-IVDs were shown to increase collagen and 
proteoglycans content by a factor of 10 over the course of 6 months in vivo, during 
which time the ECM integrated into neighboring vertebrae and provided physiological 
levels of mechanical function to the motion segment as assessed from static and 
dynamic aggregate moduli.9 Furthermore, we observed that all TE-IVDs at the C3/C4 
level remained stable in the canine spines in vivo, while all TE-IVDs implanted at C5/C6 
were displaced likely due to variations in size and angle of the VBs.15 Based on this 
previous work, we have identified two main challenges contributing to segment 
instability after placement of TE-IVDs: 1) mechanical robustness within the motion 
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segment is limited because the implant needs to be immature to promote integration; 2) 
vertebral anatomy of motion segments varies by level and is suspected to affect the 
stability of implantation, which results in implant migration out of the disc space. Axial 
dynamic distraction using an external fixator alone and in combination with cell therapy 
have been shown to promote disc repair in rabbit IVDs.17-19 To achieve IVD implant 
retention and prevent collapse of the disc space, external fixation of the vertebral bodies 
(VBs) has also been shown to provide stability in rodent caudal spines.20-21 Although 
the disc space height was maintained in these animal models, the implants were not 
exposed to physiologic loading, which was integral for TE-IVD maturation, integration 
to host tissue, and restoration of mechanical function. A bio-resorbable fixation system 
made of 85:15 polylactic-co-glycolic acid (PLGA) plates and screws (Rapidsorb®, 
Depuy Synthes Co. Johnson & Johnson, West Chester, PA), widely used for cranio-
maxillofacial trauma, provides an alternative for temporary and gradually dynamic 
stabilization of spine motion segments. The PLGA in this commercially available 
stabilization system has been well characterized for its biocompatibility and resorption 
kinetics, and is FDA approved for in vivo reconstructive procedures. 
 To address these shortcomings, we asked whether TE-IVD implantation assisted 
by a resorbable plating system restores motion segment stiffness and prevent implant 
extrusion under axial compression, thereby improving overall stability of the treated 
segment. This PLGA system has been rated by the manufacturer to retain 85% of its 
strength for up to 8 weeks, while its bulk resorption is expected to occur within 12 
months. A resorbable plate can enhance short term mechanics and keep the implant in 
place while the engineered tissues mature; however, the ability of resorbable plates to 
stabilize motion segments in combination with an engineered implant has not been 
shown. Our objectives with this study were to evaluate the restoration of the 
compressive mechanics of motion segments with a combined treatment approach of TE-
 65 
IVD implanted with a PLGA fixation system and identify the ability of these resorbable 
plates to prevent implant extrusion. 
Materials and Methods 
Cell isolation and TE-IVD fabrication 
 We adapted the cell preparation methods from previously established 
protocols.8-9 Briefly, we harvested cervical IVDs from three skeletally mature canine 
spines (18-36 months of age, Marshall BioResources, North Rose, NY), washed them 
in phosphate-buffered saline (Dulbecco’s PBS, MediaTech, Manassas, VA) with 1% 
antibiotic-antimycotic solution (AbAm, 100 μg/mL penicillin, 100 μg/mL streptomycin, 
and 2.5 μg/mL amphotericin B, MediaTech), and diced the nucleus pulposus (NP) and 
annulus fibrosus (AF) tissue regions separately. After digesting NP and AF tissues in 
0.3% wt./vol. collagenase type II (Worthington Biochemical Corp., Lakewood, NJ) at 
37 °C for 12 hours, we filtered the digested tissue solutions through a 100 μm nylon 
mesh (BD Biosciences, Bedford, MA). Subsequently, we cultured the NP and AF cells 
separately in Ham’s F-12 media (MediaTech) containing 10% fetal bovine serum 
(Gemini BioProducts, Sacramento, CA), 1% AbAm, and 25 μg/mL ascorbic acid 
(Sigma-Aldrich, St. Louis, MO) to confluence. 
 Similarly, we based the TE-IVD fabrication process on established 
techniques.9,15 First, we mixed encapsulated canine NP cells (25 x 106 cells/mL) in 3% 
wt./vol. alginate (FMC BioPolymer, Philadelphia, PA) two-to-one with a 0.02 g/mL 
calcium sulfate (Sigma-Aldrich) solution. Then, we injected the mixture into 
customized 3D-printed molds with cylindrical cavities made of acrylonitrile butadiene 
styrene plastic on a Ultimaker 2+ (Ultimaker North America, Cambridge, MA) to 
produce tissue-engineered NPs. After one hour of immersion in 60 mM calcium chloride 
(Sigma-Aldrich), we removed and placed the engineered NPs in the center of each well 
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of a 12-well plate. Next, we mixed an acidic 6 mg/mL collagen stock solution prepared 
from rat tail tendon fibers (Sprague Dawley, 7-8 weeks old, Pel-Freez Biologicals, 
Rogers, AR) with a basic solution (10x PBS, 1 N sodium hydroxide, and 1x PBS), in 
which we seeded canine AF cells (2 x 106 cells/mL) to obtain a final concentration of 4 
mg/mL. Finally, we created tissue-engineered AF layers by surrounding the engineered 
NPs with 1.5 mL of the resulting collagen/AF solution and allowing gelation at 37 °C 
for 30 min. Following gelation, we added 1mL of previously described culture media to 
each well and cultured the TE-IVDs for 4 weeks with media changes twice a week. TE-
IVD implants were made of the same cylindrical shape with an elliptical cross-section 
for all motion segment levels. 
 In addition, we also prepared a group of acellular TE-IVDs by adapting the 
protocol for high density collagen preparation as described previously.22 Briefly, we 
prepared and mixed collagen gel stock solutions at 20 mg/mL from collagen type I of 
the previously described source with the corresponding basic formulation to obtain a 
final concentration of 10 mg/mL. Then, we poured the resulting neutralized collagen 
solution into each well of 24-well plates and allowed gelation at 37 °C for 30 min before 
removing 8-mm biopsy punches to simulate mature TE-IVDs. Thereafter, we 
maintained these collagen plugs in PBS bath until used for displacement tracking. 
Motion segment preparation 
 To prepare specimens for testing, we obtained eight cervical spines of skeletally 
mature canines (18-36 months of age, Marshall BioResources) and dissected motion 
segments from levels C2/C3 through C5/C6 by isolating the IVDs with the vertebral 
bodies on the adjacent cranial and caudal sides from all nerves, dorsal spinous processes, 
corresponding ligaments, and other soft tissues surrounding the IVD (Figure 3.1A). We 
kept the spines frozen after they were harvested from the donor animals and thawed 
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them at room temperature before isolating the individual motion segments for further 
testing. We divided the specimens into two cohorts corresponding to the two distinct 
testing setups to test the biomechanical response of motion segments and to assess the 
implant retention in the disc space. For the first cohort of motion segments, we allocated 
four spines and isolated motion segments from levels C2/C4 to C4/C5 (N=3 per spine) 
through bisection of each VB transversally such that each specimen comprised a native 
IVD with cranial and caudal endplates intact and half of its corresponding VBs cut 
(Figure 3.1D). For the second cohort, we isolated motion segments from the levels 
C3/C4 and C5/C6 of four spines (N = 2 per spine) by removing the adjacent C2/C3 and 
C4/C5 IVDs such that units of IVD with their corresponding cranial and caudal VBs 
remained intact. Afterwards, we embedded the VBs of these motion segments in dental 
molding cement (COE Tray Plastic, GC America, Alsip, IL) maintaining alignment of 
the long axis of the segment perpendicular to the top and bottom ends of the potting 
molds (Figure 3.1F). 
 We tested each specimen in each of the following conditions: (1) as intact 
(CTRL); (2) after discectomy (DX); and with an implanted TE-IVD (3) without a 
resorbable plate (PLATE-) or (4) with the plate (PLATE+) (Figure 3.1D). Following 
initial testing of intact segment, we performed a standard discectomy making a box-like 
incision through the ventral side and along the IVD/endplate interface followed by 
AF/NP extraction while preserving the posterior longitudinal ligament. After testing 
specimens under DX conditions, we inserted 4 mg/mL TE-IVDs into empty disc space 
of the first cohort and acellular 10 mg/mL TE-IVDs for the second cohort. We prepared 
fixation plates by cutting longitudinally along the centerline of an 85:15 PLGA plate of 
2 x 18 – 2.0 mm holes (Rapidsorb® Rapid Resorbable Strut Plate, Depuy Synthes Co., 
West Chester, PA) and trimming transversally every two holes into fragments that 
appropriately matched the distance between endplates on the ventral side of each 
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segment (Figure 3.1B-C). Since displacement of TE-IVDs occurred ventrally in vivo, 
we aimed to apply the smallest possible plate that minimized the profile on the cervical 
spine motion segment. Following implantation of TE-IVDs and testing on all 
specimens, we sanded the cranial and caudal endplates on the ventral side of each 
segment to fit the resorbable plate closely to the VB. We secured the plate at the ventral 
midline of each specimen with two 85:15 PLGA screws measuring 2 mm diameter by 
6.0 mm long (Rapidsorb® Rapid Resorbable Cortex Screw, Depuy Synthes Co., West 
Chester, PA), after drilling and tapping holes through the endplates, one in each of the 
VBs (Figure 3.1D). We chose not to mount wider plates or larger screws, because they 
would require a more invasive resection of the bony parts of the VBs upon implantation 
and could interfere with soft tissue structures surrounding the motion segments under in 
vivo conditions. 
Biomechanical testing 
 We implemented two separate testing protocols: (1) multi-step stress relaxation 
tests to measure the biomechanical response of motion segments under unconfined 
compression; and (2) continuous compression at constant strain rate to assess the 
migration of the implanted TE-IVD. First, we took measurements of the VB dimensions, 
the outer IVD diameter, and disc height with calipers on the CTRL specimens. For the 
VB, we measured the distance between the contour of the endplate where the AF 
attaches and the edge of the VB that was cut after isolation from the cervical spine, as 
well as the major and minor axes of the cranial and caudal VBs. For all experimental 
conditions, we considered half the average disc space between endplates at the outer AF 
as the nominal height. Furthermore, we assumed rigid body motion for the VB and 
endplate, and that the change in IVD area between testing conditions was negligible. As 
such, all the axial deformations that occurred under each testing condition were assumed 
to be in the IVD. Subsequently, we reported the average measured height of the outer  
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Figure 3.1. A) Preparation of motion segment from levels C2/C3 to C4/C5 (dotted lines 
indicate vertebrae levels) for mechanical testing. B) Close-up image of PLGA plates 
and screws as supplied by manufacturer. C) Close-up detail of directions of cuts in 
PLGA plate (dotted lines) D) Sample images of the motion segments under the 
examined conditions. E) Testing protocol and setup used to assess the biomechanical 
response of a motion segment; curves show a sample of loading vs. time for stress 
relaxation conditions and a sample of the resulting load vs. displacement used to 
calculate segment stiffness. F) Representation of the motion segments with VBs fixed 
in dental cement; PLATE- and PLATE+ depict prepared specimens for implant motion 
tracking. G) Sample of a loading curve resulting from the constant strain rate protocol 




AF for DX, PLATE-, and PLATE+ groups as ratios of disc space height to intact 
segment under each condition. 
 For the first protocol, we clamped the caudal VB portion of the specimen to the 
load cell on a mechanical testing system (ELF 3200, EnduraTech, Eden Prairie, MN), 
while an impermeable plate applied 5% compressive strain steps up to 15% strain on 
the cranial VB portion (Figure 3.1E).9,23 During each of the intact and experimental 
conditions described above, we kept the specimens surrounded by a gauze soaked with 
PBS (MediaTech) containing protease inhibitors (Roche Diagnostics, Indianapolis, IN). 
From the resulting load-displacement data, we calculated an effective stiffness for the 
motion segment in equilibrium, and data from DX, PLATE-, and PLATE+ groups were 
normalized against their corresponding CTRL segments to calculate ratio of stiffness to 
intact segments under each condition.  
 For the second protocol, we clamped the potted VB of the specimen on its caudal 
end to the testing frame, while an impermeable plate compressed uniaxially at 0.5% 
strain/sec until segment collapse (Figure 3.1G). To track migration of acellular TE-IVDs 
in segments, we recorded the uniaxial compression tests at 30 frames per second. We 
used a video camcorder (Sony CX440 Handycam®, Sony Corp.) fixed on a tripod and 
controlled exposure settings and frame to focus on the disc space between endplates 
(Figure 3.3A). 
Image analysis and digital image correlation 
 We matched the frames of the resulting videos to the compression test at 
constant strain rates and selected the frames corresponding to 5% strain until collapse 
(Supp. videos S3.1 and S3.2). Then, we used open source digital image correlation 
software (Ncorr v.1.2)24 to quantify two-dimensional displacements at the region of 
interest (ROI) within the disc space corresponding to the TE-IVD and the remaining AF 
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tissues (Figure 3.3A). From the radial (horizontal) and axial (vertical) displacement 
maps (Figure 3.3B), we computed average magnitudes of the resultant displacement 
vectors in the ROI at discrete distances along the segment diameter between the ventral 
and dorsal sides of the disc space. To discretize the disc space, first we normalized the 
horizontal values of the ROI to this segment diameter and centered nominal radial 
locations around the mid-axis of the disc space (x=0). Then, we reported the mean 
displacements at each nominal radial location as the average of the values from the 
cranial endplate (y = 0) to the caudal endplate (y = disc space height) while excluding 
the empty background. We chose to compare the average magnitudes of PLATE- and 
PLATE+ experimental groups at 50% strain, since these were the maximum allowable 
strain of the intact motion segments corresponding to these groups (Figure 3.3C-D, 
Suppl. figures 3.5-3.8).  
Statistical analysis 
 We reported all data as mean ± standard deviation and evaluated data 
distribution in boxplots. For the biomechanical analysis, we conducted a repeated 
measures analysis of variance to compare the effect of segment level (C2/C3 to C4/C5) 
on the ratio of segment stiffness to intact segment in equilibrium over the experimental 
conditions DX, PLATE-, and PLATE+. We then used Tukey honest-significance 
difference post-hoc tests to identify significant differences at p < 0.05, with the Statistics 
and Machine Learning Toolbox of MATLAB R2017 (Mathworks, Natick, MA). For the 
image processing data, we used R (R-Studio, Boston, MA) and the lme4 function25 to 
perform a linear mixed effects analysis of the relationship between vector displacement 
magnitudes and treatment at discrete radial locations of un-plated and plated segments. 
As fixed effects, we considered treatment (PLATE- vs. PLATE+), nominal radial 
location (x = -1 on ventral side to x = 1 on dorsal side), and segment level (C3/C4 vs.  
 72 
 
Figure 3.2. A) Disc space height changes under the examined conditions for all motion 
segments normalized to their corresponding intact CTRL segments; $ p < 0.05 between 
DX and PLATE-, # p < 0.05 between DX and PLATE+, and * p < 0.05 between PLATE- 
and PLATE+. B) Disc height ratio for motion segments at each level between C2 and 
C5 grouped by testing condition (lines correspond to the pairs of conditions with p < 
0.05). C) Compressive stiffness of all motion segments for each experimental condition 
normalized to their corresponding intact CTRL segments; $ p < 0.05 between DX and 
PLATE-, and * p < 0.05 between PLATE- and PLATE+. D) Compressive stiffness ratio 
for motion segments at each disc level between C2 and C5 grouped by testing condition 
(arrows signal the pairs of conditions with p < 0.05). Boxplots show the data of all 
segment levels combined and their distribution through their median and quartiles, 







C5/C6) along with the two-factor interaction terms for treatment. As random effects, 
we accounted for intercepts for spine (N =4) and for the interaction between spine and 
level. We identified significant differences at p < 0.05 using Tukey adjustments for 
multiple comparisons. 
Results 
Disc space height restoration 
 Motion segments with implanted acellular TE-IVDs and resorbable plates 
attached on the ventral side recovered initial height of the disc space before loading. 
Motion segments under PLATE+ condition reached significantly higher disc height than 
either DX (p = 0.002) and PLATE- (p = 0.003). While there were no marked differences 
in changes of disc space height between levels C2/C3, C3/C4, and C4/C5 (Figure 3.2B), 
the disc space height of all motion segments dropped by almost 30% when 
discectomized compared to the CTRL condition. TE-IVD implantation alone increased 
the disc space height ratio to 0.84 ± 0.18, while plating in addition to the implant 
recovered up to 134% of original disc height (Figure 3.2A). 
Motion segment stiffness preservation  
 In equilibrium, plating partially restored segment stiffness to more than 25% of 
the intact motion segment magnitudes of 60.9 ± 30.9 kN-m. Segments in PLATE+ 
group showed a significant two-fold increase in stiffness (p = 0.001) when compared 
to the PLATE- group (Figure 3.2C). The stiffness of segments in DX group dropped 
by more than 80% of their CTRL stiffness and the stiffness ratio of PLATE- group 
segments to CTRL decreased even further at 0.13 ± 0.07. Segment stiffness ratios in 
PLATE+ and DX groups were statistically similar, despite the notable increase in disc 
height and more than 41% difference between their stiffness ratio to CTRL.  
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Figure 3.3. A) Representative frame used to track implant migration in a motion 
segment and reference axes for the positive convention in the radial and axial directions; 
red dotted line shows central axis used to distinguish ventral and dorsal sides of the 
frame, green dotted line encloses the ROI within the disc space where displacement was 
computed, and yellow dotted ellipse encircles the sub-region where TE-IVD was 
located. B) Samples of 2-D displacement maps for magnitudes in the axial (top) and 
radial (bottom) orientations; color intensity values represent the local displacements in 
mm following the positive sign convention displayed by the axes in each of the 
corresponding orientations. C) Representative plated segment with resultant vectors of 
displacement (blue arrows) and magnitudes (colormap). D) Representative un-plated 
segment with resultant vectors of displacement (blue arrows) and magnitudes 
(colormap). Combined vector fields and colormaps of displacements follow the 




Differences between stiffness ratio to CTRL were not significant across C2/C3, 
C3/C4, and C4/C5 levels (Figure 3.2D). 
Improved implant retention 
 Attaching the plate prevented extrusion of the implant through the ventral side 
of all motion segments at 50% strain. The average magnitudes of vector displacements  
in the ROI were markedly affected by the nominal location along the radial direction (p 
< 2.2 x 10-6), by the treatment groups PLATE+ against PLATE- (p = 6.1 x 10-7), and by 
the combined interactions of treatment with segment level (p = 1.3 x 10-9). Notably, the 
average displacements in the disc space remained below 0.6 mm in the dorsal side, while 
the average displacements occurring in the ventral side exceeded 1.1 mm. The specific 
region located between 30% distance from the center in the ventral side and 100% 
distance from the center in the dorsal side (dorsal edge) delimited where average 
displacements were significantly lower across all treatments and levels. The maximum 
displacements of the acellular TE-IVDs recorded in the PLATE- group were observed 
consistently at the caudal endplate near the extrusion site (Figure 3.3D, Suppl. figure 
3.7), while the maximum displacements in the PLATE+ group were distributed along 
the cranial endplate (Figure 3.3C, Suppl. figure 3.8). 
 Plating reduced implant migration between 8-32% (Figure 3.4A) at discrete 
locations of the disc space. Segments from PLATE+ group had significantly lower 
average displacement magnitudes than those from PLATE- group at nominal radial 
locations between 80% and 50% distance from the center on the ventral side, 
corresponding to the region where the implant was located (Figure 3.3C-D and 3.4B). 
We observed that implants were partially expelled from the disc space by 5-10% strain 
and 15-25% strain in PLATE- segments, at C5/C6 and C3/C4 respectively. This trend 
was consistent with the statistical inference that plating was more effective in reducing 
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implant migration at C3/C4 segments (p < 0.0001), than in C5/C6 segments (p = 0.41) 
(Suppl. table 3.1). Nevertheless, different levels had no significant fixed effects on 
average displacements at the ROI. There were also no significant random effects 
observed between spines and combining spines with levels. 
 
 
Figure 3.4. A) Processed displacement vector magnitudes measured in the ventral side 
of the selected ROI in all C3/C4 and C5/C6 motion segments; yellow box corresponds 
to the region where the TE-IVD was located; * p < 0.05 represent significant differences 
between PLATE- and PLATE+ at the corresponding radial location; data are shown as 
mean ± standard deviation. B) Representative frames of PLATE+ (top) and PLATE- 
(bottom) with resulting displacement vector fields and magnitude colormaps 
specifically corresponding to the implant migration (outlined in yellow).  
Discussion 
 In the present study, we tested the hypothesis that resorbable plating improved 
stiffness of canine cervical spine motion segments in vitro and prevented the extrusion 
of implanted TE-IVDs from the disc space. We demonstrated that the combination of 
TE-IVDs implanted with PLGA plates reconditioned motion segment stiffness in 
compression by restoring the disc space height after discectomy and stabilizing the 
segment, while retaining the implant in place. Previous efforts of total disc replacement 
with a combined approach of tissue-engineered implants and external fixation focused 
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on preventing segment collapse and implant displacement.20 However, there has been 
no previous work demonstrating the ability of an implantable bio-resorbable fixation 
system to restore motion segment stability while preserving disc space height and 
retention of an engineered implant.  
 The PLGA temporary stabilization system adequately addresses our findings in 
the in vivo canine model of cervical disc replacement,15 where some TE-IVDs displaced 
ventrally. While implanted TE-IVDs alone were able to retain up to 70% of healthy 
control disc height in motion segments in vivo and more than 80% of intact CTRL disc 
height in vitro (Figure 3.2A-B), only with the attachment of the plate we observed 
complete recovery of disc space height. The relative rigidity of the PLGA plate 
compared to the hydrogel-based TE-IVDs and the fixation of the PLGA screws through 
the endplates contributed to the increase in disc height after discectomy. Since 
attachment of the PLGA screws was performed in an angular fashion from the sanded 
surface on the ventral side of the caudal and cranial endplates through the VBs, the rigid 
straight plate was fit closely to the implanted TE-IVD, thus effectively restoring 
distraction of the VB in the PLATE+ group before loading. In preliminary studies, TE-
IVDs demonstrated apparent equilibrium moduli in compression that ranged in the 0.5-
5 kPa, which remains orders of magnitude lower than the 0.03-5.96 MPa apparent 
equilibrium modulus observed in the intact cervical spine segments gathered ex vivo. 
Meanwhile, the PLGA copolymer that constitutes the plates and screws has an initial 
elastic modulus of 3.1 GPa and an ultimate tensile strength of 66 MPa.27 The combined 
approach in PLATE+ segments achieved sufficient mechanical robustness to partially 
restore intact CTRL segment stiffness (Figure 3.2C-D) when compared to PLATE- 
segments; therefore, this partial mechanical support allows for continuous load sharing 
and dynamic mechanical stimulation to the TE-IVD, while transferring loads through 
the endplates. Furthermore, preliminary tests of cervical spine segments without 
 78 
resecting the posterior elements and soft tissues revealed that between 60-80% of 
compressive loads applied onto intact motion segments are shared by these additional 
tissues. The relative similarity of the intact stiffness ratio between DX and PLATE+ 
groups likely results from the contact between endplates after DX which confounds the 
rigidity of an empty disc space with that of a treated segment.  
 The resorbable plate is expected to provide temporary structural biomechanical 
support while promoting implant integration in the first 4 to 16 weeks, since the PLGA 
plate degrades between 4 and 12 months.26 Faster degradation kinetics in vitro than in 
human maxillofacial bones in vivo have been shown previously with PLGA implants; 
however, the stiffness of intact explants upon isolation from the surrounding fibrous 
tissue and bone could not be tested.27 Due to the slower degradation observed clinically 
in this case, the copolymer implant was expected to retain its bending strength for longer 
periods than the 75 days tested in vitro. It should be noted that the contraindications of 
the Rapidsorb® fixation system warn against its use in load-bearing applications, unless 
in conjunction with traditional rigid fixation. In human patients, a combined ACDF 
approach of a polyether ether ketone (PEEK) spacer with resorbable materials such as 
poly (L-lactide-co-D, L-lactide) (PDLLA) has been shown to provide similar fusion 
progress and stability than traditional titanium fixation;28 however, our intent with this 
study was to provide temporary stabilization to the implanted TE-IVD instead of 
promoting rigid fixation of the motion segment. In this context, degradation of the 
PLGA system is expected to promote a gradual change in load distribution between the 
TE-IVD and the PLGA plate, unlike the case of existing interbody spinal fusion 
techniques and external fixation devices previously evaluated in human cadaveric 
spines.29-32 Mackiewicz et al. confirmed in a finite element study that introducing highly 
stiff stabilizing plates into cervical spine motion segments increases stress in the 
endplate of adjacent segments and that plates that allow greater range of motion show 
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up to 30% reduction of adjacent plates resulting stress.33 Matge et al.34 discussed clinical 
and radiological observations that suggest dynamic cervical implants as a promising 
alternative to total disc replacement, anterior cervical discectomy and spinal fusion, and 
they indicate that preserving motion segment biomechanics reduces stress on facet joints 
and development of adjacent segment disease. The advantage of our combined approach 
over existing interbody cage designs and dynamic cervical prosthetics remains in that 
our TE-IVD has been shown to remodel over time and mature to restore the mechanical 
function of spine segments to native conditions, when stably implanted and fully 
engrafted.9 
 The use of video recorded frames during the uniaxial continuous compression 
protocol and digital image correlation for data processing enabled the quantitative 
analysis of implant migration within the disc space. Acellular TE-IVDs were retained 
within the disc space of all segments under PLATE+ conditions, because the PLGA 
plates served as a physical barrier that prevented complete extrusion of the implants. 
The distribution of maximum displacements along the cranial endplate in PLATE+ 
segments (Figure 3.3C) suggests a shift of the implant to accommodate to the endplate 
shape on the cranial side. As expected, the location of maximum displacements of the 
PLATE- segments occurred at the implantation site where the space with least resistance 
remained open (Figure 3.3D), since the inclined shape of the endplate in the ventral side 
combined with the lack of anchoring for the implant resulted in a wedge-like extrusion. 
These observations were consistent with the mechanism of extrusion observed in the 
displaced implants of our in vivo canine study.15 The significant reduction of implant 
migration in PLATE+ at locations in the ventral side further supports the ability of 
resorbable plating to retain the TE-IVD inside the disc space (Figure 3.4). Furthermore, 
the relatively similar displacement profiles observed in all segments outside of the 50% 
to 80% range of radial distance from central axis suggests that spine flexibility and 
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overall range of motion around the location of the implant remains unaffected. The 
quantitative analysis of implant migration also revealed level-dependent differences in 
the efficacy of our combined treatment approach. Displacements of TE-IVDs were more 
effectively reduced at C3/C4-level PLATE+ segments than in those of levels C5/C6 
(Suppl. table 3.1), likely due to the anatomic differences at the endplates of both 
segments. These differences were also reflected in vivo where 66.67% of the stably 
implanted TE-IVDs were located in C3/C4-level segments, while 100% of the TE-IVDs 
implanted in the C5/C6-level segments were displaced.15 In human cervical spines, 
marked anatomic differences exist between superior and inferior endplates at upper 
level and lower level segments.35-36 These findings provide further insights into the 
careful considerations that need to be taken when deciding location of implants in 
cervical motion segments. Whereas the reported measurements of displacement are 
limited to the resultant sum of local deformations caused by the applied load from those 
caused by rigid body motion, these parameters provide a quantitative estimate of 
segment motion under uniaxial compression. Future studies could benefit of 
differentiating texture to enhance segmentation of the implant and the surrounding 
tissues within the image and multiple projections to capture a three-dimensional range 
of motion. 
 Several limitations in this work warrant important discussion when interpreting 
our findings within the context of an ex vivo model of an in vivo scenario. First, this 
study only assesses the compressive stiffness uniaxially, which does not recapitulate 
accurately what occurs in the physiological environment in vivo. However, our 
motivation for uniaxial mechanical testing was based on the intraoperative observations 
where the implants migrated out of the disc space solely from the deformations applied 
in axial compression upon removal of the distractor pins.15 Furthermore, with the 
assistance of the surrounding muscles and ligaments, individual cervical spine segments 
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in quadrupeds are mainly loaded under axial compression to balance the bending 
moments from the weight of the head and neck.45 Challenges remain in characterizing 
the biomechanical response of motion segments with our proposed treatment under 
cyclic loading or fatigue, both of which are also relevant in spine biomechanics and help 
inspect modes of failure in the system. Future work should investigate dynamic testing 
of motion segments and their biomechanics in the full six degrees of freedom 
characteristic of the spine. Second, while favorable outcomes in terms of durability and 
minimal negative inflammatory responses have been shown in cranio-maxillo-facial 
approaches with several animal models using PLGA plates and screws,37-38 their load-
bearing capacity remains limited.39 Recent work by Maenz et al.40 with PLGA-
reinforced calcium phosphate cement in ovine VBs suggests a potential use in load-
bearing structures given the versatility and manufacturability of PLGA. Third, this study 
does not include a direct assessment of the degradation kinetics of the resorbable system 
and its effects on the load distribution across the VBs over time. While in vitro 
assessment of the degradation of the PLGA system could provide estimates on strength 
retention, the use of this resorbable system in future in vivo work is preferable to 
appropriately assess the efficacy of our proposed combined approach. Fourth, our 
surgical approach and modifications to the plate require further tuning to minimize the 
need for sanding the endplate and altering the VB profile. Since the ACDF approach is 
characterized by minimal invasiveness compared to dorsal or lateral fixation, we 
recommend exploring the attachment of customized PLGA elements that can adapt to 
the curvature of the ventral side of the motion segment. Lastly, anatomical differences 
between human and canine cervical motion segments could also have significant impact 
on the performance of the resorbable plate examined in this work; furthermore, canine 
IVDs are exposed to similar or even higher loading compared to humans.41-47 However, 
the canine spine shows analogous degenerative processes to those of humans and are 
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regularly diagnosed and treated for disc degeneration with equivalent surgical 
approaches.45-47  
 This study provides valuable insights of canine motion segment biomechanics 
and validates a combined approach of total disc replacement with TE-IVD and an 
implantable resorbable fixation system. Our findings in the current study present a 
baseline for further ex vivo and in vivo animal studies to better discern the long-term 
biomechanical and integrative properties of cervical TE-IVDs stabilized by resorbable 
plating. In addition, the method herein described to quantify displacements at specific 
locations along the radius of endplate offers a tool for estimation of loads occurring at 
the disc in diverse surgical scenarios. This work demonstrates that the combination of 
an implanted TE-IVD with a resorbable plate improves implant retention by preventing 
ventral displacement under uniaxial compression, partially restores the compressive 
stiffness of intact segments by providing a shared distribution of loads and helps avert 




Figure 3.5. Still frames from the supplemental video of a representative PLATE- 




Figure 3.6. Still frames from the supplemental video of a representative PLATE+ 
segment under uniaxial compression at 5% strain intervals up to 50% strain. 
 85 
 
Figure 3.7. Still frames from the supplemental video of the displacement magnitude 
colormap in a representative PLATE- segment under uniaxial compression at 5% strain 




Figure 3.8. Still frames from the supplemental video of the displacement magnitude 
colormap in a representative PLATE+ segment under uniaxial compression at 5% strain 





Table 3.1. Summary of vector displacement magnitudes averaged over the entire range 
of nominal radial locations from the ventral side to the dorsal side (x = -1:1 mm/R(mm)) 
and the resultant p-values from the multiple comparison tests at 0.95 confidence level. 
Data are grouped by treatment (PLATE- vs. PLATE+, and by level C3/C4 vs. C5/C6); 
linear mixed model analysis revealed significant differences between treatments at level 
C3/C4 only (* p < 0.05). 
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CHAPTER 4  
Seeding density of human mesenchymal stem cells modulate the structure and 
composition of tissue-engineered intervertebral discs  
with high-density collagen annulus fibrosus 
Abstract 
 Tissue-engineered whole intervertebral discs (TE-IVDs) have been previously 
shown to restore mechanical function in the rodent spine and promote cell viability and 
integration in the canine spine. However, the in vitro development of constructs that 
reach close-to-native IVD stiffness and composition properties remains an active area 
of study. In the present work, we assessed the combined effects of high-density collagen 
(10-20 mg/mL) annulus fibrosus (AF) scaffold and highly-contractile human 
mesenchymal stem cells (hMSCs) on the structural remodeling and composition of TE-
IVDs. Composite TE-IVDs were fabricated, with hMSCs embedded in alginate-based 
nucleus pulposus as previously established, and high-density collagen (Col) seeded with 
hMSCs at a range between 2 and 20 million cells/mL for the AF. Structural changes in 
TE-IVD morphology were assessed by disc contraction measurements and apparent AF 
densification over 3-4 weeks. After culture, samples were examined histologically and 
mechanically to identify differences in tissue composition between groups. Significant 
morphological changes and AF cell-phenotype were observed in 10 mg/mL Col TE-
IVDs at increasing seeding density with hMSCs. In 10 mg/mL Col discs, increasing 
seeding density 5-10 times from the previously reported baseline increased their 
compressive properties in a dose-dependent manner and their apparent AF density 
between 1.5-3.5 times their initial Col density. These effects were virtually negligible 
in 20 mg/mL Col discs. These findings support the potential of employing modulation 
of hMSCs seeding density in TE-IVDs with dense AF/collagen matrices to achieve a 
controllable tissue composition and structure of the remodeled AF scaffold. 
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Introduction 
 Neck and back pain are among the most debilitating conditions in the 
industrialized world and intervertebral disc (IVD) degeneration is linked as one of the 
leading causes of these afflictions.1-9 Nearly two-thirds of the population are affected by 
cervical spine-related problems7-9 and up to $100 billion in costs per year are associated 
with lower back pain.10 The IVD has very limited repair capacity due to its avascular 
nature,11 and while there are a variety of non-surgical and minimally invasive 
alternatives to treat disc degeneration, surgical intervention is required for the most 
severe cases when conservative treatments fail.12 Among the standard surgical options, 
partial or total discectomy with spinal fusion of adjacent vertebrae, and total disc 
replacement with prosthetics remain the most utilized clinically. While these solutions 
help alleviate the pain, the underlying disc pathology continues to progress and the 
function of spinal segments as a unit is altered, which can lead to recurrent surgical 
revisions and further degeneration of the adjacent segments.13-19 
 Growing interest in developing tissue-engineering strategies as biological 
alternatives to traditional degenerative disc disease therapies have been observed 
recently. Whereas some efforts focused on separately treating damage in the annulus 
fibrosus (AF) or nucleus pulposus (NP) regions,20-27 whole intervertebral disc 
replacement with tissue-engineered constructs remains an area of continuous 
improvement.28-37 We have previously demonstrated promising results in vitro and in 
vivo with composite tissue-engineered intervertebral discs (TE-IVDs) that mimic the 
native IVD structure and employ an engineered NP made of alginate surrounded by a 
fibrous engineered AF made of low-density collagen type I.34,37 Notwithstanding that 
these composite TE-IVDs restored mechanical function in the rodent spine and 
promoted cell viability and integration in the canine spine, optimum biological and 
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mechanical benchmarks of IVDs are yet to be developed in vitro before human clinical 
trials might be contemplated with these constructs.38-39  
 A major challenge to overcome for the successful clinical translation of TE-
IVDs is to ensure that the implantable construct endures the combined loading present 
in the demanding mechanical environment of the spine, while maintaining enough 
compliance to dynamically integrate with the host tissues. The native IVD in humans 
has region-dependent mechanical properties, as is the case with other animal models of 
IVD mechanics. The equilibrium modulus ranges between 5 and 65 kPa for the NP38-40 
in unconfined compression and reference aggregate modulus has been described 
between 25 to 420 kPa for the AF38,39,41-43 in confined compression. Whereas increasing 
the mechanical properties of engineered NPs is a logical step in enhancing the stiffness 
of TE-IVDs in vitro, alginate has been shown to achieve sufficient compressive 
properties to mimic the NP, especially after tissue maturation during culture.34,40 A key 
contributor to the mechanical robustness of the IVD lies in the circumferentially-aligned 
multi-laminated structure of the AF, which possesses regional variations in extracellular 
matrix composition and cell morphology.41-46 The AF is also responsible for containing 
both the tensile stresses that help preserve spinal range of motion and the hydrostatic 
pressures experienced from NP swelling. Therefore, the interplay between both tissue 
regions of the composite possesses far more importance in the success of an engineered 
construct than either one alone. To promote the development of robust TE-IVDs with 
biomimetic alginate-based NPs, emphasis on the extracellular matrix organization and 
composition in engineered AF must be critically assessed. 
 Due to the dominant presence of collagen in native IVDs and the functional 
anchorage for cells collagen provides, established work employed collagen as the basis 
for AF scaffolds and relied on cellular contraction and remodeling to produce stiff 
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composite structures and elicit tissue integration in AF repair.31,47-50 Whole disc 
engineering has long benefited from achieving the desired structural organization of 
oriented collagen fibers at the AF region with low-density (1-4 mg/mL) collagen 
formulations. In contrast, high-density formulations (10-20+ mg/mL) have been 
extensively used for other tissue engineering applications, such as meniscus, ear 
cartilage, and for extracellular matrix studies to understand the behavior of cancer 
cells.51-54 High-density collagen has also been shown to present superior stiffness with 
a well-defined fiber organization and lower hydraulic permeability than low-density 
gels, especially when remodeling by cell traction was coupled with mechanically 
relevant boundary conditions.51 In all of these systems, cellular remodeling and 
reorganization of collagen were key in achieving appropriate structure and properties. 
 Due to the deficient vascularity in the IVD and the limited nutrients transport 
and cell density for both the NP and AF regions, relatively inadequate counts of viable 
cells can be acquired from native tissues to use in engineering whole discs in vitro. 
Mesenchymal stem cells (MSCs) derived from human bone marrow offer a clinically 
relevant cell source for IVD tissue engineering. MSCs indeed survive and proliferate 
within the IVD, and they have been shown to contribute to the regenerative potential of 
restoring normal structure and function in numerous biological therapies in vitro55-59 
and in vivo.60-62 Furthermore, the ability of hMSCs to differentiate into AF-like and NP-
like tissue phenotypes has been previously demonstrated with the benefit of exerting 
greater contractile forces on collagen substrates than AF and NP cell 3D culture 
systems.58,63 Currently, MSCs are widely used for whole IVD, NP, and AF tissue 
engineering in combination with other natural and synthetic biomaterials.64-66 
 As pre-clinical studies with TE-IVDs progress towards large animal models, 
elucidating the extent to which the coupled interaction of seeding density of cells and 
 96 
density of the scaffold affect the structural organization and composition of the AF is 
even more relevant. The initial concentration of cells seeded in a collagen scaffold and 
the initial density of collagen in an AF scaffold are known to independently affect 
remodeling of engineered constructs and alter tissue composition and structure. Also, 
tissue composition and structural organization both have direct effects on the final 
mechanical and biochemical properties of an engineered construct. Although the 
combination of high-density collagen and MSCs has been successfully implemented 
before,67 a dearth of efforts to recapitulate these effects on functional composite TE-
IVDs exists to date.68 In an effort to understand the interplay between the initial density 
of a scaffold and its initial cell seeding density, we studied the potential of highly-
contractile hMSCs embedded in a dense extracellular matrix to produce organized 
collagen in engineered AF tissues. Therefore, the objectives of the current study were 
two-fold: to investigate the potential for dense collagen scaffolds seeded with hMSCs 
to improve baseline AF properties in TE-IVDs and to assess the effects of seeding 
density with hMSCs and AF scaffold density on the engineered tissue structural and 
composition properties. 
Materials and Methods 
Cell expansion and culture 
 Cryopreserved human bone marrow-derived MSCs (hMSCs) (MSC-001, 
RoosterBio Inc., Frederick, MD) were initially expanded to population doubling level 
(PDL) 6-9 and frozen in optimized freeze media with 10% DMSO (CryoStor® CS10, 
BioLife Solutions, Inc., Bothell, WA) at 10x106 hMSCs/mL using manufacturer’s 
recommendations. Then, hMSCs were thawed and washed with hBM-MSC High 
Performance Media containing (KT-001, RoosterBio, Inc.) before seeding them in T-
150 and T-500 flasks to allow for high cell yields in constrained incubator space. Cells 
were cultured at 37 °C, 5% CO2, and normoxia to PDL 14-15 for 7-10 days in hBM-
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MSC High Performance Media (Fig. 4.1A). PDL is used here to measure cellular age 
rather than the number of passages, as recommended by the manufacturer, because it 
considers the number of times the cells have doubled since their primary isolation while 
they retain pluripotency. The media was changed after 5 days if cell expansion appeared 
delayed upon visual inspection of the culture flasks. Expanded hMSCs were 
subsequently harvested from T-150 and T-500 flasks with 0.25% trypsin (MediaTech, 
Manassas, VA).; at which point, cell viability and total cell number were assessed via 
trypan blue dye and hemocytometer counting standard methods. At least two batches of 
expanded cells were required to meet the minimum cell count desired. 
Collagen solution preparation 
 Collagen type I was obtained from tendon fibers harvested from rat tails 
(Sprague Dawley, 7-8 weeks old, Pel-Freez Biologicals, Rogers, AR) as described in 
previously established work.54 Briefly, tendons were dissected, submerged in ethanol, 
and diluted in 0.1% acetic acid at 150 mL/g of dry tendon mass. After collagen from 
tendons was solubilized for 48 hours at 4 °C, the resultant solution was centrifuged at 
9000 rpm for 90 min to separate the heavy residues of fatty and non-solubilized tendon 
tissues. The clear supernatant collagen solution was collected, let freeze for 24 hours, 
and lyophilized for at least 48 hours. The lyophilized collagen was then reconstituted in 
0.1% acetic acid at 6, 20, and 30 mg/mL stock solutions for storage at 4 °C, until used 
for TE-IVD fabrication.  
Tissue-engineered disc NP fabrication 
 Composite alginate and collagen TE-IVDs were constructed following 
previously established techniques using expanded hMSCs.31 The total count of viable 
cells was divided into two subsets. The first subset was spun down, and the cell pellet 
encapsulated in 3% weight per volume alginate (FMC BioPolymer, Philadelphia, PA) 
dissolved in phosphate-buffered saline (Dulbecco’s PBS, MediaTech) at 15±5x106 
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hMSCs/mL, while the second subset was initially suspended in 25-40 mL of the high-
performance media in a centrifuge tube and set inside the incubator until use for the 
collagen/AF portion. The alginate suspension with encapsulated hMSCs was mixed 
two-to-one with a 0.02 g/mL CaSO4 (Sigma-Aldrich, St. Louis, MO) solution in a three-
way syringe stopcock setup (Fig. 4.1C). To produce tissue-engineered NPs, this new 
mixture was subsequently injection molded into the cavities designed with native canine 
NPs dimensions of 3D-printed molds (Fig. 4.1B) made of acrylonitrile butadiene styrene 
plastic on a Ultimaker 2+ (Ultimaker North America, Cambridge, MA). After filled 
molds were immersed in 60 mM CaCl2 (Sigma-Aldrich) for an hour, the engineered 
NPs were cut out and centered inside each well of a 24-well plate (Fig. 4.1D and F). 
Tissue-engineered AF fabrication and disc culture 
 To produce engineered AF with high-density collagen gels, we adapted the 
procedure from previous work42-44 and used the space between the NP and the 
boundaries of the wells of a 24-well plate as AF molds (Fig. 4.1E-F). A total of eight 
groups were created to examine the effects of increasing collagen concentration in AF 
scaffold and increasing seeding density of hMSCs in TE-IVDs: one baseline 4 mg/mL 
Col group with 2x106 hMSCs/mL; four groups of 10 mg/mL Col with 2x106, 5x106, 
10x106 and 20x106 hMSCs/mL; and three groups of 20 mg/mL Col with 2x106, 10x106, 
and 20x106 hMSCs/mL. The combination of 10 mg/mL Col with 5x106 hMSCs/mL was 
explored uniquely to account for the two-to-one ratio of collagen concentration 
(mg/mL) to cells seeding density (106 hMSCs/mL) observed in the baseline group. 
Stock collagen solutions at 6, 20, and 30 mg/mL were used for fabricating TE-IVDs 
with final collagen concentrations 4, 10, and 20 mg/mL in the AF, respectively. Several 
batches of TE-IVDs were cultured given the constraints of incubator space and limited 
number of hMSCs that could be expanded at a time. However, not all experimental 
 99 
conditions were assessed simultaneously; therefore, the total count of samples initially 
fabricated per group ranged between four and eight.  
 
Figure 4.1. A) Commercially available human MSCs were acquired in highly 
concentrated frozen vials and expanded to PDL 6-9 first, frozen, and then re-plated to 
PDL 14-15 expansions. B) 3D-printed molds were designed in CAD software with 
cylindrical cavities that matched 70% of the ventral-dorsal and lateral-lateral 
dimensions of native canine NPs. C) Three-way stopcock setup used to combine cell-
seeded alginate suspension in one syringe with another syringe containing calcium 
sulfate immediately before injection molding. D) Schematic of an engineered NP made 
of crosslinked alginate/hMSCs and modeled as an elliptical cylinder. E) Combinations 
of hMSCs seeded at various Col concentrations were created by modifying relative 
ratios of cell-media suspensions, PBS, NaOH, and stock collagen solutions; shown in 
the table are the experimental groups and baseline control group examined. F) The wells 
of tissue culture plates were used as molds to surround engineered NPs with hMSCs-
seeded Col mixtures and produce TE-IVDs. G) Gross image of a native canine IVD 
shown to compare TE-IVDs morphology. H-L) Representative TE-IVDs images of the 
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control 4 mg/mL Col disc group (H), 10 mg/mL Col discs at 10x106 and 20x106 
hMSCs/mL (I-J), and 20 mg/mL Col discs at 10x106 and 20x106 hMSCs/mL (K-L). 
 The preparation of each group in a batch, starting with the groups with the 
highest cell seeding density to the lowest, proceeded in the following fashion: 1) The 
concentrated cell suspension prepared from the second subset of hMSCs was spun down 
and resuspended into the required volume, Vcells 0, to meet the highest seeding density 
desired, [MSCs]f, of the batch as described by equation 1: 
    [𝑀𝑆𝐶𝑠]𝑓 =
[𝑀𝑆𝐶𝑠]0∙𝑉𝑐𝑒𝑙𝑙𝑠0
𝑉𝑡𝑜𝑡𝑎𝑙𝑓
,   (1) 
where [MSCs]0 denotes the concentration of resuspended cells in stock and Vtotal f is 
the total volume of the desired AF solution. 2) Basic diluting solutions that consisted of 
10x concentrated PBS, 1x PBS, and 1 N NaOH were kept ice cold and mixed in 
centrifuge tubes, at the volumetric ratios (equations 2-4) that correspond to the desired 
total AF volume, Vtotal f: 
   𝑉(10𝑥𝑃𝐵𝑆)0 = 0.1 ∙ (𝑉𝑡𝑜𝑡𝑎𝑙𝑓 − 𝑉𝑐𝑒𝑙𝑙𝑠0),   (2) 
    𝑉(𝑁𝑎𝑂𝐻)0 = 0.023 ∙ 𝑉𝑐𝑜𝑙0,    (3) 
 𝑉𝑡𝑜𝑡𝑎𝑙𝑓 − 𝑉𝑐𝑜𝑙0 − 𝑉𝑐𝑒𝑙𝑙𝑠0 = 𝑉(1𝑥𝑃𝐵𝑆)0 + 𝑉(10𝑥𝑃𝐵𝑆)0 + 𝑉(𝑁𝑎𝑂𝐻)0, (4) 
where Vcol 0 is the volume of collagen initially added from the stock, and V(1xPBS)0, 
V(10xPBS)0, and V(NaOH)0 refer to the volumes of the components of the basic 
diluting solution described above. 3) Using a three-way syringe stopcock setup, the ice-
cold acidic stock solution of collagen required for the final collagen concentration in the 
AF, [Col]f, (equation 5) was initially mixed with the appropriate volume of basic 
diluting solution to neutralize pH and maintain 300 mOsm in the collagen: 
    [𝐶𝑜𝑙]𝑓 =
[𝐶𝑜𝑙]0∙𝑉𝑐𝑜𝑙0
𝑉𝑡𝑜𝑡𝑎𝑙𝑓
,    (5) 
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4) Immediately afterwards, the neutralized collagen solution was mixed with the 
required volume of cell suspension in high-performance media, Vcells 0, using the 
syringe stopcock setup and extruded through the injection tip around the NPs following 
a circumferential direction of deposition up to a Vtotal f = 750 μL inside each well. 5) 
Next, steps 2 through 4 were repeated with the different collagen groups under the same 
high cell seeding density, after which the remaining volume of cell suspension was 
diluted to the next tier of cell seeding density. The iterative process described above 
continued with further serial dilutions of the cell suspension until all groups of the 
lowest cell seeding density of the batch were completed. 
 Lastly, the collagen in the 24-well plate was allowed to polymerize at 37 °C for 
30 min before adding 1mL of culture media that consisted of DMEM without sodium 
pyruvate (MediaTech), 10% fetal bovine serum (Gemini BioProducts, Sacramento, 
CA), 1% antibiotic-antimycotic solution (100 μg/ml penicillin, 100 μg/ml streptomycin, 
2.5 μg/ml amphotericin B, MediaTech) and 2.5% HEPES buffer (MediaTech) to each 
well. Within the first 48 hours of culture, the composite units of hMSC-seeded alginate 
NP and collagen AF that comprised the TE-IVDs were transferred from a 24-well plate 
to individual 6-well plates grouped by combinations of cell seeding density and collagen 
concentration in AF scaffold. The TE-IVDs were carefully covered with 2-3 mL of 
previously described culture media in each well such that the discs did not float in their 
wells. Discs were subsequently cultured for 3-4 weeks with media changes twice a 
week. 
Morphological analysis 
 TE-IVDs were allowed to contract over a period of 23-28 days, during which 
time photographs were taken every 2-4 days coinciding with media changes. The 
photographs of each TE-IVD (N= 4) were taken at close range such that the bottom of 
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the well and the TE-IVD contour were at the same focal point (Fig. 4.1H-L). Photos 
were then uploaded to ImageJ (National Institutes of Health, Bethesda, MD) and scales 
were set against the bottom of the well with known dimensions. For each timepoint, 
measurements were taken of the well bottom area (or initial disc area) and the contours 
corresponding to the whole TE-IVD and the NP region only. Since discs were 
transferred from 24-well plates to 6-well plates after TE-IVD fabrication, a conversion 
factor for the ratio of the dimensions was calculated from the measurements provided 
in the specifications of the manufacturer and considered in the reported values. In a 
conventional Excel spreadsheet, ImageJ measurements along with their corresponding 
conversion factors were used to compute whole TE-IVD contraction at each timepoint 
as a ratio of current area relative to the initial area (or well bottom area). Furthermore, 
the contour of the NP region at each timepoint was subtracted from the whole disc to 
account for the relative area corresponding to the AF only. Considering the assumptions 
that the change in height of the TE-IVD was negligible during culture and that the total 
collagen remodeling in the AF was such that the deposition of de novo collagen balances 
the loss of scaffold collagen to the culture media, therefore, a relative change in AF area 
is reported as an apparent change in the initial collagen density of the AF scaffold. This 
is shown in the following equation: 
    𝐶𝑡 = 𝐶0 (
𝐴0−𝐴𝑁𝑃,𝑡
𝐴𝐼𝑉𝐷,𝑡−𝐴𝑁𝑃,𝑡
),    (6) 
where A0 represents the initial whole disc area (or bottom area of the well), ANP, t 
corresponds to the NP contour at the given timepoint, AIVD, t is given by the whole TE-
IVD contour at the given timepoint, and C0 and Ct are the initially known collagen 
density and current timepoint’s apparent collagen density in the AF, respectively.  
 Conventional histological techniques were also applied to the constructs to 
compare the construct morphology, cell distribution, and deposition of relevant 
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extracellular matrix in 10 mg/mL and 20 mg/mL TE-IVDs. By the end of the culture 
period, one or two samples from each group were fixed in 10% phosphate-buffered 
formalin for 48 hours, followed by at least a 24 hours relocation in 70% ethanol. They 
were then embedded in paraffin and sectioned at 5 um-thick transversal slices. The 
sections were stained with Safranin-O to observe GAG content and distinguish NP vs. 
AF morphology after images were taken by a trained observer with light microscopy.  
Mechanical analysis 
 The effective composite mechanical properties of the TE-IVDs were assessed 
following previously established protocols for unconfined stress-relaxation tests.69 
Briefly, individual specimens (N= 2-8) were placed in a custom-made smooth 
impermeable cup mounted on the load cell of a Bose EnduraTech testing frame (ELF 
3200, Bose, Inc., Eden Prairie, MN), while an impermeable metallic cap placed at the 
tip of a displacement actuator applied 5% compressive strain steps up to 50% strain on 
the top surface of the TE-IVD. The TE-IVDs were kept submerged in PBS (MediaTech) 
containing protease inhibitors (Roche Diagnostics, Indianapolis, IN) during testing. 
After mechanical testing, the time-dependent stress response at each strain step was fit 
to a poro-viscoelastic response curve (equation 7) to obtain effective compressive 
stresses in equilibrium (Fig. 4.2A).  
    𝜎𝑐𝑜𝑚𝑝 = 𝐴(1 − 𝑒
−𝑡/𝜏) + 𝐵,    (7) 
From the resulting compressive stress-strain data, an effective elastic modulus, Eeq, for 
the TE-IVD in equilibrium was calculated (Fig. 4.2B). In addition, to account for the 
non-linear elasticity observed in TE-IVDs, the effective equilibrium stress vs. stretch 




Figure 4.2. A) Representative sample graphs of poro-viscoelastic response to stress-
relaxation tests in unconfined compression from 5-50% strain. B) Representative plots 
of resulting compressive stress-strain in equilibrium and linear fit to calculate effective 
elastic modulus, Eeq. C) Representative plot of effective equilibrium stress vs. stretch 
data fit to the hyperelastic Holmes-Mow constitutive law for aggregate modulus, HA0, 
equilibrium stress-stiffening coefficient, β, calculations. 
defined by equation 8 following a non-linear least squares regression in MATLAB 
R2017 (Mathworks, Natick, MA) (Fig. 4.2C): 








,   (8) 
where the reference aggregate modulus, HA0, and compressive stress-stiffening 
coefficient at large strains, β, are the relevant material parameters. 
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Figure 4.3. A-B) Boxplots of experimental and control Eeq data grouped by cells and 
collagen combinations with marked outliers as red asterisks depicted in standard values 
and log transformed values. C-D) Boxplots of experimental and control HA0 and β data 
grouped by cells and collagen combinations with red asterisks marking outliers. 
 The mechanical data corresponding to effective elastic modulus at equilibrium, 
aggregate modulus, and compressive stress-stiffening coefficient for the 10 mg/mL 
collagen and 20 mg/mL collagen TE-IVDs were fit to a 4-parameter logistic regression 
or dose response model (equation 9), where the mechanical response estimates, M = < 
Eeq, HA0, β >, occurred between a minimum response, Mmin (the value of M at S = 0), 
and a maximum response, Mmax (the value of M at S = ∞), as a function of the initial 
cell seeding density, [x0], at the AF. This equation was given by: 
  𝑀[𝑥0] = 𝑀𝑚𝑖𝑛 +
(𝑀𝑚𝑎𝑥−𝑀𝑚𝑖𝑛)
1+𝑒−𝑏 ∙ ( [𝑥0]−𝐸𝐶50 )
,   (9) 
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where b represents the Hill’s slope of transition to maximum mechanical response and 
the inflection point, EC50, indicates the initial cell seeding density at which 50% of the 
maximum mechanical response is observed. Outliers obtained from boxplots of each 
group of cells and collagen combinations (Fig 4.3A-D) were not included in the 
sigmoidal curve fits.    
Statistical analysis 
 Measured data for TE-IVD contraction ratio and apparent AF density over time 
were reported as mean ± standard deviation. For these data, a linear mixed-effects 
analysis was conducted to inspect the relationship between contraction ratio and two 
factors, scaffold concentration and cell seeding density, at discrete timepoints. As fixed 
effects, we considered collagen in scaffold (4 mg/mL, 10 mg/mL, and 20 mg/mL), cell 
seeding density (2x106/mL,10x106/mL, and 20x106/mL), and nominal timepoints in 
days (t = 0, 2, 4, 7, 10, 14, 18, 21, and 23), along with all the two-factor interaction 
terms. As random effects, we accounted for intercepts for sample (N= 4). The time-
dependent and -independent effects of scaffold concentration and cell seeding density 
on the apparent AF density were also analyzed with a linear mixed-effects model 
following similar factors as described with the contraction ratio. In both cases, linear 
mixed-models were fit using the lme4 function71 in R (R-Studio, Boston, MA). For both 
analyses, significant differences between estimates for each available combination of 
collagen and cell against other combinations at any given timepoint were identified at p 
< 0.05 using Tukey adjustments for multiple comparisons. The same post hoc tests were 
performed between said estimates against the previous timepoints within each collagen 
and cell combination (Fig. 4.4A-B). 
 Data distribution of the mechanical response parameters Eeq, HA0, and β were 
observed in boxplots to exclude outliers and negative equilibrium or aggregate moduli 
values from further analysis. A Monte Carlo analysis was conducted for each group of 
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cell and collagen combination to determine the uncertainty in the curve fit coefficients 
(Mmax, Mmin, b, and EC50).
72 A log transform of the non-negative data was taken to 
provide a normal distribution for each group and the measured standard deviations were 
used to generate 100 simulations of data sets with 10 normally distributed random 
samples each. Each data set was refit to the model curve described in equation 7 by 
minimizing the RMS error in MATLAB. The coefficients for 10 mg/mL and 20 mg/mL 
curves were compared with a one-way ANOVA for the collagen factor using R-Studio 
to identify significant differences at p < 0.05. Measured data were shown along the curve 
fits as mean ± standard error, while the curve fit coefficients compared in bar charts 
were represented as mean ± standard deviation (Fig. 4.5 and Supplemental Figs. 4.8-
4.9).  
 Lastly, correlation analyses were performed for the mechanical response in 
equilibrium, Eeq, and the IVD ratio to initial area and apparent AF density at the end of 
culture period as variables dependent upon initial cell and collagen content. The IVD 
ratio to initial area was expressed as percentage of the original area and the equilibrium 
modulus was averaged before fitting the data to a plane. Critical correlation values were 
determined using r-tables with p< 0.05 considered significant.  
Results 
Morphological analysis 
 Over the 3.5-4 weeks culture period, the collagen AF in the TE-IVDs contracted 
around the NP reducing the whole disc area relative to the initial area, as shown by the 
contraction ratio measurements (Figure 4.4A). No significant differences in AF 
contraction were observed between all 10 mg/mL Col discs and the baseline 4 mg/mL 
Col discs group at day 2. Conversely, the 20 mg/mL Col discs significantly expanded 
to 111 ± 6.2% (p= 0.040 for 4 mg/mL and p= 0.049 for 10 mg/mL) after they were 
transferred from the 24-well plate to the 6-well plate within the first 2 days. In fact, 
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through the entire culture period, all 20 mg/mL Col disc groups retained greater area 
ratios to their initial disc area (p < 0.01) than the baseline group and all 10 mg/mL Col 
discs. By the first week, the 10 mg/mL Col discs with 20x106 hMSCs/mL significantly 
exceeded the contraction observed on the baseline group by 25.9% (p= 8x10-4) and on 
the other 10 mg/mL Col disc groups with lower seeding densities by 20.1 to 23.4% (p= 
0.004 and p= 0.035 for 2x106 and 10x106 hMSCs/mL, respectively). Only after two 
weeks, the 10 mg/mL Col discs with 10x106 hMSCs/mL contracted 31.7% past the 
baseline group (p< 1x10-4). Nevertheless, the 10 mg/mL Col discs with 2x106 
hMSCs/mL retained similar contraction ratios to the baseline group TE-IVDs at all 
times. 
 Significant changes in AF contraction over time for each group were only 
observed in the TE-IVDs with 4 mg/mL Col and 10 mg/mL Col and at different 
timepoints. By the fourth day, the control 4 mg/mL group had a significant decrease in 
area (p= 0.007) to 81.3 ± 6.9% from its initial area. Meanwhile, the 10 mg/mL Col discs 
with 10x106 and 20x106 hMSCs/mL had significant contractions from previous 
timepoints only after one week, until their second week when they reached 57.9 ± 2.2% 
(p= 0.003) and 36.8 ± 4.0% (p= 1x10-4) from their initial areas, respectively. However, 
the 10 mg/mL Col discs with 2x106 hMSCs/mL exhibited negligible contraction over 
the culture period similar to the 20 mg/mL Col discs. 
 In terms of the apparent AF density based on the relative AF area, as the 
embedded hMSCs pulled on collagen fibers and contracted around the NP, the TE-IVDs 
experienced changes in collagen AF density ranging between a 3.5-fold increase and a 
loss of up to 9.4% after 23 days (Fig. 4.4B). As expected for each timepoint, given their 
initial collagen density, the control 4 mg/mL  
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Figure 4.4. A-B) Progression over 23 days of TE-IVD contraction ratios, and apparent 
AF density based on relative AF area and initial collagen density; $ p< 0.05 vs. group 
color in same timepoint, # p< 0.05 vs. same group area ratio at t= 0, * p< 0.05 vs. same 
group area ratio up to at least 3 previous timepoints. C-D) Gross image of a 10 mg/mL 
Col disc with 20x106 hMSCs/mL and close-up (4x) of its NP/AF interface revealed by 
Safranin O staining. E-F) White arrows point to the contraction-driven remodeling of 
collagen fibers around the NP/AF interface in close-up images (20x) and (40x) of the 
10 mg/mL Col disc with 20x106 hMSCs/mL. G-H) White arrows point air bubbles 
trapped in AF scaffold in close-up images (20x) and (40x) of a 20 mg/mL Col disc with 
20x106 hMSCs/mL. 
Col groups were significantly different from all 10 mg/mL Col discs and all 20 mg/mL 
Col discs. Interestingly, between days 7 and 10, the 20 mg/mL with 20x106 hMSCs/mL 
Col discs had statistically similar apparent AF density to the 20 million cells-seeded 10 
mg/mL Col TE-IVDs. By the first week, the 10 mg/mL Col discs with 20x106 
hMSCs/mL had 27.7% to 31.2% significantly greater apparent density than their 2 
million (p= 0.016) and 10 million cells-seeded (p= 0.042) counterparts, respectively. At 
day 14, the apparent AF density of 10 mg/mL Col discs with 10x106 hMSCs/mL was 
no significantly different than the 20 mg/mL Col discs with 10x106 and 20x106 
hMSCs/mL; and by day 18, it surpassed their 2 million cells-seeded counterparts by 
1.82-fold (p< 1x10-4).  
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 Evidently, the most pronounced changes in apparent AF density over time 
occurred in 10 mg/mL Col TE-IVDs. Since the first week of culture onwards, the 10 
mg/mL Col discs with 20x106 hMSCs/mL reached between 1.7- to 3.5-fold increase in 
apparent AF density (p< 0.05) from its initial collagen density. After week 2, the 
apparent AF density of 2 million cells-seeded 10 mg/mL Col peaked at 1.5 times the 
initial density (p= 2x10-4), while the 10 million cells-seeded cohort reached more than 
1.8 times the initial density (p< 1.1x10-3) from this timepoint forward. Although the 
control 4 mg/mL Col discs had an apparent AF density increase by up to 25.7% at day 
4, there were no significant differences over time. Similarly, the 20 mg/mL Col discs 
ranged in apparent AF density between 89.8% and 101%, without significant time-
dependent differences in any of the AF scaffolds seeded with 2x106, 10x106, or 20x106 
hMSCs/mL.  
 Histological examination of the tissue structure at the AF of 10 mg/mL and 20 
mg/mL TE-IVDs at the end of the culture period uncovered stark differences in collagen 
remodeling driven by the cell-dependent contraction of the scaffold around the NP 
(Figure 4.4C-H). Firstly, a tight tissue boundary appeared to form at the NP/AF interface 
of the 10 mg/mL Col disc, but was absent in the 20 mg/mL Col disc. Although the 
depicted representative samples were both initially seeded with 20x106 hMSCs/mL, 
greater cell proliferation was apparent in the 10 mg/mL Col disc than in the 20 mg/mL 
one. The distribution of cells in the 10 mg/mL AF was also clearer along the 
circumferentially-aligned collagen fibers than in the 20 mg/mL AF, where they appear 
scattered and scarce. Additionally, notable gap-holes observed in the AF of the 20 
mg/mL Col specimen suggested the presence of air bubbles. Nevertheless, Safranin O 
staining denoted a proteoglycan-rich extracellular matrix was at the NP region in both 
specimens with reasonable distinction.  
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Mechanical analysis 
 Testing the composite TE-IVDs in unconfined compression provided effective 
stress responses consistent with biphasic behavior of hydrogels. The goodness of fit for 
the effective elastic modulus in equilibrium, Eeq, given by the coefficient of 
determination, R2, varied between 94.8% in average for all 10 mg/mL Col TE-IVDs and 
95.0% in average for all 20 mg/mL Col TE-IVDs. A total of 4 outliers and the data 
corresponding to the baseline 4 mg/mL group were excluded from the 4-parameter dose 
response curve fit for equilibrium modulus as a function of cell concentration. From the 
simulated data sets corresponding to the data distribution of equilibrium moduli in 10 
mg/mL and 20 mg/mL Col TE-IVDs, the mean RMS error remained between 8.3 and 
3.6, and coefficients of variation (CV) of the RMS error between 23.1% and 22.8% for 
the 10 mg/mL and the 20 mg/mL groups, respectively. 
 Increase in the initial seeding density of hMSCs had a more pronounced dose-
dependent effect in the mean equilibrium modulus of 10 mg/mL Col discs than in 20 
mg/mL Col TE-IVDs (Fig. 4.5A). The mean equilibrium modulus remained relatively 
similar in the 20 mg/mL discs, with a 2.5-fold average increase from the Eeq, min to Eeq, 
max, in comparison to the 10 mg/mL discs whose Eeq, min rose to a nearly 30-fold Eeq, max, 
with increasing cell content. Surprisingly, the maximum Eeq reached by 10 mg/mL discs 
at 15.1 ± 2.2 kPa was significantly higher (p< 1x10-4) than the 4.2 ± 0.7 kPa of 20 
mg/mL discs (Fig. 4.5B). Additionally, the EC50 was also determined to be significantly 
higher (p< 1x10-4) in discs with a lower collagen density-AF than in those with a higher 
density-AF, with half-maximum mechanical responses observed at 6.8 ± 1.8 x106 and 
2.6 ± 0.3 x106 hMSCs/mL, respectively (Fig. 4.5D). Conversely, the 20 mg/mL discs 
had 3.3-times the minimum Eeq (p< 1x10
-4, Fig. 4.5C) and 4.4-times the Hill’s slope of 
transition to maximum mechanical response (p< 1x10-4, Fig. 4.4E) than 10 mg/mL 
discs.   
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Figure 4.5. A) Curve fit of effective elastic modulus in equilibrium of composite TE-
IVDs as a function of hMSCs initial seeding density in AF, grouped by density of 
collagen/AF scaffold; N = 1-7, mean ± SE. B-E) Coefficients generated from Monte 
Carlo simulations including maximum and minimum effective elastic moduli, EC50 in 
hMSCs seeding density, and transition slope; N= 100; mean ± SD; bars: p< 0.05. 
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 From the Holmes-Mow model analysis, the mean R2 values of 91.4 ± 21.6% for 
the 10 mg/mL Col TE-IVDs and 93.3 ± 15.5% for the 20 mg/mL Col TE-IVDs described 
reasonable curve fits of the nonlinear response of the compressive stresses in 
equilibrium as a function of stretch (Supplemental Figs. S.8-4.9). However, the dose 
response analysis for the aggregate modulus, HA0, and stress-stiffening coefficient, β, as 
a function of increasing cell seeding density resulted in coefficients of variation of the 
RMS error higher than 25%. For the HA0 mechanical response parameter, the mean RMS 
errors of 13.3 (CV= 52%) and 0.96 (CV= 31.5%) were observed in 10 mg/mL and 20 
mg/mL groups, respectively. For the β response parameter, the mean RMS errors of 10 
mg/mL discs and 20 mg/mL discs were determined as 6.01 (CV= 49.3%) and 1.27 (CV= 
27.9%). Although the data appeared to fit the nonlinear model, the effects of cell seeding 
density on the aggregate modulus was no different than that of the effective elastic 
equilibrium modulus. Furthermore, the stress-stiffening coefficient fit was far too poor; 
thus, the nonlinear model did not provide any additional insights than what the linear 
elastic model offered.  
Global correlation analysis 
 Three-dimensional multiple correlation analyses identified the effects of the 
independent variables initial cell seeding density and initial Col concentration in AF 
scaffolds, on the contraction ratio of TE-IVDs, their apparent AF density, and the 
average effective equilibrium modulus at the end of culture. All morphological data for 
the 4 mg/mL baseline, 10 mg/mL, and 20 mg/mL Col discs were plotted together and 
fit to a plane in the same graph (Fig. 4.6A-B). Final disc size as percentage of original 
disc area and AF apparent density displayed strong positive correlations (p< 0.01 for 
IVDsize and p< 0.05 for ρapp) between the initial cell and Col content. As expected, both 
higher initial hMSCs content and relatively-lower initial Col density had the most TE-
IVD contraction determined from the reduced final disc size. This relationship was  
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Figure 4.6. Correlation of collagen concentration and initial seeding density at the AF 
with contraction data as determined from IVD size (A) and apparent AF density (B). 
Equations describing the correlation factors are shown above each graph; r (26) = 0.479, 
p< 0.01 for IVDsize and r (26) = 0.374, p< 0.05 for ρapp. 
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described with the slope for Col as 3.72 (mg Col 0/mL)
-1 and the slope for hMSCs as -
2.11 (million cells/mL)-1, appreciated in Fig. 4.6A. Apparent densification of the AF 
peaked at the highest initial hMSCs content, with initial Col concentration having a 
weak indirectly proportional effect. From the corresponding equation plane in Fig. 4.6B 
the cell content slope denotes that an estimated 0.86 mg final Col/hMSC is contributed 
to the AF density, while the initial collagen content slope seems to slightly diminish the 
final AF density by 0.05 mg Col final per mg Col 0. For the mechanical data, the average 
equilibrium moduli of all 4 mg/mL baseline, 10 mg/mL, and 20 mg/mL Col discs were 
fit to a plane and displayed along with the set of individual data points per group (Fig. 
4.7A-B). Although there was no significant positive correlation observed between initial 
cell and Col content for the mean equilibrium moduli (r(6)= 0.707 > 0.43), a prominent 
positive correlation was found between initial cell density and the final apparent AF 
density for the same equilibrium statistic (p< 0.02). Notably in Fig. 4.7A, the initial Col 
concentration was a poor predictor for increasing mean equilibrium modulus with a 
slope of – 0.21 kPa (mg Col 0/mL)-1, whereas the expected contribution of the initial 
content of hMSCs was 0.35 kPa (106 MSCs/mL)-1. Conversely, Fig. 4.7B shows that 
increasing final apparent AF density correlated well with increasing mean equilibrium 
modulus as evident by the 0.37 kPa (mg Col 0/mL)-1, but the initial cell density slope 
appeared negligible at a slope of -0.01 kPa (106 MSCs/mL)-1. In this context, the extent 
to which cells drive the structural remodeling of the available collagen content into a 
dense matrix served as a better predictor of TE-IVD stiffness than the amount of 





Figure 4.7. A) Correlation of starting collagen concentration and initial seeding density 
at the AF with mean effective equilibrium data from each combination group. B) 
Correlation of apparent AF density at the end of culture period and initial seeding 
density at the AF with mean effective equilibrium data from each combination group. 
Equations describing quantitatively the correlation factors are shown above each graph; 
r (6) = .789, p< 0.02 for Eeq vs. Cells vs. ρapp. 
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Discussion  
 The goal of this study was to examine the role of scaffold density as prescribed 
by the initial collagen concentration and initial cell seeding density on the final 
composition and structure of TE-IVDs. The current work also served as a proof of 
concept for the generation of TE-IVD constructs with dense AF matrices. Composite 
TE-IVDs with AF scaffolds of moderately high initial density (10 mg/mL) contracted 
significantly over time until they reached and retained their final shape with relevant 
tissue structure and cell morphology both at the NP and the AF. Composite TE-IVDs 
with excessively dense AF scaffolds (20 mg/mL) did not contract at all and retained 
their original morphology without changes in tissue structure and adequate cell shapes. 
These observations were directly coupled with cell content, suggesting that the initial 
seeding density of the engineered AF modulates the final tissue composition in concert 
with AF scaffold density. The compressive properties of the discs were also influenced 
by the hMSCs initial seeding density in a dose-dependent manner, but the contribution 
of the initial collagen concentration to the mechanical response was only relevant to the 
extent that the hMSCs were able to remodel the AF scaffold over the culture period. 
Moreover, once the final remodeled structure and composition were set, then the 
stiffness of the TE-IVD were highly correlated with their structure described by an 
apparent final AF density.  
 Remodeling of the AF extracellular matrix was dependent on both initial cell 
density and initial collagen content. In this study, significant morphological changes 
occurred in 10 mg/mL Col discs, driven by the hMSCs traction on the AF scaffold and 
the boundary imposed by the alginate NP, that surpassed the changes in baseline and 20 
mg/mL Col discs over 3-4 weeks (Fig. 4.4A). This is consistent with the well-known 
property of cell seeded collagen gels, that contraction decreases with increasing 
concentrations of collagen.54,73-75 The AF contraction of 10 mg/mL groups deviated 
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from that observed in the baseline group within the first week of culture in a seeding 
density-dependent fashion. At increasing cell densities, this effect was intensified 
leading to final TE-IVD areas of lower than 40% of their original size. Furthermore, 
contraction rates observed in 10 mg/mL Col discs with cell seeding densities above the 
2x106 cells/mL baseline resulted in AF contraction that was accelerated after the first 
week and diminished after the second week of culture. This contraction rate change was 
also observed in the baseline discs, but not on the 20 mg/mL Col discs. Collectively, 
these findings suggest an inherent potential for hMSCs embedded in collagen matrices 
to adjust scaffold density until a contraction plateau is reached, which is a desirable trait 
for tuning the extent of scaffold remodeling in vitro.  
 The quantification of apparent density based on AF ratio to disc provided 
insights on time-dependent changes of tissue composition during culture that are also 
influenced by initial concentration of hMSCs. Apparent densification of the high-
density collagen gel led 10 mg/mL Col discs to match the initial scaffold density of 20 
mg/mL Col discs within one or two weeks (Fig. 4.4B), in response to the contraction 
observed in the AF. Moreover, this time dependence of apparent AF density of 10 
mg/mL Col discs varied as increasing initial cell-seeding concentrations accelerated 
collagen remodeling. Herein we assumed that hMSCs controlling collagen turnover in 
AF scaffolds retained a relatively constant total collagen content between timepoints to 
use the initial collagen density as a relevant parameter. Previous work by Puetzer and 
Bonassar showed in fact that up to 40% and 60% collagen can be lost to the culture 
medium in 10 mg/mL and 20 mg/mL Col scaffolds, after 4 weeks.51 As such, apparent 
AF density results discussed here should not be confused with true collagen 
concentration, which could be more accurately approximated by biochemical assays and 
volumetric information. Rather, apparent AF density provides a measure of structural 
organization as a function of initial collagen content and tissue composition. In this 
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context, we demonstrated that moderately-dense collagen scaffolds undergo structural 
remodeling in a time- and cell content-dependent form. 
 Limited changes in the apparent AF density and contraction-induced matrix 
remodeling of the 20 mg/mL and baseline groups indicate that an excessively dense 
matrix and a low cell-seeding density are both similarly deterrent of remodeling activity 
and structural organization at the AF. Surprisingly, the baseline group discs did not 
present AF contraction and remodeling as shown before.76 This finding could be 
attributed to relatively low homogeneity in the hMSCs suspensions prepared in series 
for the AF portion of the several groups in each fabrication batch. Changes in apparent 
AF density and matrix remodeling, as prominent or limited they appeared, were 
supported histologically with the highly porous appearance of the AF scaffold in 20 
mg/mL contrasting the dense organization of collagen in the AF scaffold of 10 mg/mL 
discs (Fig. 4.4C-H). While the present study focuses on the effects rather than the 
mechanism by which cells differentiate into chondrocyte-like and fibrochondrocyte-like 
phenotypes distinctive of the NP and AF regions in native IVDs, abnormal round-
shaped cells were preserved in the AF region of 20 mg/mL possibly indicating poor cell 
differentiation. However, histological evaluation of the TE-IVDs at 10 mg/mL collagen 
unveiled elongated cells that were oriented concentrically around the engineered NP 
and resemble the characteristic phenotype of cells in the AF. In previous work, similar 
effects were demonstrated with hMSCs in 4 mg/mL baseline constructs in both hypoxic 
or normoxic culture conditions.76 Interestingly, the effect of initial seeding density of 
hMSCs at the AF in 20 mg/mL Col discs was also virtually negligible, likely since the 
hMSCs were unable to reorganize or circumferentially align the dense scaffold into 
distinctive fibers. In McCorry et al., high-density collagen constructs seeded with 
bovine MSCs exhibit abnormally-shaped fiber bundles in comparison with those 
constructs seeded with fibrochondrocytes or in co-culture of MSCs and 
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fibrochondrocytes.77 They also observed that MSCs seeded alone increased GAG and 
collagen production in high-density collagen, both of which contribute to preferred 
tissue composition in TE-IVDs as well. This suggests a potential for using AF cells in 
co-culture with hMSCs in future studies with the interest of providing the desired 
microenvironment to promote adequate differentiation of hMSCs, extracellular matrix 
composition, and reorganization of scaffold fibers.  
 A directly proportional effect was appreciated between initial cell seeding 
density at the AF and the mechanical response of TE-IVDs in equilibrium. Conversely, 
increasing initial collagen content had an unexpected negative correlation to the mean 
effective equilibrium modulus (Fig. 4.7A). Compressive properties of collagen gels are 
known to be relatively low, especially if cell-seeding effects on remodeling are not 
appreciated. Although high-density collagen has been shown to achieve superior 
stiffness with cell-seeded constructs, in the current work, this paradigm is inverted 
indicating that initial scaffold density alone, without accounting for internal structure 
remodeling, is a poor predictor for tissue stiffness. Moreover, increasing the initial cell 
seeding density elicit a dose response to the equilibrium modulus in 10 mg/mL and 20 
mg/mL Col discs (Fig. 4.5A). Analysis of the curve-fitting parameters for this dose-
dependent behavior revealed that the maximum equilibrium modulus and half-
maximum mechanical response was decreased in the TE-IVDs with the highest AF 
collagen content (Fig. 4.5B-E). The final AF density parameter described from TE-IVD 
morphology was also weakly correlated to the initial collagen content (Fig.4.6B), thus 
supporting the idea that an initially dense scaffold is not sufficiently functional without 
structural remodeling. Nevertheless, the strong correlation between this final AF density 
parameter with the mean effective equilibrium modulus and initial cell seeding density 
further highlights the importance of structural organization and matrix remodeling as a 
strong predictor of composite TE-IVD stiffness. The challenge in remodeling highly 
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dense matrices into a tightly organized structure can be overcome when combining the 
appropriate cell content to an adequately formulated dense scaffold.  
 The current study offered new insights on the interplay between cell seeding and 
initial scaffold densities on the structural and composition properties of TE-IVDs, 
however, several limitations in this work should be acknowledged. Sample size for each 
group of cell content and collagen concentration was limited due to batch culture design 
for simultaneous testing of several experimental conditions and constraints of incubator 
space and limited number of hMSCs expanded at a time. It is possible that low statistical 
power overlooked significant differences between groups of combined formulations; 
this was relatively apparent after the Monte Carlo simulations supported tightly 
normalized populations of simulated samples. This low number of samples tested point 
to the need for a higher number of cell expansions and possibly combining with relevant 
region-specific NP and AF cells in co-culture with hMSCs. The culture of TE-IVDs 
seeded with hMSCs without any mechanical conditioning, growth factor and/or 
chemical stimuli in their media could have implications on their metabolic activity in 
3D culture over 3-4 weeks. It should also be noted as a limitation that assays to identify 
trilineage potential and differentiating markers of hMSCs were not conducted on this 
population of cells, since we relied on the instructions of the manufacturer that guarantee 
pluripotency up to the PDL range we used. Nevertheless, extracellular matrix 
environment and choice of scaffold material have been shown to provide necessary 
biophysical signals for hMSCs to differentiate into region-specific cells with NP- and 
AF-like phenotypes.76 The use of scaffolds as sole indicators of differentiating potential 
eliminates confounding effects of combining too many factors with an already limited 
sample availability. Future work should ensure a thorough characterization of the 
differentiating potential of the hMSCs population used in TE-IVD constructs in addition 
to assessment of shapes characteristic to the desired phenotype. Another limiting aspect 
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of this study lies in the assumptions made for mechanical testing, more specifically with 
utilizing the Holmes-Mow model for unconfined compression measurements without 
hydraulic permeability data. Also, poor fits of stress-stiffening coefficient relayed that 
there could be influencing effects missed due to low statistical power or because the 
strain-dependent behavior is traditionally characterized in a confined compression 
testing framework. To this end, our inferences focused on the effective mechanical 
response in equilibrium as described by Kim et al., where a biphasic poroelastic model 
can be reduced to one or two coefficients.69 We have not focused on hydraulic 
permeability data in this context to consolidate the number of variables describing 
correlating factors and because data analysis yielded poor coefficients of determination 
arguably due to the significantly different radial boundaries on each group. 
Computational analyses with simulated hydraulic permeability data could reveal 
additional effects supporting our findings, but we have considered them beyond the 
scope of this work. 
 In the present study, we demonstrated that high-density collagen can be used as 
an AF scaffold to generate TE-IVDs with enhanced structural organization and tissue 
composition over previously established baseline formulations. Our findings also 
supported that remodeling of the AF ECM in TE-IVDs was dependent on both initial 
cell density and initial collagen content. Such remodeling was observed as cell traction 
forces pulled on the collagen matrices and recreated circumferentially oriented denser 
AF. Densification of the AF over time was mostly mediated by initial concentration of 
hMSCs, where increasing seeding density resulted in higher structural organization in 
moderately-dense matrices. Therefore, excessively dense matrices and low cell-seeding 
densities both counteracted the remodeling potential in the TE-IVDs. Higher structural 
organization was also shown to correlate directly with greater compressive properties 
in equilibrium, and similarly dependent upon initial cell content more than initial 
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collagen concentration. This is the first study to our knowledge that employed high-
density collagen for AF scaffold in composite IVD replacements. Previous studies on 
high-density collagen scaffolds for AF engineering have focused on the collagen as a 
carrier for AF cells or MSCs to fill AF defects.68,78 Future work should consider co-
culture of MSCs with tissue-specific cells to further enhance the structural organization 




Figure 4.8. A) Curve fit of effective aggregate modulus of composite TE-IVDs as a 
function of hMSCs initial seeding density in AF, grouped by density of collagen/AF 
scaffold; N= 1-3; mean ± SE. B-E) Coefficients generated from Monte Carlo 
simulations including maximum and minimum effective aggregate moduli, EC50 in 
hMSCs seeding density, and transition slope; N= 100; mean ± SD; bars: p< 0.05.  
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Figure 4.9. A) Curve fit of effective equilibrium stress-stiffening coefficient of 
composite TE-IVDs as a function of hMSCs initial seeding density in AF, grouped by 
density of collagen/AF scaffold; N= 1-3; mean ± SE. B-E) Coefficients generated from 
Monte Carlo simulations including maximum and minimum β coefficient, EC50 in 
hMSCs seeding density, and transition slope; N= 100; mean ± SD; bars: p< 0.05.  
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CHAPTER 5  
Concluding Remarks 
Summary 
 This dissertation sought to develop canine disc-sized composite TE-IVDs for 
the in vivo evaluation of a pre-clinical canine cervical spine model of total disc 
replacement (TDR) to support the long-term goal of advancing TE-IVDs closer to 
translation into humans. In the process of investigating the efficacy of this animal 
model, not only was the proof of concept objective met successfully, but challenges for 
achieving a clinically applicable TE-IVD construct related to motion segment stability 
upon implantation and implant pre-operative composition and structure were also 
identified (Chapter 2). The stability of canine motion segments was then investigated 
with a novel treatment approach of a resorbable plating system combined with 
implanted TE-IVDs, which was found to partially restore the compressive stiffness of 
segments, provide separation of endplates, and prevent implant migration out of the disc 
space (Chapter 3). Finally, the effect on TE-IVD structure and composition of initial 
collagen AF concentration was found to be unexpectedly minimal as compared to the 
effect that the initial seeding density of human MSCs has in remodeling the AF scaffold 
into its final apparent AF density (Chapter 4). This chapter discusses the main findings 
on this dissertation and suggests future directions that can build on this subject.  
Canine in vivo model for cervical disc replacement 
 In chapter 2, we demonstrated that fabrication of alginate- and collagen-based 
TE-IVDs was scalable to produce canine-sized constructs and that stable implantation 
of these constructs integrate into host tissue and preserves disc hydration and height for 
up to 16 weeks in vivo. In addition, from the testing conditions for surgical intervention, 
we found that PLL resection failed to prove a differentiating effect overall in stably 
implanted TE-IVDs. We also discovered that most of the constructs that were retained 
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in the disc space post-operatively were implanted in level C3/C4. The fact that roughly 
50% of all the TE-IVDs were displaced suggests that there is a need to ensure a roster 
of TE-IVDs of different sizes before the clinicians, since the constructs are designed to 
hold in the disc space via press fitting. It is also known that motion segments along the 
spine have different geometries and anatomical dimensions from each other; therefore, 
morphology of the vertebral endplate arguably plays a greater role of responsibility for 
the extruded discs than the TE-IVD fabrication process. 
 The canine cervical spine provides several advantages to study TDR with TE-
IVDs. The similarities between human cervical spine and canine cervical spines are 
more pronounced in the degenerative process that affects IVD ageing and in their 
kinematic patterns. In rat tails, the highly compressive loading environment with 
minimal torsional rotation and bending moments was enough to allow the press-fit 
implantation of TE-IVDs. In the canine model, as it occurs with human spines, the 
loading environment in vivo consisted of coupled bending and torsional loadings; 
although the higher compressive stresses in the canine neck and the inclined 
morphology of the cervical endplates aggravated the stability of implanted TE-IVDs. 
Another aspect that warrants close attention is the increased diffusion length of larger 
TE-IVDs as the size scaling changes from rat- and canine-sized discs to humans. In 
preliminary in vitro work for this study (Appendix A), 70% smaller TE-IVDs than 
normal canine IVDs were observed to outperform the size-accurate TE-IVDs. To 
successfully scale up the TDR of TE-IVDs to human spines, alternative approaches that 
acknowledge these limitations should be explored; considering anchoring of TE-IVDs 
to the endplates or employing flexible biomaterials that promote implant stability and 
guarantees diffusion of metabolites to the disc space in the long term are encouraged. 
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Combined replacement treatment of TE-IVDs with bioresorbable stabilization 
 In chapter 3, we proposed a novel combination of treatment employing a 
bioresorbable fixation plate along with the implanted TE-IVDs. We tested the 
hypothesis that a combined treatment approach of implanted TE-IVDs with resorbable 
PLGA plating will improve the stiffness of canine cervical spine motion segments ex 
vivo and prevent the extrusion of TE-IVD constructs from the disc space. This combined 
treatment was idealized from our findings in the in vivo model described in chapter 2; 
instability of the motion segments after discectomy displaced implanted TE-IVDs out 
of the disc space ventrally. Our ex vivo model captured the mechanism of implant 
extrusion observed in the canine surgeries upon placement in the disc space without the 
resorbable plating. Combining resorbable plating with implanted TE-IVDs improved 
the stability of the motion segments, by increasing the effective stiffness of the segment 
over the solely implanted treatment and significantly reducing the resultant 
displacement of TE-IVDs, thereby preventing extrusion of the implants. 
Structure and composition of TE-IVDs by cell and collagen densities 
 In chapter 4, we investigated the interactions between collagen scaffold density 
and initial cell content in the context of structural remodeling of the AF and resultant 
tissue composition. We hypothesized that high-density collagen scaffolds seeded with 
hMSCs will improve baseline AF properties in TE-IVDs in terms of tissue structure and 
composition. Our findings in this study suggest that the initial seeding density rather 
than collagen concentration had the most impact in remodeling the AF scaffold, since 
the structural orientation from which the tissue stiffness rises, and the ECM deposition 
are directly linked to the metabolic activity of the embedded cells. The extent to which 
the collagen concentration affects the ECM remodeling is in fact detrimental in that 
denser matrices require significant more energy expense for cell traction forces to act 
on them; moreover, excessively stiff hydrogels could lead to deviations of hMSCs from 
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a predominantly chondrogenic pathway to a mineralized and rigid scaffold while in 
tissue culture. In the pursuit of scaling up tissue-engineered constructs, material 
composition, tissue stiffness, and cell viability within regions of larger diffusion 
distances can all counteract each other. From this work, it is believed that in dense 20 
mg/mL matrices, hMSCs were unable to remodel the collagen scaffold simply because 
they were not obtaining the nutrients required to effect sufficient contractile forces. 
Conversely, the 10 mg/mL matrices at increasing cell content remodeled the AF scaffold 
as expected, affecting TE-IVD stiffness in a form dependent on initial cell seeding dose. 
Conclusion 
 Overall, this body of work represents an insightful contribution to the field of 
intervertebral disc engineering. This work serves as a significant stepping stone in the 
advancement of clinical translation of total replacement with TE-IVDs. In addition, the 
methodologies discussed throughout each chapter are applicable to other fields. For 
example, displacement field analysis of implant motion could provide a tool for 
estimation of localized strains under various surgical conditions in neurology and with 
a milieu of potential treatments. Moreover, understanding the interplay between hMSCs 
and dense collagen scaffolds can help improve on engineered constructs for other 
fibrous tissues, such as tendons, cardiac muscle, and neural tissues. 
Future Directions 
  The work outlined in this dissertation lays the foundation for a number of future 
directions. This section includes recommendations for in vitro maturation of TE-IVDs 
to further improve construct properties as well as suggestions for ex vivo and in vivo 
studies with the canine cervical spine model of TDR. 
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Improving TE-IVDs in vitro 
 The tunability of AF scaffolds and the effects of initial cell seeding on dense 
matrices can be capitalized to improve designs of composite TE-IVDs at scales closer 
to human discs. A regional variation of dense AF scaffolds with a moderate collagen 
concentration at the outer AF and low-density collagen in the inner AF will provide the 
ideal 3D culture environment for cells to remodel into a native-like IVD structure. 
Keeping the NP as a highly porous matrix, as with alginate hydrogels, will remain 
essential for facilitating the diffusion of nutrients within the proposed TE-IVD. As 
shown in chapter 4, the appropriate combination of cell contents in dense matrices will 
require further studies to enhance the resulting AF architecture in TE-IVDs with 
regional variations of remodeling, thereby improving tissue composition and function. 
 Co-culture of AF and NP cells with bone-marrow derived MSCs has been 
extensively shown to enhance the maturation of engineered tissues in vitro. Future 
studies of TE-IVDs with hMSCs could employ formulaic combinations of cells derived 
from partial and/or total discectomies in patients and commercially available hMSCs to 
effectively obtain a sufficient number of cells to populate human-sized TE-IVDs. The 
basis for the proposed study has been previously attempted in our group with the 
isolation of hMSCs from bone marrow aspirate. The advantage in this case would be 
that AF and NP tissues will help guide the formation of relevant ECM due to cell-cell 
signaling in concert with the already characterized cell-material interactions.
 Hybrids of synthetic fibers embedded in collagen gels represent a potential 
avenue to develop novel AF scaffold designs. Previous work had employed hybrids of 
synthetic fibers and hydrogels, such as silk and fibrin gel scaffolds of Park et al., while 
others have artificially recreated the AF architecture with PGA/PLA or PCL alone 
without accounting for the developmentally-inspired remodeling observed in collagen-
based AF scaffolds. In this context, a hybrid scaffold that employs resorbable fibers 
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(e.g. PLGA) with an initially laminated architecture and a dense-collagen matrix 
capable of cell-induced traction constitutes a new generation of composite TE-IVDs. 
The advantage of such a proposed construct relies on the opportunity to initially guide 
cell alignment with the resorbable fibers and simultaneously promoting channels for 
collagen fiber remodeling. 
Improving Canine TDR studies 
 To truly understand the performance of TE-IVDs in vivo after TDR, the 
importance of testing motion segments in torsion and in bending with implanted 
constructs cannot be overlooked. The range of motion in the cervical spine represents a 
challenge for the current generation of TE-IVDs that rely entirely on a press-fit 
implantation as in the rat tail model. Employing the digital correlation displacement 
mapping technique described in chapter 3 during torsion and bending testing ex vivo 
could help identify mechanisms of failure within motion segments that resemble the 
complex loading environment in living subjects. In addition, ex vivo testing of motion 
segments under uniaxial dynamic compression is a strongly recommended next step to 
better assess the long-term effects of unstable implantation of TE-IVDs.  
 A combined approach of treatment is still recommended for the next phase of in 
vivo testing of TE-IVDs, especially when the geometry of the endplates is considered. 
While resorbable plating served as a valuable initial step towards combining temporary 
spinal stabilization with TE-IVD integration, using flexible resorbable materials as 
physical barrier in lieu of a rigid plate could provide better outcomes in the long term.  
Lastly, the next phase for in vivo studies in canine cervical spines would need to build 
upon the acquired insights of ideal surgical conditions (i.e. implantation level) and 
optimized TE-IVD fabrication (e.g. moderately dense matrices with higher degree of 
AF remodeling). 
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 Given the number of finite element models currently used in the literature to 
describe spine biomechanics, recreating a clinically relevant simulation of mechanical 
testing of motion segments would prove beneficial to better understand distribution of 
loads in the disc space under various treatments such as the ones described in chapter 3. 
Furthermore, a computational 3D model of the alginate- and collagen- composite TE-
IVDs developed in the Bonassar Lab represents an area of interest that remains 
unexplored, which could be useful in the design of the next generation of composite TE-
IVDs. Abundant work has been done in mechanically describing alginate and collagen 
gels individually, however, little has been done to understand the extent to which these 
materials contribute to the effective stiffness observed in composite structures such as 
TE-IVDs. It is recommended here to use a framework based on biochemical constituents 
similar to that of constitutive modeling of native fibrocartilaginous tissues, especially 
with further scaling up of constructs towards human-sized TE-IVDs.  
 The ultimate goal of this research is to clinically translate the state of TE-IVD 
technology for a biologically-based TDR alternative treatment of DDD. This work 
demonstrated the feasibility of a clinically-relevant animal model of TDR to further 
study novel TE-IVD approaches. The basis for ex vivo testing of canine motion 
segments to analyze novel treatments was also proposed. Lastly, the significance of the 
appropriate content of a clinically relevant cell source in the context of capability to 
remodel dense AF scaffolds was identified. Altogether, these findings provide new 
baseline conditions from which to produce the next generation of TE-IVDs. 
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APPENDICES 
Appendix A: Scaling up the fabrication of alginate and collagen tissue-engineered 
intervertebral discs for a pre-clinical canine model3 
 Introduction 
 Whole tissue-engineered intervertebral disc (TE-IVD) scaffolds have been 
produced in the last decade as a biological alternative to treat degenerative disc disease 
(DDD). Investigators have proposed diverse approaches to construct composite 
scaffolds with distinct nucleus pulposus (NP) and annulus fibrosus (AF) regions 
designed for total disc replacement.1-6 Efforts led to in vivo studies in athymic mice and 
rats that have yielded promising results, in terms of tissue integration, biochemical 
composition, and mechanical function.5,7 However, small animal models limit the 
composite TE-IVDs to a different biomechanical environment from what occurs in the 
human spine and have a considerably different anatomy. To date, a larger animal model 
with comparable loading patterns and anatomical features remain to be studied. Small 
breeds of dogs develop spontaneous cervical disc degeneration and have been used as 
animal models for biomechanical studies of disc diseases and surgical procedures.8-10 
The current work seeks to utilize our previously established methods2 to scale up the 
manufacture of composite alginate and collagen TE-IVDs for a canine cervical spine 
model and characterize the mechanical and morphological properties of canine-sized 
TE-IVDs. 
Materials and Methods 
 Direct measurements of the C2/C3 and C3/C4 IVDs were obtained from three-
year old beagles and the dorsoventral, lateral-lateral, and disc height dimensions were 
used to create customized models of molds with NP-sized cavities in Solid Works. The 
                                                 
3 Portions of this appendix were published in the Transactions of the Orthopaedic Research Society 
Annual Meeting in 2014, New Orleans, LA: Jorge A. Mojica-Santiago, Peter Grunert, MD, Roger Hartl, 
MD, Lawrence J. Bonassar, PhD. Fabrication of canine-sized alginate/collagen tissue-engineered 
intervertebral discs. http://www.ors.org/Transactions/60/0732.pdf 
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CAD mold models were fabricated in UV-cured acrylic plastic using 3D printing 
technology. Four groups of TE-IVDs were produced by varying the size of the disc and 
the number of AF layers.2 NP and AF cells were isolated from the lumbar spine of 
skeletally mature Finn/Dorset cross male sheep and cultured for 3 weeks. NP cells were 
encapsulated in 3% alginate and injected into the molds to produce NP scaffolds, while 
AF cells were seeded in 2mg/mL solution of collagen type I gel to create the AF layers. 
Two groups consisted of double-layered discs - mold cavity dimensions were 1:1 and 
3:4 of the CAD model - and a group of single layered discs. The composite discs were 
cultured for 2-4 weeks and disc size measurements were taken twice a week using 
ImageJ to measure the annular contraction and the NP/AF ratio. Samples were tested 
under unconfined axial compression using multi-step stress relaxation methods, and the 
instantaneous and equilibrium moduli were obtained to assess their viscoelastic 
response.11 Statistical significance in all results was determined at a 95% level of 
confidence with a p-value lower than 0.05, using a single factor analysis of variance 
followed by a post-hoc Scheffé Test. 
Results 
 The single-layered discs had significantly greater ratios of NP:AF (0.6±0.1 %) 
than both double-layered groups by the end of the culture period (Fig.1, right). A 
contraction ranging from 13.8 to 17.9% of the original size was observed in both single-
layered and double-layered TE-IVDs by the first week (Fig.1, left). With a mean 
equilibrium modulus of 1.4±0.6 kPa, the large double-layered discs resulted 
significantly greater than the 0.3±0.2 kPa of the single-layered group, but there were no 
significant differences between the mean equilibrium modulus of small double-layered 
discs (0.7±0.6 kPa) and the other groups (Fig.2, right). Within the double-layered 
groups, the large discs presented a significantly greater instantaneous modulus (2.1±0.9 
kPa) than their 25% smaller counterparts, which yielded mean modulus values of 
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1.0±0.7 kPa (Fig.2, left). The mean elastic modulus of the single layered discs (0.4±0.1 
kPa) resulted significantly different to the large multilamellar disc only. 
 
Appendix Figure 1. Disc ratio to the initial area (left) was significantly decreased 
between time points (#, p < 0.05) after 1 week in all groups, and significant differences 
in contraction (*, p< 0.05) were found in 1Layer discs at 1.5 weeks and 2Layer at 2 
weeks, when compared to each other. At week 2, NP ratio to the total area (right) was 
significantly greater in 1Layer large discs than in both double layered discs (bars, p < 
0.05), but the 2Layer discs were closer to native disc morphology. Data shown as mean 
± standard deviation. 
 
Appendix Figure 2. (Left) 2Layer large discs under uniaxial compression showed 
significantly higher effective Eq. Mod. and Inst. Mod. (bars, p < 0.05) than their single 
layered counterparts and the 2Layer small discs but showed no significant differences 






Appendix Figure 3. Biochemical composition of the TE-IVDs changed significantly 
with the addition of a collagen AF layer. Cell proliferation was generally improved in 
the NP of smaller discs (top left) as indicated by DNA content, but 1Layer small discs 
showed significantly less DNA content (bars, p < 0.05) than all other groups (top right). 
Collagen and proteoglycan deposition in the AF of 1Layer large discs surpassed that of 
all other groups (bars, p < 0.05, left side of middle and bottom). Smaller discs with 
double-AF revealed increased GAGs at the NP (middle right) than their 1Layer 
counterparts and showed significantly greater collagen content than all large discs 





 The present studies showed that canine-sized composite TE-IVDs can be 
successfully produced by the same methods used for our in vivo rat TE-IVDs [7]. The 
implants were based of direct measurements from beagle IVDs and their size and shape 
were comparable to their native counterparts. Composite discs with double layers 
showed higher mechanical properties than those with a single layer, but they also exhibit 
lower NP:AF ratios than their mono-layered counterparts. The addition of collagen-
based AF layers coupled with a decrease of the NP:AF ratio accounts for the production 
of stiffer implants, and thus provided valuable insights with respect to how differences 
in fabrication parameters have an effect in the compressive properties of the tissue-
engineered constructs. Fundamentally, the low relative stiffness of alginate-based NP 
can reduce the effect of the overall composite stiffness as its relative volume increases. 
Therefore, in the design and scale up of alginate/collagen composite TE-IVDs, the 
morphological and composition characteristics allow modifying the construct properties 
to desired conditions. 
 This work demonstrates the use of established fabrication methods of composite 
alginate/collagen TE-IVDs, which have proven successful in rat in vivo models, as a 
scalable process to construct canine-sized cervical TE-IVDs. Such a large animal model 
with comparable morphology and biomechanical environment to human spine is 
required to translate this technology to clinical use as an alternative to total disc 




Appendix Table 1. Summary of NP area ration, mechanical properties and 
biochemical composition measurements in two distinct sizes of TE-IVDs with 1 and 2 
AF layers. The dotted box highlights the group corresponding to the design conditions 
selected for the subsequent in vivo study, particularly due to the highest cell content 
achieved. Data statistics shown as mean ± standard deviation. 
References 
1. Nesti+ Tiss Eng Pt A 2008;  
2. Bowles+ Tiss Eng Pt A 2010;  
3. Nerurkar+ Spine 2010;  
4. Lazebnik+ J Tiss Eng Regen Med 2011;  
5. Zhuang+ Biochem Biophys Res Commun 2011;  
6. Park+ Tiss Eng Pt A 2012;  
7. Bowles+ PNAS 2011;  
8. Shores+ Comp Cont Educ Pract Vet 1982;  
9. Smith+ Eur Spine J 2002;  
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Appendix B: Riboflavin crosslinking and high-density collagen enhance 
mechanical and biochemical properties of tissue-engineered intervertebral discs4 
Introduction 
 Composite tissue-engineered intervertebral disc (TE-IVD) scaffolds with 
distinct nucleus pulposus (NP) and annulus fibrosus (AF) regions have been produced 
in the last decade as a proposed biological alternative to total disc replacement with 
synthetic implants.1-6 TE-IVDs that have been tested in vivo with murine models 
provided promising outcomes;5,7 however, these small animal models differ from the 
human spine in loading patterns and anatomical features. Current efforts have focused 
on evaluating the TEIVDs in a canine cervical spine model; thus, a scaled-up approach 
of fabricating composite alginate and collagen TE-IVDs has been characterized.8 In 
order to restore the biomechanical function of the spinal motion segment, the stiffness 
of the TE-IVDs must be increased to withstand significantly high compressive loads in 
vivo. Riboflavin has been shown to effectively crosslink collagen gels9 and increase gel 
stiffness without affecting cell viability. High density collagen gels have also been 
shown to help mechanically repair annular defects in vivo and vitro.10 This work seeks 
to examine the effect of scaffold density and crosslinking on the mechanical and 
biochemical properties of TE-IVDs. 
Materials and Methods 
 NP and AF cells were isolated from the cervical spine of skeletally mature 
beagles and cultured for 2 weeks. NP cells were encapsulated in 3% alginate and 
injected into the molds to produce NP scaffolds, while AF cells were seeded in 2mg/mL 
solution of collagen type I gel to create the AF layers. Two groups of TE-IVDs were 
                                                 
4 Portions of this appendix were published in the Transactions of the Orthopaedic Research Society 
Annual Meeting in 2015, Las Vegas, NV: Jorge A. Mojica-Santiago, Yu Moriguchi, MD-PhD, Peter 
Grunert, MD, Roger Hartl, MD, Lawrence J. Bonassar, PhD. Effect of Scaffold Density and Crosslinking 




produced using previously shown methods2 by varying the size of disc and four 
subgroups were fabricated: double AF layer low density collagen (LDC) at 2 mg/mL, 
riboflavin-crosslinked LDC discs (LDC+Ribo) at 0.5 mM, double AF layer high density 
collagen (HDC) at 4 mg/mL, and riboflavin-crosslinked HDC discs (HDC+Ribo) at 
0.5mM. All groups were cultured for 2 weeks and tested using multi-step stress 
relaxation tests with unconfined axial compression to determine instantaneous (IM) and 
equilibrium moduli (EM).11 NP and AF scaffold regions were individually examined 
for DNA, proteoglycan (GAG), and collagen (Hypro) composition using conventional 
biochemical assays.12-14 Statistical significance in all results was determined at a 95% 
level of confidence with a p-value lower than 0.05, using a single factor analysis of 
variance followed by a post-hoc Scheffé Test. 
 
Appendix Figure 4. To examine the effect of scaffold density and crosslinking with 
riboflavin on the mechanical and biochemical properties of canine TE-IVDs, a total of 
eight groups were examined after 2 weeks of culture. The diagram (left) shows the steps 
followed to induce collagen crosslinking in TE-IVDs, whereas the table (right) shows 
the experimental design layout to summarize varied conditions. 
Results 
 The LDC subgroup of large discs had nearly three times the equilibrium modulus 
(EM) (1.7±0.5 kPa) of their smaller counterparts with similar density and showed higher 
EM than large discs with HDC [Figure 5, top right]. No significant differences were 
observed between all other subgroups of small discs and large discs and in the 
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instantaneous modulus (IM) of all groups [Figure 5, top left]. Smaller discs with only 
LDC favored cell proliferation at NP region greater than in all other groups [Figure 5, 
bottom right]; however, the AF showed significantly greater DNA content in small discs 
with HDC + Ribo than in all but the small discs LDC group [Figure 5, bottom left]. 
Production of GAG and collagen in the AF was not statistically different across all 
groups. [Figure 6, left side in top and bottom rows]. Nevertheless, GAG production 
increased significantly in the NP of large discs with un-crosslinked highly dense AF 
scaffolds (HDC + Ribo) [Figure 6, top right]. Collagen production was notably 




Appendix Figure 5. Effective compressive properties (top row) of whole discs and cell 
proliferation metrics (bottom) at the NP and AF regions of the TE-IVDs. Dotted line 
refers to properties measured in previous work for comparison purposes. Bars indicate 
statistically significant differences between group pairs at both ends of the bar. Data 





Appendix Figure 6. Biochemical composition of the ECM in TE-IVDs assessed by 
proteoglycan content (GAG, top row) and collagen content (Hypro, bottom row) 
separated by NP and AF regions. Bars indicate statistically significant differences 
between group pairs at both ends of the bar. Data shown as mean ± standard deviation. 
Discussion 
 The present studies showed that the GAG composition in the NP of canine-sized 
composite TE-IVDs can be successfully improved by riboflavin-crosslinking and high-
density collagen approaches. In equilibrium, size of the composite disc was shown to 
have the most effect on effective compressive stiffness than other variables. Notably, 
crosslinking of a collagen scaffold with double AF density increased the compressive 
properties in most small discs to that of large discs. This contrasts with previous studies, 
where bi-layered large discs showed greater effective stiffness than bi-layered small 
discs. The combination of high density collagen with riboflavin also increased cell 
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density at the AF of small discs, although the decreased matrix deposition in the NP of 
all other groups suggests that localized effects occur from these treatments. Likely, a 
denser crosslinked scaffold effectively reduces diffusion of metabolites through the AF 
thereby affecting cell proliferation and subsequent matrix production at the NP.  
 Utilizing chemically-driven crosslinking and denser scaffolds appear to have 
greater effect on biochemical properties of the TE-IVDs. This work demonstrates the 
use of established methods to evaluate crosslinking and scaffold density changes on a 
composite alginate and collagen TE-IVD, which have proven successful in rat in vivo 
models. Characterizing the effects of these approaches in canine-sized constructs helps 
to further develop a pre-clinical cervical spine model. 
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Appendix C: MATLAB codes for data analysis and figure plots  
 
Viscoelasticfit.m for motion segment analysis  
 
%Input Initialization 




filename = '8-24-16S1C34TEIVD+' 
%filename = '10mg0M_01-22-18_4' 
string = sprintf('%s Model Fit 
Summary.txt',filename); 
diary(string) 
fprintf('Initialized data: \n') 
rawdata = 
importdata(sprintf('%s.txt',filename)); 
time = rawdata.data(:,2); 
% disp = rawdata.data(:,3); 
% load = rawdata.data(:,4); 
disp = rawdata.data(:,4); 
load = rawdata.data(:,5); 
% thickness = 1.74 
% diameter = [8.51;9.61] 
% offset = 0 
% %don't use less than 5 steps: 
% steps = offset-
thickness*[.05,.1,.15,.2,.35,.45]' 
% start = [-1;10;-.005] 
thickness = 1.7; 
diameter = [11.69;14.66]; 
steps = -1*[0,.085,.17,.255,.34]'; 
offset = 0; 
start = [-10;100;-5]; 
%------------------------------------------------------
-------------------% 













fprintf('Estimated coefficients for each step: 
\n') 









%%modelfit = fittype('a - exp(-time/tau) + 
b','dependent',{'load'},'independent',{'time'},'co
efficients',{'a','b','tau'},'options',fo); 
for j = 1:length(steps) 
    stepload{1,j} = 
load(ismembertol(disp,steps(j))); 
    steptime{1,j} = 
time(ismembertol(disp,steps(j)))-
min(time(ismembertol(disp,steps(j)))); 
    %stepload{1,j} = load(disp == steps(j)); 
    %steptime{1,j} = time(disp == steps(j))-
min(time(disp == steps(j))); 
    %[loadfit,gof{k},output{k}] = 
fit(steptime{1,k},stepload{1,k},modelfit) 




    %loadcoeffs(:,k) = loadfit.Coefficients; 
    loadfit = 
fitnlm(steptime{1,j},stepload{1,j},modelFun,st
art) 
    subplot(length(steps)-
2,2,j+2),scatter(steptime{1,j},stepload{1,j},10,'
filled','DisplayName','data'); 
    hold on 
    
plot(steptime{1,j},predict(loadfit,steptime{1,j}
),'LineWidth',2,'DisplayName','fit'); 
    xlabel('time [s]'),ylabel('load [N]'); 
    
legend('Location','southeast'),legend('boxoff'); 
    hold off 







%Visualization of Stress vs. Strain & Load vs. 
Displacement Curves 
strain = (steps-offset)/thickness; 



















xlabel('disp [mm]'),ylabel('load [N]'); 
legend('Location','northwest'),legend('boxoff'); 
hold off 







Mechanova2.m for repeated measures ANOVA of motion segment mechanics 
 
%These are some of the linear and mixed 
effects models attempted at first, 
%but given the lack of significance of added 
effects and similar 
%significance from the repeated measures 
model, the former weren't used. 




% m2 = 
fitlme(mechanics,'EqMod~Condition+Level+C
ondition:Level+(1|Spine)'); 
% m3 = 
fitlme(mechanics,'EqMod~Condition+(1|Level
)'); 




%This model was adapted from the 
Longitudinal Data Ranova Example: 
%The raw data is entered as a table into matlab 
and the desired response 
%is selected from the column. In this case, the 
eq. stiffness ratio is 
%registered for 12 specimens measured at 3 
consecutive experimental  
%conditions (Dx,Plate-,Plate+). Experimental 
conditions are considered as  
%repeated measures (within subjects), and 
specimens are grouped into 
%3 categories (C2/3 to C4/5) each sourced 
from 4 independent spines. 
  
mechanics = readtable('Matlab 
Mechanics.xlsx'); 

































%Graph boxplots of the data with relevant p-
values. Requires to look at the 
%pairwise comparisons first before deciding 
where to add the significant 











title('Ratio of stiffness relative to intact 
segment by experimental 
condition','FontSize',14), 
ylabel('\bf Stiffness Ratio [kN-m/kN-
m]','FontSize',14),ylim([0 0.5])  
ax = gca; ax.XAxis.LineWidth = 2.5; 
ax.YAxis.LineWidth = 2.5; 
ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
ax.XAxis.FontSize = 14; ax.YAxis.FontSize = 
14; 
ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
p = pairwisecond.pValue; 
str1 = {sprintf(' $ p = %.3f ',p(2)),sprintf(' $ p = 
%.3f \n * p = %.3f ',p(2),p(4)),sprintf(' * p = 
%.3f ',p(4))}; 
str2 = {sprintf(' N = %2.0f 
',length(EqStiffRatiomatrix))}; 
locx = [1,2,3]; 
locy = [max(EqStiffRatiomatrix)]; 
text(locx,locy + 
0.025,str1,'FontWeight','bold','FontSize',14); 









AllMechTable.m for mechanical analysis of TE-IVD mechanics 
 
%Viscoelastic & Holmes-Mow fits for unconf 
comp multistep stress relaxdata% 
filename = '20mgMechData.xlsx'; 
rawdata = importdata(filename);             %load 
raw data spreadsheet into  
                                            %structure of 
matrix arrays 
size(rawdata.data); 
ncols = size(rawdata.data,2); 
nrows = size(rawdata.data,1); 
SpecMat = rawdata.data(:,1:6:ncols); 
CollMat = rawdata.data(:,2:6:ncols); 
CellMat = rawdata.data(:,3:6:ncols); 
Time = rawdata.data(:,4:6:ncols); 
Pos = rawdata.data(:,5:6:ncols); 
Load = rawdata.data(:,6:6:ncols); 
%dxMat = diff(Pos);                          %height 
change row(i+1)-row(i) 
%dtMat = diff(Time);                         %time 
change row(i+1)-row(i) 
%Rate = dxMat./dtMat;                        
%calculate strain rate per elm 
  
%initialize values of height and two diameters 
in mm 
%these values correspond to 4mg/ml samples 
% height = [1.74,1.21,1.6]; 
% dMat = [11.56,14.36,11.25]; 
% dMat(2,:) = [12.98,9.08,15.64]; 
%these values correspond to 10mg/ml samples 
% height = 
[2.24,1.5,2.48,1.74,1.68,1.3,1.26,1.92,1.78,2.2,
1.83,1.24,... 
%    1.18,1.82,3,2,2,1.97,1.34,2.24,2.72,1.78]; 
% dMat = 
[8.8,8.4,8.19,9.61,11.45,5.42,12.08,9.54,12.49,
13.17,11.34,... 
%    
9.23,11.16,11.52,7,6.5,6.3,5.26,8.13,6.65,5.77,
4.53]; 





%    
11.39,11.56,10.76,7,7.4,6.8,5.09,10.19,6.29,5.4
6,4.93]; 
%these values correspond to 20mg/ml samples 
% height = 
[2.4,2.1,1.66,2.5,1,2.01,2.7,2.29,2.3,1.3,1.62,2.
56,2,1,1,3,... 
%     2.8,2.8,2.06,1.5,1.92]; 
% dMat = 
[7.8,8.54,7.94,8.8,14,13.73,12.4,14.58,12.74,1
3.35,13.43,13.8,... 
%     
11.56,13.75,13.75,8,7.5,8,11.72,16.01,12.74]; 
% dMat(2,:) = 
[7.8,8.54,7.94,8.8,13,12.38,15.01,15.23,14.69,
13.25,14.24,... 
%     
13.65,12.37,13.75,13.75,10,9,9,13.51,13.29,15.
06]; 
%these values correspond to 60mg/ml samples 
(actual native IVDs) 
% height = [4,5,5,5]; 
% dMat = [14,14.6,14.6,13.34]; 
% dMat(2,:) = [12,13,14.3,12.6]; 
  
hMat = repmat(height,nrows,1); 
Pos0 = (Pos-Pos(1,:)); 
StrainMat = (Pos-Pos(1,:))./hMat; 
Davg = mean(dMat); 
AMat = 
repmat(.25*pi*power(Davg,2),nrows,1); 
%matrix of ref. config. area 
PMat = (Load-Load(1,:))./AMat;               
%1stP-K stress matrix in MPa 
steps = [.05,.1,.15,.2,.25,.3,.35,.4,.45,.5]; 
nsteps = length(steps); 
% TimeSteps = cell(length(steps),no_samples); 
% StrainSteps = 
cell(length(steps),no_samples); 
% LoadSteps = cell(length(steps),no_samples); 
% PSteps = cell(length(steps),no_samples); 
% coeff = cell(size(TimeSteps)); 
% R2 = cell(size(TimeSteps)); 
% instress = cell(1,no_samples);tau = 
cell(1,no_samples); 
% eqstress = cell(1,no_samples);plotR2 = 
cell(1,no_samples); 
% strain = cell(1,no_samples);stretch = 
cell(1,no_samples); 
% A = cell(size(TimeSteps)); 
% B = cell(size(TimeSteps)); 
% C = cell(size(TimeSteps)); 
% EMcoeff = cell(1,no_samples); 
% EMR2 = cell(1,no_samples); 
% permstress = cell(1,no_samples);Ha = 
cell(1,no_samples); 
% perm = cell(1,no_samples); 
% Kcoeff = cell(1,no_samples); 
% KR2 = cell(1,no_samples); 
  
%data parsing and rearranged until here, next 
comes the splitting into the 
%individual steps for each one of the tested 
samples 
%no_samples = size(PMat,2);                   
%total no. of samples or last sample of interest 
from the spreadsheet 
%you may start the counter j with whichever 
sample graph you want to see,or 
%enter 1 if you are plotting all samples 
(requires high processing power) 
sample1 = inputdlg('Enter no. of the first 
sample to plot'); 
sample1 = str2double(sample1); 
no_samples = inputdlg('Enter no. of last 
sample in the range of interest'); 
no_samples = str2double(no_samples); 
for j = sample1:no_samples 
    for i = 1:nsteps 
        TimeSteps{i,j} = Time(ismembertol(-
StrainMat(:,j),steps(i),1e-2,'DataScale',1),j); 
        TimeSteps{i,j} = TimeSteps{i,j} - 
min(TimeSteps{i,j}); 
        StrainSteps{i,j} = 
StrainMat(ismembertol(-
StrainMat(:,j),steps(i),1e-2,'DataScale',1),j); 
        LoadSteps{i,j} = Load(ismembertol(-
StrainMat(:,j),steps(i),1e-2,'DataScale',1),j); 
        PSteps{i,j} = (1e3)*PMat(ismembertol(-
StrainMat(:,j),steps(i),1e-2,'DataScale',1),j); 
    end 
end 
for j = sample1:no_samples 
    figure('Name',sprintf('Load vs. time for 
e/step in sample %d',j)), 
    fig = gcf;fig.OuterPosition = [-
5.5,34.5,1381,885];hold on 
    for i = 1:nsteps 
        
subplot(ceil(nsteps/2),2,i),scatter(TimeSteps{i,j
},LoadSteps{i,j}) 
        xlabel('Time [s]'),ylabel('Load 
[N]'),title(sprintf('step %d',i)); 
    end 
    hold off 






%questdlg('Would you like to continue to 
perform poroviscoelastic step fits?'); 
w = warndlg('Continue to perform individual 
steps model fits.', 'Continue?'); 
drawnow                                    % Necessary to 
print the message 
waitfor(w); 
  
%proceed to perform the individual fits using 
the poroviscoelastic model  
%Aj*exp(Bj*x)+Cj similar to A(1-exp(-
t/tau)+B, where Aj=-A (lastpt-1stpt), 
%B=-1/tau (random guess- alginate has 
tau~=3-6), C=A+B (~=last pt of curve) 
poroviscFun = 'A*exp(B*x)+C'; 
poroviscfit = 
fittype(poroviscFun,'coefficients',{'A','B','C'}); 
for j = sample1:no_samples 
    figure('Name',sprintf('Stress vs. time model 
fits for e/step sample %d',j)), 
    fig = gcf;fig.OuterPosition = [-
5.5,34.5,1381,885];  %shows full screen 
    for i = 1:nsteps 
        guessA = -PSteps{i,j}(size(PSteps{i,j},1)-
5)+PSteps{i,j}(1); 
        guessB = -.05; 
        guessC = PSteps{i,j}(size(PSteps{i,j},1)-
5); 
        [f1,good1] = 
fit(TimeSteps{i,j},PSteps{i,j},poroviscfit,'Start
Point',[guessA,guessB,guessC]); 
        coeff{i,j} = coeffvalues(f1); 
        R2{i,j} = good1.rsquare; 
        
subplot(ceil(nsteps/2),2,i),scatter(TimeSteps{i,j
},PSteps{i,j}); 
        hold 
on,plot(TimeSteps{i,j},f1(TimeSteps{i,j}),'rx-
'); 
        xlabel('Time [s]'),ylabel('Stress 
[kPa]'),title(sprintf('step %d',i)); 
        legend('Raw Data','A*exp(B*x)+C')     
    end 
    hold off 




w = warndlg('Continue to stress-strain and 
perm-strain plots.', 'Continue?'); 
drawnow      
waitfor(w); 
  
%plot the eq.stress, inst. stress and perm. as a 
function of strain 
for j = sample1:no_samples 
    figure('Name',sprintf('Stress vs. strain for 
sample %d',j)), 
    fig = gcf;fig.OuterPosition = [-
5.5,34.5,1381,885]; 
    for i = 1:nsteps 
        A{i,j} = coeff{i,j}(1); 
        B{i,j} = coeff{i,j}(2); 
        C{i,j} = coeff{i,j}(3); 
    end 
    instress{:,j} = 
cellfun(@minus,C(1:nsteps,j),A(1:nsteps,j)); 
    tau{:,j} = cellfun(@rdivide,num2cell(-
ones(nsteps,1)),B(1:nsteps,j)); 
    eqstress{:,j} = 
cellfun(@minus,num2cell(zeros(nsteps,1)),C(1
:nsteps,j)); 
    strain{:,j} = -
cellfun(@mean,StrainSteps(1:nsteps,j)); 
    stretch{:,j} = 1-strain{:,j}; 
    plotR2{:,j} = [R2{:,j}]'; 
     
    
subplot(3,1,1),plot([strain{:,j}],[eqstress{:,j}],'
o-') 
    xlabel('Strain'),ylabel('Stress [kPa]'),title('Eq. 
Stress vs. Strain'); 
    for i = 1:length(strain{:,j}) 
        
text(strain{:,j}(i),eqstress{:,j}(i),sprintf('\nR^2 
= %1.2f',plotR2{:,j}(i))) 
    end 
    
subplot(3,1,2),plot([strain{:,j}],[instress{:,j}],'x
-') 
    xlabel('Strain'),ylabel('Stress 
[kPa]'),title('Inst. Stress vs. Strain'); 
    subplot(3,1,3),plot([strain{:,j}],[tau{:,j}],'+-
')   
    xlabel('Strain'),ylabel('Tau [sec]'),title('Tau 
vs. Strain');     
     
    %checkpoint asking if the figs. and pts. are 
adequate and reasonable 
    check1 = questdlg('Do you want to exclude 
any step points?','Check plots'); 
    while strcmp(check1,'Yes') == 1 
        prompt1 = (['Enter the step points you 
want to exclude' newline... 
            '(in column vector if more than one 
point [#;#;#])']); 
        dlg_title1 = 'Exclude steps'; 
        ans1 = inputdlg(prompt1,dlg_title1); 
        ans1 = str2num(ans1{:}); 
        if isempty(ans1) == 1 
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            return; 
        elseif any(ans1) < 1  
            error('You entered a step point that does 
not exist, please try again'); 
            return; 
        elseif any(ans1) > nsteps 
            error('You entered a step point that does 
not exist, please try again'); 
            return; 
        else 
            instress{:,j}(ans1) = []; 
            tau{:,j}(ans1) = []; 
            eqstress{:,j}(ans1) = []; 
            strain{:,j}(ans1) = []; 
            stretch{:,j}(ans1) = []; 
            plotR2{:,j}(ans1) = []; 
             
            fig; 
            
subplot(3,1,1),plot([strain{:,j}],[eqstress{:,j}],'
o-') 
            xlabel('Strain'),ylabel('Stress 
[kPa]'),title('Eq. Stress vs. Strain'); 
            for i = 1:length(strain{:,j}) 
                
text(strain{:,j}(i),eqstress{:,j}(i),sprintf('\nR^2 
= %1.2f',plotR2{:,j}(i))) 
            end 
            
subplot(3,1,2),plot([strain{:,j}],[instress{:,j}],'x
-') 
            xlabel('Strain'),ylabel('Stress 
[kPa]'),title('Inst. Stress vs. Strain'); 
            
subplot(3,1,3),plot([strain{:,j}],[tau{:,j}],'+-')   
            xlabel('Strain'),ylabel('Tau 
[sec]'),title('Tau vs. Strain'); 
             
            check1 = questdlg('Do you want to 
exclude any step points?','Check Plots'); 
        end 
    end 




w = warndlg('Continue to choose linear region 
for elastic mod.', 'Continue?'); 
drawnow      
waitfor(w); 
  
%Choose the linear region for modulus 
calculations inst. and in eq. 
for j = sample1:no_samples 
    figure('Name',sprintf('Linear stress-strain for 
sample %d',j)), 
    fig = gcf;fig.OuterPosition = [-
5.5,34.5,1381,885]; 
    check2 = 'Yes'; 
    while strcmp(check2,'Yes') == 1 
        
subplot(2,1,1),plot([strain{:,j}],[eqstress{:,j}],'
o-') 
        xlabel('Strain'),ylabel('Stress 
[kPa]'),title('Eq. Stress vs. Strain'); 
        for i = 1:length(strain{:,j}) 
            
text(strain{:,j}(i),eqstress{:,j}(i),sprintf('\nR^2 
= %1.2f',plotR2{:,j}(i))) 
        end 
        prompt2 = {sprintf('Enter lower bound of 
the linear region for sample %d',j),... 
            sprintf('Enter upper bound of the linear 
region for sample %d',j)}; 
        dlg_title2 = 'Choose linear region'; 
        num_lines = 1;def_ans = 
{'1',num2str(length(strain{:,j}))}; 
        ans2 = 
inputdlg(prompt2,dlg_title2,num_lines,def_ans
); 
        lims = str2double(ans2); 
        if lims(1) > lims(2) 
            error('You have entered a step point 
that does not exist, please try again'); 
            return 
        elseif lims(2) > 
cellfun(@str2num,def_ans(2)) 
            error('You have entered a step point 
that does not exist, please try again'); 
            return 
        end 
        [f2,good2] = 
fit(strain{:,j}(lims(1):lims(2)),eqstress{:,j}(lim
s(1):lims(2)),'poly1'); 
        EMcoeff{:,j} = coeffvalues(f2); 
        EMR2{:,j} = good2.rsquare; 
        
fig;subplot(2,1,2),scatter(strain{:,j},eqstress{:,j
},'Filled'),hold on 
        plot(f2,'rx-'),hold off 
        str1 = [newline,newline,'\sigma_{eq}=']; 
        str2 = sprintf('%3.2f',EMcoeff{:,j}(1)); 
        str3 = '\epsilon +'; 
        str4 = sprintf('(%2.2f)',EMcoeff{:,j}(2)); 
        str5 = sprintf('\nR^2 = %1.2f',EMR2{:,j}); 





            
strcat(str1,str2,str3,str4,str5),'FontSize',14); 
        xlabel('Strain, 
\epsilon'),ylabel('Compressive 
stress,\sigma_{eq} [kPa]'); 
        legend('Raw Data','Linear Elasticity Fit') 
        check2 = questdlg('Do you want to 
redefine the linear region?','Check fit'); 
    end 
    savefig(sprintf('Linear_stress-
strain_sample%d.fig',j)); 
end 
w = warndlg('Continue to fit Holmes-Mow 
permeability model.', 'Continue?'); 
drawnow      
waitfor(w); 
  
%Use Holmes-Mow hydr. permeability 






for j = sample1:no_samples 
    permstress{:,j} = eqstress{:,j}-
EMcoeff{:,j}(2); 
    Ha{:,j} = 1e3*permstress{:,j}./strain{:,j}; 
    perm{:,j} = (.25*power(Davg(:,j)*1e-
3,2))./(pi^2*Ha{:,j}.*tau{:,j}); 
    [f3,good3] = 
fit(stretch{:,j},perm{:,j},Permfit); 
    Kcoeff{:,j} = coeffvalues(f3); 
    KR2{:,j} = good3.rsquare; 
    figure('Name',sprintf('Permeability vs. 
stretch for sample %d',j)), 
    fig=gcf;fig.OuterPosition = [-
5.5,34.5,1381,885]; 
    scatter(stretch{:,j},perm{:,j},'v','Filled'),hold 
on 
    plot(f3,'rx-'); 
    str1 = [newline,newline,'K =']; 
    str2 = sprintf('(%1.2e)',Kcoeff{:,j}(1)); 
    str3 = '((\lambda-0.2)/0.8)'; 
    str4 = sprintf('^{%2.2f}',Kcoeff{:,j}(2)); 
    str5 = '*exp[0.5'; 
    str6 = sprintf('(%2.2f)',Kcoeff{:,j}(3)); 
    str7 = '(\lambda^2-1)]'; 
    str8 = sprintf('\nR^2 = %1.2f',KR2{:,j}); 
    
text(median(stretch{:,j}),f3(median(stretch{:,j}
)),... 
            
strcat(str1,str2,str3,str4,str5,str6,str7,str8),'Font
Size',14); 
    xlabel('Stretch, \lambda'),ylabel('Hydr. 
Perm.,K [m^4/N-s]'); 
    legend('Raw Data','(K_0)((\lambda-
0.2)/0.8)^{\alpha}*exp[0.5*M*(\lambda^2-
1)]') 
    legend('Location','southwest') 
    hold off 
    
savefig(sprintf('HM_perm_sample%d.fig',j)); 
end 
w = warndlg('Continue to fit Holmes-Mow 
modulus stiffening model.', 'Continue?'); 
drawnow      
waitfor(w); 
  
%Use Holmes-Mow model to calculate 
stiffening coeff. and initial agg. mod. 






for j = sample1:no_samples 
    [f4,good4] = fit(stretch{:,j},-
eqstress{:,j},HMfit); 
    HMcoeff{:,j} = coeffvalues(f4); 
    HMR2{:,j} = good4.rsquare; 
    figure('Name',sprintf('Stress-stretch for 
sample %d',j)), 
    fig = gcf;fig.OuterPosition = [-
5.5,34.5,1381,885]; 
    plot(f4,'rx-',stretch{:,j},-eqstress{:,j},'o'); 
    str1 = 
[newline,newline,newline,'\sigma_{eq}=']; 
    str2 = sprintf('(%3.2f/2)',HMcoeff{:,j}(1)); 
    str3 = '(\lambda^2 - 1)'; 
    str4 = '/\lambda'; 
    str5 = 
sprintf('^{2(%2.2f)+1}',HMcoeff{:,j}(2)); 
    str6 = 
sprintf('*exp[(%2.2f)',HMcoeff{:,j}(2)); 
    str7 = sprintf('\nR^2 = %1.2f',HMR2{:,j}); 
    text(median(stretch{:,j}),-
median(eqstress{:,j}),... 
            
strcat(str1,str2,str3,str4,str5,str6,str3,']',str7),'Fo
ntSize',14); 
    xlabel('Stretch, 
\lambda'),ylabel('Compressive 
stress,\sigma_{eq} [kPa]'); 





    savefig(sprintf('Holmes-
Mow_stress_fits_sample%d.fig',j)); 
end 
% for filenames ending in .xlsx use the 
following code to save analyzed data 
save(strcat(filename(1:(end-
5)),'.mat'),'A','AMat','B','C','CellMat',... 
    
'coeff','CollMat','Davg','dMat','EMcoeff','EMR
2','eqstress','Ha',... 
    
'height','hMat','HMcoeff','HMR2','instress','Kco
eff','KR2','Load',... 
    
'LoadSteps','no_samples','nsteps','perm','permst
ress','plotR2','PMat',... 
    
'Pos','Pos0','PSteps','R2','sample1','SpecMat','st
eps','strain',... 
    
'StrainMat','StrainSteps','stretch','tau','Time','Ti
meSteps'); 
w = warndlg('Continue to create longform table 
arrays for R-Studio', 'Continue?'); 
drawnow      
waitfor(w); 
  
%Set up longform table for statistical analysis 
in R-Studio 
%Consolidate sample columns into rows with 
the column designations as shown 















    
repmat(dates(3),3,1);repmat(dates(2),2,1);repm
at(dates(4),3,1);... 
    repmat(dates(3),3,1)]; 
DateNat = [repmat(dates(2),4,1)]; 
  
load('4mgMechData.mat'); 
for j = sample1:no_samples 
    EqMod(j,:) = EMcoeff{:,j}(1); 
    EMgof(j,:) = EMR2{:,j}; 
    HM0(j,:) = HMcoeff{:,j}(1); 
    Beta(j,:) = HMcoeff{:,j}(2); 
    HMgof(j,:) = HMR2{:,j}; 
end 




T04.Collagen = string(CollMat(1,:)');T04.Cells 
= string(CellMat(1,:)'); 
T04.Date = Date04;T04.EqMod = 
M04(:,1);T04.EMgof = M04(:,2); 
T04.HM0 = M04(:,3);T04.Beta = 
M04(:,4);T04.HMgof = M04(:,5); 
figure,boxplot(M04(:,1),T04.Cells);hold on 
    
scatter([ones(3,1)],M04(:,1),'filled','LineWidth'
,5);hold off 
    title('Eq.Mod. of 4mg/mL TE-
IVDs','FontSize',14), 
    ylabel(' E_{eq} [kPa]'),xlabel('Cells, 
[M/mL]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M04(:,2),T04.Cells);hold on 
    
scatter([ones(3,1)],M04(:,2),'filled','LineWidth'
,5);hold off 
    title('Fits of E_{eq} for 4mg/mL TE-
IVDs','FontSize',14), 
    ylabel('R^2'),xlabel('Cells, [M/mL]'),ax = 
gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M04(:,3),T04.Cells);hold on 
    
scatter([ones(3,1)],M04(:,3),'filled','LineWidth'
,5);hold off 
    title('Holmes-Mow Mod. of 4mg/mL TE-
IVDs','FontSize',14), 
    ylabel(' H_{A0} [kPa]'),xlabel('Cells, 
[M/mL]'),ax = gca;  
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    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M04(:,4),T04.Cells);hold on 
    
scatter([ones(3,1)],M04(:,4),'filled','LineWidth'
,5);hold off 
    title('Stress-stiffening coeff. of 4mg/mL TE-
IVDs','FontSize',14), 
    ylabel('\bf \beta','FontSize',14),ax = gca;  
    ax.XAxis.LineWidth = 2.5; 
ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M04(:,5),T04.Cells);hold on 
    
scatter([ones(3,1)],M04(:,5),'filled','LineWidth'
,5);hold off 
    title('Fits of Holmes-Mow for 4mg/mL TE-
IVDs','FontSize',14), 
    ylabel('R^2'),xlabel('Cells, [M/mL]'),ax = 
gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
  
load('10mgMechData.mat'); 
for j = sample1:no_samples 
    EqMod(j,:) = EMcoeff{:,j}(1); 
    EMgof(j,:) = EMR2{:,j}; 
    HM0(j,:) = HMcoeff{:,j}(1); 
    Beta(j,:) = HMcoeff{:,j}(2); 
    HMgof(j,:) = HMR2{:,j}; 
end 




T10.Collagen = string(CollMat(1,:)');T10.Cells 
= string(CellMat(1,:)'); 
T10.Date = Date10;T10.EqMod = 
M10(:,1);T10.EMgof = M10(:,2); 
T10.HM0 = M10(:,3);T10.Beta = 
M10(:,4);T10.HMgof = M10(:,5); 
figure,boxplot(M10(:,1),T10.Cells);hold on 
    
scatter([ones(4,1);ones(2,1)*2;ones(4,1)*3;one
s(4,1)*4;ones(8,1)*5],... 
        M10(:,1),'filled','LineWidth',5);hold off 
    title('Eq.Mod. of 10mg/mL TE-
IVDs','FontSize',14), 
    ylabel(' E_{eq} [kPa]'),xlabel('Cells, 
[M/mL]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M10(:,2),T10.Cells);hold on 
    
scatter([ones(4,1);ones(2,1)*2;ones(4,1)*3;one
s(4,1)*4;ones(8,1)*5],... 
        M10(:,2),'filled','LineWidth',5);hold off 
    title('Fits of E_{eq} for 10mg/mL TE-
IVDs','FontSize',14), 
    ylabel('R^2'),xlabel('Cells, [M/mL]'),ax = 
gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M10(:,3),T10.Cells);hold on 
    
scatter([ones(4,1);ones(2,1)*2;ones(4,1)*3;one
s(4,1)*4;ones(8,1)*5],... 
        M10(:,3),'filled','LineWidth',5);hold off 
    title('Holmes-Mow Mod. of 10mg/mL TE-
IVDs','FontSize',14), 
    ylabel(' H_{A0} [kPa]'),xlabel('Cells, 
[M/mL]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 




    
scatter([ones(4,1);ones(2,1)*2;ones(4,1)*3;one
s(4,1)*4;ones(8,1)*5],... 
        M10(:,4),'filled','LineWidth',5);hold off 
    title('Stress-stiffening coeff. of 10mg/mL 
TE-IVDs','FontSize',14), 
    ylabel('\bf \beta','FontSize',14),ax = gca;  
    ax.XAxis.LineWidth = 2.5; 
ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M10(:,5),T10.Cells);hold on 
    
scatter([ones(4,1);ones(2,1)*2;ones(4,1)*3;one
s(4,1)*4;ones(8,1)*5],... 
        M10(:,5),'filled','LineWidth',5);hold off 
    title('Fits of Holmes-Mow for 10mg/mL TE-
IVDs','FontSize',14), 
    ylabel('R^2'),xlabel('Cells, [M/mL]'),ax = 
gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
  
load('20mgMechData.mat'); 
for j = sample1:no_samples 
    EqMod(j,:) = EMcoeff{:,j}(1); 
    EMgof(j,:) = EMR2{:,j}; 
    HM0(j,:) = HMcoeff{:,j}(1); 
    Beta(j,:) = HMcoeff{:,j}(2); 
    HMgof(j,:) = HMR2{:,j}; 
end 




T20.Collagen = string(CollMat(1,:)');T20.Cells 
= string(CellMat(1,:)'); 
T20.Date = Date20;T20.EqMod = 
M20(:,1);T20.EMgof = M20(:,2); 
T20.HM0 = M20(:,3);T20.Beta = 
M20(:,4);T20.HMgof = M20(:,5); 
figure,boxplot(M20(:,1),T20.Cells);hold on 
    
scatter([ones(4,1);ones(5,1)*2;ones(4,1)*3;one
s(8,1)*4],M20(:,1),... 
        'filled','LineWidth',5);hold off 
    title('Eq.Mod. of 20mg/mL TE-
IVDs','FontSize',14), 
    ylabel(' E_{eq} [kPa]'),xlabel('Cells, 
[M/mL]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M20(:,2),T20.Cells);hold on 
    
scatter([ones(4,1);ones(5,1)*2;ones(4,1)*3;one
s(8,1)*4],M20(:,2),... 
        'filled','LineWidth',5);hold off 
    title('Fits of E_{eq} for 20mg/mL TE-
IVDs','FontSize',14), 
    ylabel('R^2'),xlabel('Cells, [M/mL]'),ax = 
gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M20(:,3),T20.Cells);hold on 
    
scatter([ones(4,1);ones(5,1)*2;ones(4,1)*3;one
s(8,1)*4],M20(:,3),... 
        'filled','LineWidth',5);hold off 
    title('Holmes-Mow Mod. of 20mg/mL TE-
IVDs','FontSize',14), 
    ylabel(' H_{A0} [kPa]'),xlabel('Cells, 
[M/mL]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M20(:,4),T20.Cells);hold on 
    
scatter([ones(4,1);ones(5,1)*2;ones(4,1)*3;one
s(8,1)*4],M20(:,4),... 
        'filled','LineWidth',5);hold off 
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    title('Stress-stiffening coeff. of 20mg/mL 
TE-IVDs','FontSize',14), 
    ylabel('\bf \beta','FontSize',14),ax = gca;  
    ax.XAxis.LineWidth = 2.5; 
ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
figure,boxplot(M20(:,5),T20.Cells);hold on 
    
scatter([ones(4,1);ones(5,1)*2;ones(4,1)*3;one
s(8,1)*4],M20(:,5),... 
        'filled','LineWidth',5);hold off 
    title('Fits of Holmes-Mow for 20mg/mL TE-
IVDs','FontSize',14), 
    ylabel('R^2'),xlabel('Cells, [M/mL]'),ax = 
gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 14; 
ax.YAxis.Label.FontSize = 14; 
    ax.XAxis.FontSize = 14; ax.YAxis.FontSize 
= 14; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
  
C04 = table2cell(T04);C10 = 
table2cell(T10);C20 = table2cell(T20); 
TCell = cat(1,C04,C10,C20);T = 
cell2table(TCell,'VariableNames',... 






    
'M04','M10','M20','T04','T10','T20','C04','C10','
C20','TCell','T'); 






AFContraction.m for analysis of pre-collected IVD and AF contraction data 
 
% Import ContractionLong.xlsx using import 
tool 
Cont = ContractionLong; 
% IVD = Cont.IVDratio; Coll = 
Cont.Collagen; Cells = Cont.Cells; 
% NP = Cont.NPratio; AF = Cont.AFrho; Day 




 NP04_2 = 
Cont.NPratio(Cont.Collagen==4&Cont.Cells=
=2); 
 AF04_2 = 
Cont.AFrho(Cont.Collagen==4&Cont.Cells==
2); 





 NP10_2 = 
Cont.NPratio(Cont.Collagen==10&Cont.Cells
==2); 
 AF10_2 = 
Cont.AFrho(Cont.Collagen==10&Cont.Cells=
=2); 






 NP10_10 = 
Cont.NPratio(Cont.Collagen==10&Cont.Cells
==10); 
 AF10_10 = 
Cont.AFrho(Cont.Collagen==10&Cont.Cells=
=10); 








 NP10_20 = 
Cont.NPratio(Cont.Collagen==10&Cont.Cells
==20); 
 AF10_20 = 
Cont.AFrho(Cont.Collagen==10&Cont.Cells=
=20); 






 NP20_2 = 
Cont.NPratio(Cont.Collagen==20&Cont.Cells
==2); 
 AF20_2 = 
Cont.AFrho(Cont.Collagen==20&Cont.Cells=
=2); 






 NP20_10 = 
Cont.NPratio(Cont.Collagen==20&Cont.Cells
==10); 
 AF20_10 = 
Cont.AFrho(Cont.Collagen==20&Cont.Cells=
=10); 






 NP20_20 = 
Cont.NPratio(Cont.Collagen==20&Cont.Cells
==20); 
 AF20_20 = 
Cont.AFrho(Cont.Collagen==20&Cont.Cells=
=20); 







    
IVD04_2(17:20),IVD04_2(21:24),IVD04_2(25
:28),IVD04_2(29:32),... 




    
NP04_2(17:20),NP04_2(21:24),NP04_2(25:28
),NP04_2(29:32),... 




    
AF04_2(17:20),AF04_2(21:24),AF04_2(25:28
),AF04_2(29:32),... 




























    
IVD10_20(13:16),IVD10_20(17:20),IVD10_2
0(21:24),IVD10_20(25:28),... 




    
NP10_20(13:16),NP10_20(17:20),NP10_20(21
:24),NP10_20(25:28),... 






    
AF10_20(13:16),AF10_20(17:20),AF10_20(21
:24),AF10_20(25:28),... 




    
IVD20_2(17:20),IVD20_2(21:24),IVD20_2(25
:28),... 




    
NP20_2(17:20),NP20_2(21:24),NP20_2(25:28
),... 




    
AF20_2(17:20),AF20_2(21:24),AF20_2(25:28
),... 




    
IVD20_10(13:16),IVD20_10(17:20),IVD20_1
0(21:24),IVD20_10(25:28),... 




    
NP20_10(17:20),NP20_10(21:24),NP20_10(25
:28),... 




    
AF20_10(17:20),AF20_10(21:24),AF20_10(25
:28),... 




    
IVD20_20(13:16),IVD20_20(17:20),IVD20_2
0(21:24),IVD20_20(25:28),... 




    
NP20_20(13:16),NP20_20(17:20),NP20_20(21
:24),NP20_20(25:28),... 




    
AF20_20(13:16),AF20_20(17:20),AF20_20(21
:24),AF20_20(25:28),... 























    
'20mg/mL_{2M}','20mg/mL_{10M}','20mg/m
L_{20M}'},'Location',... 
    
'southoutside','Orientation','horizontal','FontSiz
e',16,... 
    'FontWeight','bold');legend('boxoff') 
ylabel('Ratio of Disc Area'),xlabel('Time 
[Days]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 20; 
ax.YAxis.Label.FontSize = 20; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 20; 
    ax.XAxis.FontWeight = 'bold'; 























    
'20mg/mL_{2M}','20mg/mL_{10M}','20mg/m
L_{20M}'},'Location',... 
    
'southoutside','Orientation','horizontal','FontSiz
e',16,... 
    'FontWeight','bold');legend('boxoff') 
ylabel('NP Area in Disc [%]'),xlabel('Time 
[Days]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 20; 
ax.YAxis.Label.FontSize = 20; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 20; 
    ax.XAxis.FontWeight = 'bold'; 





















    
'20mg/mL_{2M}','20mg/mL_{10M}','20mg/m
L_{20M}'},'Location',... 
    
'southoutside','Orientation','horizontal','FontSiz
e',16,... 
    'FontWeight','bold');legend('boxoff') 
ylabel('Apparent AF density 
[mg/mL]'),xlabel('Time [Days]'),ax = gca;  
    ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.Label.FontSize = 20; 
ax.YAxis.Label.FontSize = 20; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 20; 
    ax.XAxis.FontWeight = 'bold'; 





% % mdl = 
fitlm(tbl,'IVDratio~Collagen*Cells*Day') 
% % anova(mdl) 
% [~,~,stats] = 
anovan(tbl.IVDratio,{tbl.Collagen tbl.Cells 
tbl.Day},... 
%   
'model','interaction','varnames',{'Collagen','Cell
s','Day'}) 
% [results,means] = 
multcompare(stats,'Dimension',[1 2]) 
% [results,means] = 
multcompare(stats,'Dimension',[1 3]) 
% [results,means] = 
multcompare(stats,'Dimension',[2 3]) 
% [results,means] = 
multcompare(stats,'Dimension',[1 2 3]); %3240 
multiple 
% %comparisons because 
9days*3cellconc*3collconcs. 
% sigdif = results(results(:,6)<0.05,[1:2,6]); 
% % %repeated measures cannot work due to 
unbalanced design (some days have 
% % more specimens than others) consider 
mixed-effects model instead, since 
% % three-way anova is also not useful (time 
measures are not independent) 















%     
tblrm.IVDratio(tblrm.Day==0),tblrm.IVDratio(
tblrm.Day==7),... 
%     
tblrm.IVDratio(tblrm.Day==14),tblrm.IVDrati
o(tblrm.Day==23),... 




% rmdl = fitrm(rmtable,'day0-
day23~Collagen*Cells','WithinDesign',Days); 
  
datadistplots.m for boxplots and surface graphs of global correlation analysis 
 









a = get(get(gca,'children'),'children');   % Get 
the handles of all the objects 
t = get(a,'tag');   % List the names of all the 
objects 
idx=strcmpi(t,'box');  % Find Box objects 
boxes=a(idx);          % Get the children you 
need 
set(boxes,'linewidth',2); % Set width 
set(a(strcmpi(t,'median')),'linewidth',2); % Set 
width 
set(a(strcmpi(t,'outliers')),'linewidth',5); % Set 
width 
set(a(strcmpi(t,'upper adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'upper whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'')),'fontsize',0.1); % Set boxplot 
fontsize 
set(a(strcmpi(t,'')),'color',[1 1 1]); 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 32; 
    ax.XAxis.Label.FontSize = 32; 
ax.YAxis.Label.FontSize = 32; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
xticks(ax,[1,2,3,4,5,6,7,8]);xticklabels(ax,{'2:4'
,'2:10','2:20',... 
    '5:10','10:10','10:20','20:10','20:20'}); 
% 
% Log-normalized Eq Mod vs. Cells & 








a = get(get(gca,'children'),'children');   % Get 
the handles of all the objects 
t = get(a,'tag');   % List the names of all the 
objects 
idx=strcmpi(t,'box');  % Find Box objects 
boxes=a(idx);          % Get the children you 
need 
set(boxes,'linewidth',2); % Set width 
set(a(strcmpi(t,'median')),'linewidth',2); % Set 
width 
set(a(strcmpi(t,'outliers')),'linewidth',5); % Set 
width 
set(a(strcmpi(t,'upper adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'upper whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'lower adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'lower whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'')),'fontsize',0.1); % Set boxplot 
fontsize 
set(a(strcmpi(t,'')),'color',[1 1 1]); 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 32; 
    ax.XAxis.Label.FontSize = 32; 
ax.YAxis.Label.FontSize = 32; 
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    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
xticks(ax,[1,2,3,4,5,6,7,8]);xticklabels(ax,{'2:4'
,'2:10','2:20',... 
    '5:10','10:10','10:20','20:10','20:20'}); 
% 
% Holmes-Mow Agg. Mod vs. Cells & 
Collagen Data Distribution Plot 
figure,boxplot(Mech.HM0,[Mech.Cells,Mech.
Collagen]); 






a = get(get(gca,'children'),'children');   % Get 
the handles of all the objects 
t = get(a,'tag');   % List the names of all the 
objects 
idx=strcmpi(t,'box');  % Find Box objects 
boxes=a(idx);          % Get the children you 
need 
set(boxes,'linewidth',2); % Set width 
set(a(strcmpi(t,'median')),'linewidth',2); % Set 
width 
set(a(strcmpi(t,'outliers')),'linewidth',5); % Set 
width 
set(a(strcmpi(t,'upper adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'upper whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'lower adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'lower whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'')),'fontsize',0.1); % Set boxplot 
fontsize 
set(a(strcmpi(t,'')),'color',[1 1 1]); 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 32; 
    ax.XAxis.Label.FontSize = 32; 
ax.YAxis.Label.FontSize = 32; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
xticks(ax,[1,2,3,4,5,6,7,8]);xticklabels(ax,{'2:4'
,'2:10','2:20',... 
    '5:10','10:10','10:20','20:10','20:20'}); 
% 
% Holmes-Mow Stiffening Beta vs. Cells & 









a = get(get(gca,'children'),'children');   % Get 
the handles of all the objects 
t = get(a,'tag');   % List the names of all the 
objects 
idx=strcmpi(t,'box');  % Find Box objects 
boxes=a(idx);          % Get the children you 
need 
set(boxes,'linewidth',2); % Set width 
set(a(strcmpi(t,'median')),'linewidth',2); % Set 
width 
set(a(strcmpi(t,'outliers')),'linewidth',5); % Set 
width 
set(a(strcmpi(t,'upper adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'upper whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'lower adjacent 
value')),'linewidth',2); % Set width 
set(a(strcmpi(t,'lower whisker')),'linewidth',2); 
% Set width 
set(a(strcmpi(t,'')),'fontsize',0.1); % Set boxplot 
fontsize 
set(a(strcmpi(t,'')),'color',[1 1 1]); 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 2.5; 
    ax.XAxis.FontSize = 20; ax.YAxis.FontSize 
= 32; 
    ax.XAxis.Label.FontSize = 32; 
ax.YAxis.Label.FontSize = 32; 
    ax.XAxis.FontWeight = 'bold'; 
ax.YAxis.FontWeight = 'bold'; 
xticks(ax,[1,2,3,4,5,6,7,8]);xticklabels(ax,{'2:4'
,'2:10','2:20',... 
    '5:10','10:10','10:20','20:10','20:20'}); 
% 
% 
% Import ContractionLong.xlsx using import 
tool 
Cont = ContractionLong; 
















col04 = cells04; 
cells10 = 
Mech.Cells(Mech.Collagen==10&Mech.Cells
~=5); col10 = cells10; 
cells20 = Mech.Cells(Mech.Collagen==20); 











    
mean(rhoAF(13:16)),mean(rhoAF(17:20)),mea
n(rhoAF(21:24)),... 
    mean(rhoAF(25:28))]; 
  
col04(col04==2) = avgrhoAF(1); 
col10(col10==2) = avgrhoAF(2); 
col10(col10==10) = avgrhoAF(3); 
col10(col10==20) = avgrhoAF(4); 
col20(col20==2) = avgrhoAF(5); 
col20(col20==10) = avgrhoAF(6); 





avgCol = [4,10,10,10,20,20,20]; 
% 
% Import MechDataLong.xlsx using import 
tool 
MechData = MechDataLong1; 
[sf1 gosf1] = 
fit([MechData.Cells,MechData.Collagen],Mec
hData.EM,... 
    'poly11','Exclude',[4:7,9,21,26:29,30,41]) 




    
MechData.Collagen(MechData.Collagen==4&
MechData.Cells~=0),..., 
    
MechData.EM(MechData.Collagen==4&Mech
Data.Cells~=0),50,... 




    
MechData.Collagen(MechData.Collagen==10
&MechData.Cells~=0),..., 
    
MechData.EM(MechData.Collagen==10&Mec
hData.Cells~=0),50,... 
    'MarkerEdgeColor','k','MarkerFaceColor','r') 
scatter3(MechData.Cells(MechData.Collagen=
=20&MechData.Cells~=0),... 
    
MechData.Collagen(MechData.Collagen==20
&MechData.Cells~=0),..., 
    
MechData.EM(MechData.Collagen==20&Mec
hData.Cells~=0),50,... 




ylabel('Collagen in AF 
[mg/mL]','FontSize',20); 
xlabel('MSCs in AF 
[10^6/mL]','FontSize',20),ax=gca; 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 
2.5;ax.ZAxis.LineWidth = 2.5; 
ax.XAxis.FontSize = 30; ax.YAxis.FontSize = 
30;ax.ZAxis.FontSize = 30; 
ax.XAxis.Label.FontSize = 
32;ax.YAxis.Label.FontSize = 
32;ax.ZAxis.Label.FontSize = 32; 
ax.XAxis.FontWeight = 
'bold';ax.YAxis.FontWeight = 
'bold';ax.ZAxis.FontWeight = 'bold'; 
lg = legend('4 mg/mL baseline','10 mg/mL','20 
mg/mL');legend('boxoff'); 
lg.FontWeight = 'bold';lg.FontSize = 
20;lg.Location = 'West'; 
str = sprintf('R^2 = %.2f',gosf1.rsquare); 
a = annotation('textbox',[.5 .5 .3 
.3],'String',str,'FitBoxToText','on'); 
a.LineStyle = 'none'; a.FontSize = 20; 
a.FontWeight = 'bold'; 
a.FontName = 'Times New Roman'; 
  
% Mech = MechDataLong1; 
% Mech([9,21,30,41],:) = []; 
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%     
MechData.Collagen(MechData.Collagen==4&
MechData.Cells~=0),..., 
%     
MechData.EM(MechData.Collagen==4&Mech
Data.Cells~=0),50,... 





    
Mech.Collagen(Mech.Collagen==10&Mech.C
ells~=0),..., 
    
Mech.EM(Mech.Collagen==10&Mech.Cells~
=0),50,... 
    'MarkerEdgeColor','k','MarkerFaceColor','r') 
scatter3(Mech.Cells(Mech.Collagen==20&Me
ch.Cells~=0),... 
    
Mech.Collagen(Mech.Collagen==20&Mech.C
ells~=0),..., 
    
Mech.EM(Mech.Collagen==20&Mech.Cells~
=0),50,... 




ylabel('Col density in AF, \rho 
[mg/mL]','FontSize',20); 
xlabel('MSCs in AF 
[10^6/mL]','FontSize',20),ax=gca; 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 
2.5;ax.ZAxis.LineWidth = 2.5; 
ax.XAxis.FontSize = 30; ax.YAxis.FontSize = 
30;ax.ZAxis.FontSize = 30; 
ax.XAxis.Label.FontSize = 
32;ax.YAxis.Label.FontSize = 
32;ax.ZAxis.Label.FontSize = 32; 
ax.XAxis.FontWeight = 
'bold';ax.YAxis.FontWeight = 
'bold';ax.ZAxis.FontWeight = 'bold'; 
lg = legend('10 mg/mL','20 
mg/mL');legend('boxoff'); 
lg.FontWeight = 'bold';lg.FontSize = 
20;lg.Location = 'West'; 
str = sprintf('R^2 = %.2f',gosf2.rsquare); 
a = annotation('textbox',[.5 .5 .3 
.3],'String',str,'FitBoxToText','on'); 
a.LineStyle = 'none'; a.FontSize = 20; 
a.FontWeight = 'bold'; 
a.FontName = 'Times New Roman'; 
% 
%%This is the one: 
[sf3 gosf3] = 
fit([avgCells',avgCol'],avgEM','poly11') 
figure,s1 = plot(sf3),hold on 
scatter3(MechData.Cells(MechData.Collagen=
=4&MechData.Cells~=0),... 
    
MechData.Collagen(MechData.Collagen==4&
MechData.Cells~=0),..., 
    
MechData.EM(MechData.Collagen==4&Mech
Data.Cells~=0),80,... 




    
Mech.Collagen(Mech.Collagen==10&Mech.C
ells~=0),..., 
    
Mech.EM(Mech.Collagen==10&Mech.Cells~
=0),80,... 
    'MarkerEdgeColor','k','MarkerFaceColor','r') 
scatter3(Mech.Cells(Mech.Collagen==20&Me
ch.Cells~=0),... 
    
Mech.Collagen(Mech.Collagen==20&Mech.C
ells~=0),..., 
    
Mech.EM(Mech.Collagen==20&Mech.Cells~
=0),80,... 
    
'MarkerEdgeColor','k','MarkerFaceColor','b'),h
old off; 
s1.FaceAlpha = 0.5; 
zlabel('E_{eq} [kPa]','FontSize',36); 
ylabel('Col density in AF, \rho 
[mg/mL]','FontSize',36); 
xlabel('MSCs in AF 
[10^6/mL]','FontSize',36),ax=gca; 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 
2.5;ax.ZAxis.LineWidth = 2.5; 
ax.XAxis.FontSize = 36; ax.YAxis.FontSize = 





36;ax.ZAxis.Label.FontSize = 36; 
ax.XAxis.FontWeight = 
'bold';ax.YAxis.FontWeight = 
'bold';ax.ZAxis.FontWeight = 'bold'; 
lg = legend('4 mg/mL','10 mg/mL','20 
mg/mL');legend('boxoff'); 
lg.FontWeight = 'bold';lg.FontSize = 
36;lg.Location = 'West'; 
str = sprintf('R^2 = %.2f',gosf3.rsquare); 
a = annotation('textbox',[.5 .5 .3 
.3],'String',str,'FitBoxToText','on'); 
a.LineStyle = 'none'; a.FontSize = 36; 
a.FontWeight = 'bold'; 




figure,s2 = plot(sf4);hold on, 
scatter3(cells04,col04,vecEM04,50,... 
    'MarkerEdgeColor','k','MarkerFaceColor',[0 
0.5 0]) 
scatter3(cells10,col10,vecEM10,50,... 
    'MarkerEdgeColor','k','MarkerFaceColor','r') 
scatter3(cells20,col20,vecEM20,50,... 
    
'MarkerEdgeColor','k','MarkerFaceColor','b'),h
old off; 
s2.FaceAlpha = 0.5; 
zlabel('E_{eq} [kPa]','FontSize',20); 
ylabel('App. AF density, \rho [mg 
Col/mL]','FontSize',20); 
xlabel('Cells in AF 
[10^6MSCs/mL]','FontSize',20),ax=gca; 
ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 
2.5;ax.ZAxis.LineWidth = 2.5; 
ax.XAxis.FontSize = 36; ax.YAxis.FontSize = 
36;ax.ZAxis.FontSize = 36; 
ax.XAxis.Label.FontSize = 
36;ax.YAxis.Label.FontSize = 
36;ax.ZAxis.Label.FontSize = 36; 
ax.XAxis.FontWeight = 
'bold';ax.YAxis.FontWeight = 
'bold';ax.ZAxis.FontWeight = 'bold'; 
lg = legend('4 mg/mL','10 mg/mL','20 
mg/mL');legend('boxoff'); 
lg.FontWeight = 'bold';lg.FontSize = 
36;lg.Location = 'East'; 
str = {sprintf('R^2 = %.2f',gosf4.rsquare),'Fit to 
E_{eq,avg}'}; 
a = annotation('textbox',[.5 .5 .3 
.3],'String',str,'FitBoxToText','on'); 
a.LineStyle = 'none'; a.FontSize = 36; 
a.FontWeight = 'bold'; 




figure,s3 = plot(sf5),hold on, 
scatter3(cellsAF(1:4),collAF(1:4),rhoAF(1:4),8
0,... 




    'MarkerEdgeColor','k','MarkerFaceColor','r') 
scatter3(cellsAF(17:28),collAF(17:28),rhoAF(
17:28),80,... 
    
'MarkerEdgeColor','k','MarkerFaceColor','b'),h
old off; 
s3.FaceAlpha = 0.5; 
zlabel('\rho_{AF,app} [mg/mL]','FontSize',36); 




ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 
2.5;ax.ZAxis.LineWidth = 2.5; 
ax.XAxis.FontSize = 36; ax.YAxis.FontSize = 
36;ax.ZAxis.FontSize = 36; 
ax.XAxis.Label.FontSize = 
36;ax.YAxis.Label.FontSize = 
36;ax.ZAxis.Label.FontSize = 36; 
ax.XAxis.FontWeight = 
'bold';ax.YAxis.FontWeight = 
'bold';ax.ZAxis.FontWeight = 'bold'; 
lg = legend('4 mg/mL','10 mg/mL','20 
mg/mL');legend('boxoff'); 
lg.FontWeight = 'bold';lg.FontSize = 
36;lg.Location = 'East'; 
str = {sprintf('R^2 = %.2f',gosf5.rsquare)}; 
a = annotation('textbox',[.5 .5 .3 
.3],'String',str,'FitBoxToText','on'); 
a.LineStyle = 'none'; a.FontSize = 36; 
a.FontWeight = 'bold'; 
a.FontName = 'Times New Roman'; 
  
contAF = 100*contAF; 
[sf6 gosf6]= 
fit([cellsAF,collAF],contAF,'poly11') 









    'MarkerEdgeColor','k','MarkerFaceColor','r') 
scatter3(cellsAF(17:28),collAF(17:28),contAF(
17:28),80,... 
    
'MarkerEdgeColor','k','MarkerFaceColor','b'),h
old off; 
s4.FaceAlpha = 0.5; 
zlabel('TE-IVD Size [% Original 
Area]','FontSize',36); 




ax.FontName = 'Times New Roman'; 
ax.XAxis.LineWidth = 
2.5;ax.YAxis.LineWidth = 
2.5;ax.ZAxis.LineWidth = 2.5; 
ax.XAxis.FontSize = 36; ax.YAxis.FontSize = 
36;ax.ZAxis.FontSize = 36; 
ax.XAxis.Label.FontSize = 
36;ax.YAxis.Label.FontSize = 
36;ax.ZAxis.Label.FontSize = 36; 
ax.XAxis.FontWeight = 
'bold';ax.YAxis.FontWeight = 
'bold';ax.ZAxis.FontWeight = 'bold'; 
lg = legend('4 mg/mL','10 mg/mL','20 
mg/mL');legend('boxoff'); 
lg.FontWeight = 'bold';lg.FontSize = 
36;lg.Location = 'East'; 
str = {sprintf('R^2 = %.2f',gosf6.rsquare)}; 
a = annotation('textbox',[.5 .5 .3 
.3],'String',str,'FitBoxToText','on'); 
a.LineStyle = 'none'; a.FontSize = 36; 
a.FontWeight = 'bold'; 
a.FontName = 'Times New Roman';  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
